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Abstract 
Bluetongue virus (BTY) is an orbivirus of the Reoviridae family that infects sheep and 
other ruminants. BTY has three non-structural proteins, NS I, NS2 and NS3/3A. NS I 
forms tubular structures and its function is currently unknown. To investigate the role of 
NS I in BTY infection, the interactions of NS I with mammalian and insect cellular 
proteins, and BTY viral proteins, were examined. BTY NS I was identi tied as 
interacting with aldolase A, NUBP 1, Pyruvate kinase M2, cathespin B, SUM 0-1 and 
peptide TY7 using the yeast two-hybrid system, ELISA and immunofluorescence 
analysis. TY7 and NS I caused extensive cell death within 24h of co-expression; this 
cell death was not apoptosis and reduced BTY yield by 37%. The interaction of NS I 
with SUMO-I and its importance in BTY infection was confinned using siRNA to 
knockdown SUMO-I during BTY-IO infection. Knockdown of SUMO-I elicited a 
dramatic reduction in virus yield by 73%. NS I interactions with proteins of the insect 
vector Culicoides were also examined. A putative interaction between NS 1 and the 
ubiquitin activating enzyme El (UBA EI) ofCulicoides was identified during screening 
of a phage library, this has not been confirmed by other means. NS 1 interactions with 
other BTY proteins were analysed using immunoprecipitation and a strong interaction 
between NS 1 and YP7 was identified; this was confim1ed using the yeast two-hybrid 
system and immunoflourescence. Two main roles have been hypothesised for NS I from 
this data; firstly it is likely that NS I interaction with SUMO-I and UBA E I allows the 
targeting of specific proteins for sumoylation and ubiquitination allowing NS 1 to 
modify the host response to BTY infection. Secondly it is possible that NS I serves as an 
anchor for YP7 and virus cores allowing the build up of cores at the cytoskeleton in 
close proximity to YP2 for subsequent assembly and release. RNAi against NS J 
eliminated tubule formation but did not affect virus yield or YP7 and SUMO-J 
distribution and expression. It is therefore likely that the function of NS I does not rely 
on tubule fom1ation and that tubules are a form of storage for the active monomer of 
NSI. 
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1: Introduction 
1.1: The Reoviridae 
The members of the Reoviridae family infect an extremely diverse host range including 
humans, birds, reptiles, fish, insects and plants. There are several notable human viruses 
within the Reoviridae including rotavirus and Colorado tick fever virus. Common 
characteristics of the Reoviridae are a genome of 9 to 12 dsRNA segments that usually 
encode only one major protein per segment (Attoui, Mohd Jaafar et al. 2005). Despite 
the phylogenetic relationship displayed by the genera within the Reoviridae little 
genomic sequence homology exists. 
There are currently 12 genera within the Reoviridae (Table 1.1), plus I proposed genus, 
that are composed of 75 different virus species; a further 30 virus species are as yet 
unassigned (Brussaard, Noordeloos et al. 2004; Attoui, Mohd Jaafar et al. 2005; 
Fauquet 2005). Many of the plant viruses within this family and mammalian viruses 
from the Orbivirus, Coltivirus and Seadornavirus genera are transmitted between hosts 
by arthropod vectors. Viruses from the other genera within the Reoviridae are thought 
to be transmitted horizontally and/or vertically between host organisms (Attoui, Mohd 
Jaafar et al. 2005). 
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Genus Number of Host range Example Viruses 
genome 
segments 
Rotavirus 11 Humans & other mammals Rotavirus A, B & C 
Orbivirus 10 Mammals Bluetongue Virus, 
Vector: Culicoides, African horse sickness 
mosquitoes & ViruS 
~hlebotomines 
Seadomavirus 12 Humans. Banna Virus, Kadipiro 
Vector: Mosquitoes virus 
Coltivirus 12 Humans, cattle & pigs Colorado tick fever 
Vector: Mosquitoes & ticks virus, Eyach virus 
Phytoreovirus 12 Plants Rice dwarf virus 
Vector: Cicadellidae 
Leaiboppers 
Oryzavirus 10 Plants Rice ragged stunt virus 
Vector: Fu/goridae 
Planthoppers 
Fijivirus 10 Plants Nilaparvata lugens 
Vector: Delphacid ViruS 
planthoppers 
Idnoreovirus 10 Insects Idnoreovirus 2 
Cypovirus 10 Insects Bombyx mori 
cytoplasmic 
polyhedrosis virus I 
Aquareovirus 11 Fish & molluscs Golden shiner reovirus, 
Grass carp reovirus 
Orthoreovirus 10 Mammals & birds Mammalian 
orthoreovirus 
Mycoreovirus 11 or12 Fungi Rosellina anti-rot virus, 
Cryphonectria 
parasitica reovirus 
Proposed 9 Mosquitoes 
genus: 
Dinovemavirus 
Table 1. 1: Genera within the Reoviridae family. 
In addition to the genomic similarities of the viruses within the Reoviridae a number of 
other structural traits exist. The virions are non-enveloped with concentric protein layers 
that display icosahedral symmetry and enclose the genome. There are two main types of 
core structure within this family, those with turreted cores and those with cores lacking 
17 
turrets. The turreted core viruses have 12 icosahedrally arranged turrets on the surface 
of the core and include viruses within the Orthoreovirus and Cypovirus genera (Baker, 
Olson et al. 1999; Hill, Booth et al. 1999; Attoui, Mohd laafar et al. 2005). The non-
turreted viruses have no turrets at the 5-fold axis of the icosahedral core giving a 
smoother, although sometimes bristly, appearance to the core particles and include 
viruses within the Rotavirus and Orbivirus genera (Grimes, Burroughs et (II. 1998; 
Baker, Olson et al. 1999; Attoui, Mohd laafar et al. 2005). 
1.2: Orbiviruses 
The Orbiviruses are one of the twelve genera within the Reoviridae and are non-
turreted, arthropod transmitted arboviruses. Orbiviruses are transmitted between their 
vertebrate hosts by hematophagous arthropods; these include ticks, mosquitoes and 
Culicoides species midges, the precise arthropod varies between the viruses. There are 
20 species within the orbivirus genus (Table 1.2) and within many of these are several 
serotypes (http://www.iah.bbsrc.ac.ukldsRNA virus proteins/ReoID/orbiviruses.htmn 
November 2005). The host ranges are diverse and include rodents, cattle, kangaroos, 
birds, primates and humans. The Bluetongue virus group consists of 24 different 
serotypes all displaying differential prevalence in different areas of the world. 
Bluetongue Virus (BTV) is the prototypic orbivirus and has been extensively studied, 
both at the molecular level and epidemiologically. 
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Virus Unassigned Viruses 
--
Bluetongue virus Andasibe virus 
~ 
African horse sickness virus Tracambe virus 
Palyam virus Codjas virus 
Great Island virus Ife virus 
Saint croix river virus ltupranga virus 
Eubenangee virus Arkonam virus 
Equine encephalosis virus Chobar Gorge virus j 
Epizootic haemorrhagic disease virus Fromede virus 
Changuinola virus Gomoka virus 
Corriparta virus Tracambe virus 
Lebombo virus J apanaut virus 
Orungo virus Kammavanpettal virus 
Umatilla virus Matucare virus 
Wallal virus Tembe virus 
Warrego virus Lake clarendon virus 
Kemerovo virus Ndelle virus 
Wongorr virus Paroo virus 
leri virus Picola virus 
Peruvian horse sickness virus 
Wad medani virus 
--
Table 1. 2: Species of virus within the Orbivirus genera and those not yet assigned. 
1.3: Bluetongue Virus 
BTV is an arbovirus that is vectored by the Culicoides genera of biting insects, which 
are found in many areas of the world and are potentially capable of supporting the 
spread of BTV infection to new countries. Subsequently BTV already has an economic 
impact across many areas of the world including Europe, with the most recent outbreak 
in Spain July 2005 (Purse, Mellor et al. 2005). 
BTV causes disease in sheep, goats, cattle and wild ruminants, rangIng from 
asymptomatic infection to a disease causing high morbidity and mortality, which is 
most severe in sheep and deer. Mortality is usually low although in some sheep flocks 
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mortality may be as high as 50% 
(http://www.defra.gov.uk/animalhldiseases/notifiable/diseaselbluetongue.htm 
November 2005), with surviving animals displaying a loss of condition and subsequent 
reduction in meat and wool production. 
In sheep the disease is characterised and easily identifiable by changes to the mucous 
linings of the mouth and nose and the coronary band of the foot. Symptoms of the 
disease displayed in sheep are a fever lasting for several days in addition to increased 
respiration and hyperaemia (redness) of the lips, mucous linings of the mouth and nose 
and eyelids. Swelling and excess salivation and frothing from the mouth with excess 
nasal discharge are commonly present. In cattle the disease is usually mild or 
asymptomatic and is therefore difficult to diagnose from disease symptoms; diagnosis is 
by laboratory confirmation (www.iah.bbsrc.ac.uk/schools/factfiles/BTV.htm. 
http://www.defra.gov.uk/animalhldiseases/notifiable/diseaseIbluetongue.htm November 
2005). 
1.3.1: Virion Structure 
BTV particles are non-enveloped with two protein shells comprised of seven viral 
proteins. The major protein shells are the 'core', consisting of VP3, VP7, VPI, VP4, 
VP6 and the viral dsRNA genome, and the outer capsid consisting ofVP2 and VP5 (Fig 
1.1). Ten double-stranded RNA genome segments S 1 - S I 0 each encode one protein 
which is translated from the first AUG on the mRNA. S I 0 encodes two proteins from 
the same frame; NS3 and NS3A which differ by 13 amino acids as a result of translation 
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initiation from a second initiation codon (Lee and Roy 1986; French, Inumaru et al. 
1989). 
The termini of each segment are conserved and the 5' and 3' termini have partial 
inverted complementarity and may allow formation of panhandle structures. 
Cryoelectron microscopy analyses and density mapping of BTV and other dsRNA 
viruses indicated that the genomic RNA displayed a highly ordered organisation 
(Prasad, Rothnagel et at. 1996; Grimes, Burroughs et al. 1998; Gouet, Diprose et al. 
1999). The RNA is packaged as well-ordered layers surrounding the structural proteins 
VP 1, VP4 and VP6 and appears to be organised by structural features formed by VP3 in 
the internal surface of the core shell (Gouet, Diprose et al. 1999) . 
VP2 
D VP5 
-
VP7 
D VP3 
VPl 
VP6 
D VP4 
~ dsRNA 
Figure 1. 1: Schematic of Bluetongue virus based on the structure derived from 
cryoelectron microscopy data. 
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1.3.2: The Outer capsid and virus entry 
VP2 and VP5 fonn the unique outer capsid of the virion (Fig 1.2) that is different to the 
T= 13 icosahedral symmetry seen for the reo viruses and rotaviruses within the 
Reoviridae. The outer capsid is an organisation of two distinct shapes the VP2 triskelion 
and the globular VP5 (Fig 1.2). There are 60 VP2 triskelions and 120 globular VP5 in 
every outer capsid (Nason, Rothagel et af. 2004). 
VP2 is a haemaggluttinin that is directly involved with attachment of the virus to the 
host cell receptor and its subsequent intemalisation by receptor mediated endocytosis 
(Hassan and Roy 1999; Hassan, Wirblich et aJ. 2001). VP2 is the most variable viral 
protein; it dictates the virus serotype and carries the neutralising epitopes of the virus. 
VP2, along with VP5, has been shown to trigger apoptosis in mammalian cells without 
the need for virus replication or expression of any other viral proteins (Mortola, Noad et 
af. 2004). 
VP5 shares structural features with class I fusion proteins of enveloped viruses and is 
capable of causing membrane fusion and the fonnation of syncitia when it is fused to a 
transmembrane anchor and expressed on the cell surface (Forzan, Wirblich et al. 2004). 
Fusion activity is strictly pH-dependent and is triggered by short exposure to low pH; 
no cell-cell fusion is observed at neutral pH. The first 40 amino acids of VP5 which 
fonn two amphipathic helices are necessary for fusion activity and the addition of VP2 
expressed on the cell surface using a transmembrane anchor also inhibits the fusogenic 
activity ofVP5. After internalisation of the virion, the clathrin coat of the vesicle is lost 
resulting in a large endocytic vesicle from which the core particle is released into the 
cytoplasm. VP5 is likely to mediate membrane fusion within the endocytic entry vesicle 
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of BTV resulting in the egress of the core particle into the cell cytoplasm (Hassan, 
Wirblich et al. 2001; Forzan, Wirblich et al. 2004). 
Figure 1. 2: Image reconstruction of the three-dimensional cryo-EM structures of 
a BTV particle. Visible are the distinctive triskelion VP2 trimers (red) and VPS 
trimer globular domains (yellow). The outer core protein VP7 is just visible 
beneath the VPSlayer (blue) (Nason, Rothagel et af. 2004). 
1.3.3: The Core Proteins and virus replication 
The viral core is released into the cytoplasm from the endosome after entry; the outer 
capsid proteins are removed at some point during entry and membrane permeablisation 
of the endosome. The viral core is a highly stable, transcriptionally active particle that is 
formed from VP3, VP7, VPl, VP4 and VP6 in addition to the viral genome. In contrast 
to the outer capsid the core particle does show T=13 icosahedral symmetry (Nason, 
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Rothagel et aZ. 2004). A lattice of sixty VP3 dimers form the scaffold of the core with 
VP7 trimers arranged on the sw·face of the VP3 layer (Fig 1.3). The VP3 layer forms an 
icosahedral lattice that interacts with the dsRNA genome at its five-fold axis. VP7 exists 
as a trimer which forms pentameric rings around the fivefold axis of the VP3 scaffold 
(Grimes, Burroughs et al. 1998). 
(a) (b) (c) 
Figure 1. 3: Image reconstruction of the BTV core from tlrree-dimensional cryo-
EM studies. (a) The whole BTV core viewed along the icosahedral three-fold axis 
showing VP7 trimers (purple). (b) The inner lattice of VP3 (blue) along the same 
axis and (c) The innermost density of the 3 minor core proteins in association with 
the genome. The red flower shaped densities represent the locations of the 
structural proteins VPl, VP4 and VP6 lying at the 5 fold axis; represented in green 
are the ordered strands of genomic RNA (Grimes, Jakana et aL 1997). 
All viral genomic RNA is found within core particles where both genome replication 
and production of mRNA occurs. The enclosure of the dsRNA prevents the activation 
of the interferon pathways and other dsRNA based antiviral mechanisms, preserving the 
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integrity of the viral genome and the viability of the cells for virus replication. The three 
core proteins VP1, VP4 and VP6 are the enzymatic proteins necessary for genome 
replication and transcription. 
VP4 exists as a dimer and has all of the enzymatic properties needed for the 5' capping 
of the viral messenger RNA acting as a guanylyltransferase, methyItransferase and RNA 
triphosphatase (Martinez-Costas, Sutton et al. 1998; Ramadevi, Burroughs et (II. 1998; 
Ramadevi and Roy 1998). VP6 exists as a hexamer (Kar and Roy 2003) and binds to 
single-stranded RNA, double-stranded RNA and DNA, and has a helicase activity 
which is involved in unwinding double-stranded RNA during transcription and genome 
replication (Stauber, Martinez-Costas et al. 1997). The largest BTV protein is the viral 
RNA-dependent RNA polymerase, VPl, which shows homology to other RNA 
polymerases and is active in vitro in the absence of other core proteins (Urakawa, Ritter 
et al. 1989; Boyce, Wehrfritz et al. 2004). VPl is responsible for the transcription of 
mRNA which exits the core to be translated via cellular machinery; in the presence of 
magnesium ions and NTP substrates the core enzymes are activated causing a 
conformational change at the five-fold axis opening a pore through the VP3 and VP7 
layers through which mRNA molecules pass into the cytosol (Gouet, Diprose et al. 
1999). 
1.3.4: Non-Structural Proteins and virus assembly and egress 
In addition to the seven structural proteins BTV has four non-structural proteins NS I , 
NS2, NS3 and NS3A encoded by segments S6, S8, and S 1 0 (as determined by the 
migration pattern obtained for the 10 dsRNA segments in acrylamide gel 
25 
electrophoresis. NB the segments display a different migration pattern when analysed 
by agarose gel electrophoresis) . 
The infecting core particle, released from the endosome into the cytoplasm, is rapidly 
surrounded by a dense fibrillar network termed the viral inclusion body (VIB) . NS2 is a 
phosphoprotein which is the major component of vms that accumulate in infected cells 
(Fig 1.4); VTBs are also rich in mRNAs (Thomas, Booth et af. 1990). NS2 alone is 
capable of fonning inclusion bodies, when expressed using a recombinant baculovirus, 
in the absence of other viral proteins including core proteins (Thomas, Booth et af. 
1990). The core structural proteins VP3 and VP7 are also found within the VlB 
indicating that core particles may assemble within or near to the periphery of the VIB 
(Hyatt and Eaton 1988). 
Figure 1. 4: Electron microscopy study of BTV infected mammalian SVP ceUs. 
vms formed during BTV infection are visible throughout the ceU (indicated by the 
arrows) (Brookes, Hyatt et aL 1993). Bar represents 100nm. 
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NS2 has a high affinity for single-stranded RNA species, with a preference for binding 
BTV RNA over non-specific RNA species (Thomas, Booth et al. 1990; Zhao, Thomas 
et al. 1994; Fillmore, Lin et al. 2002; Lymperopoulos, Wirblich et al. 2003). It is 
probable that viral RNA segments have structural or sequence specificities, that are 
recognised by NS2, that allow recruitment and sorting of genome segments for new 
core particles which must contain one of each of the 10 segments. It is also possible that 
NS2 does not sort the RNA segments but recruits and therefore condenses them, which 
allows selective RNA-RNA interactions to occur between each genome segment 
followed by packaging of the genome into a new core particle. 
BTV has no lipid envelope and egress of the progeny virions from mammalian cells is 
predominantly via cell lysis. By contrast egress from infected insect cells is via local 
disruptions in the plasma membrane allowing virions to leave without destroying the 
cells integrity giving more efficient vectoring of the virus by the insect (Beaton, 
Rodriguez et af. 2002). BTV has not been detected with a lipid envelope indicating that 
if virus egress occurs via budding through the plasma membrane, rather than through 
small channels, the envelope is lost extremely quickly afterwards. NS3 and NS3A are 
BTV glycoproteins which accumulate to low levels in infected mammalian cells; in 
infected insect cells the levels of NS3 and NS3A are extremely high (French, Inumaru 
et al. 1989; Guirakhoo, Catalan et al. 1995). It is possible that the difference in NS3 
levels detected within the two cell types may account for the differences in virus egress. 
NS3 is transported through the Golgi apparatus to the cell membrane where it has two 
cytoplasmic domains linked by two membrane spanning domains. Co-expression of 
NS3 and BTV virus like particles (VLP) from recombinant baculoviruses in Spodoptera 
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frugiperda (Sf) cells facilitates the release of VLP from the cells. NS3 is detected in the 
cell membrane at the site of virus release (Hyatt, Zhao et at. 1993). Yeast two-hybrid 
analysis determined that NS3, but not NS3A, interacts via a putative amphipathic helix 
at its N-terminus with the calpactin light chain, p 11, of the annexin II complex (Beaton, 
Rodriguez et af. 2002). The annexin II complex has been implicated in trafficking of 
vesicles and other membrane associated events along the endocytic and secretory 
pathways. pl1 is known to interact with phospholipids and cytoskeletal proteins and by 
undergoing a conformational change may allow the fusion of two membranes leading to 
exocytosis (Nakata, Sobue et af. 1990). Inhibition of NS3-p 11 interaction by the use of 
a small peptide mimicking the p 11 binding sequences down-regulated virus release 
confirming the importance of this interaction in virus egress (Beaton, Rodriguez et ul. 
2002). 
NS3 also has late domain motifs located in its N-terminus which have been identified in 
various viral proteins including HIV Gag and Ebola virus VP40 (Martin-Serrano, Zang 
et af. 2001; Wirblich, Bhattacharya et af. 2006). The late domain motifs bind a variety 
of proteins, including TsglOI and pll (Ono and Freed 2004), which are involved in the 
formation of special endocytic vesicles, multivesicular bodies (MVBs). The formation 
of MVBs involves invagination of the endosomal membrane away from the cytoplasm, 
a process which is topologically identical to the formation of many enveloped virus 
particles (Pomillos, Garrus et af. 2002; Raiborg, Rusten et at. 2003). TsglOl interacts 
with the PTAP late domain motif of HIV (Garrus, von Schwedler et at. 2001) 
facilitating virus egress via budding at the plasma membrane. Both mammalian and 
insect (Drosophila) TsglOl have been shown to interact with the PSAP late domain 
motif of BTV NS3, and knockdown of Tsg101 in mammalian cells using siRNA, 
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inhibited virus release by 65% (Wirblich, Bhattacharya et al. 2006). Like many proteins 
that bind TsgI0l NS3 also binds to NEDD4 and related members of the ubiquitin ligase 
family. 
It is obvious that NS3 plays an important role in virus egress from infected cells but 
whether or not this results in the differences in release seen in vertebrate and 
invertebrate cells is still to be confinned. Since no BTV is detected with envelope, if 
NS3-TsgI01/pll interaction is used for virus egress then it can be assumed that there 
must be an enveloped stage in the BTV life cycle even if this is only transient. 
1.3.5: NSI 
NS 1 is the most abundant viral protein expressed in BTV infected cells and is found 
throughout the cytoplasm (Fig 1.5) (Huismans 1979). In infected vero cells NS I is first 
detected at 5 hours post infection by immunofluorescence staining and flow cytometry 
(Whetter, Gebhard et al. 1990). 552 amino acid NS 1 is expressed from genome segment 
6 and is 64 kDa; NS I has a low number of charged amino acids and is high in cysteine 
residues with several hydrophobic regions (Roy and Gonnan 1990). NS 1 alone 
multimerises into large tubule structures; no other viral proteins are required for the 
fonnation of tubules when NS 1 is expressed in mammalian or insect cell lines (Urakawa 
and Roy 1988). 
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Figure 1. 5: Sfinsect cell infected with a recombinant baculovirus expressing NSl. 
NSI tubules are visible throughout the cytoplasm (Urakawa and Roy 1988). F 
indicates fibrous structures with the arrow heads indicating tubules lying 
alongside the fibrous structures. 
Cryoelectron microscopy shows that tubules are on average 52.3nm in diameter and up 
to 1000nm in length with a helical configuration (Fig 1.6) (Rewat, Booth et al. 1992; 
Hewat, Booth et aZ. 1992). The NS 1 monomer forms a dimer like structure which is 
assembled in a helically coiled ribbon with approximately 21 dimers per turn to form 
the tubule. Mutational analysis ofNS! detetmined that the amino and carboxy termini, 
as well as a pair of internal cysteine residues at positions 337 and 340 are essential for 
tubule formation. If the internal cysteine residues at positions 337 and 340 are mutated 
into serine, large aggregates of ribbon like structures were identified but no tubules were 
detected (Monastyrskaya, Booth et aZ. 1994). 
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Figure 1. 6: Structural analysis of NSI tubules showing a distinct ribbon like 
structure of NSI dimers forming a helical coil which is the basis of the NSl tubule. 
There are approximately 21 dimers per turn and the average tubule has a 
diameter of 52.3nm and is up to 1000nm in length (Hewat, Booth et al. 1992). 
The primary antigenic site of NS 1 has been localised to the carboxy terminus 
(Monastyrskaya, Gould et al. 1995) and extra peptide sequences can be added to this 
with no disruption oftubule formation (Mikhailov, Monastyrskaya et al. 1996). Foreign 
sequences representing 44 amino acids (aa) from Clostridium difficile toxin A, 48 aa of 
the hepatitis B virus preS2 region, and the whole 116 aa of bovine leukaemia virus p 15 
protein were inserted at the C-terminus of BTV - IONS 1 with no disruption to tubule 
formation (Mikhailov, Monastyrskaya et al. 1996). Furthermore the addition of these 
sequences lead to their display on the outer surface of the tubule and they were highly 
immunogenic. 
To analyse the immunogenic nature of chimeric tubules, NSI tubules carrying a single 
CD8+ T cell epitope fi'om the lymphocytic choriomeningitis virus (LCMV) 
nucleoprotein were expressed. These chimeric tubules were recognized by MHC class I 
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restricted T cell hybridoma in vitro and induced in vivo strong CDS+ class I-restricted 
CTL responses in immunized mice. Further, the immunized mice were protected when 
challenged with a lethal dose of LCMV. This finding has allowed novel recombinant 
vaccines to be made against several diseases (Mikhailov, Monastyrskaya et al. 1996). 
Amino acids 135-144 of Foot and mouth disease virus (FMDV) VPI were added to the 
C-terminus of NS 1 eliciting a strong CD4+ T helper cell response and a humoral 
immune response that was protective in mice subsequently challenged with FMDV 
(Ghosh, Borca et al. 2002; Ghosh, Deriaud et al. 2002). Most recently 527 amino acids 
of the HIV -1 clade A consensus-derived immunogen, HIV A, was expressed fused with 
NSI (Larke, Murphy et al. 2005). When injected into BALB/c mice by several routes, 
chimeric NS I.HIV A tubules induced HIV -I-specific major histocompatibility complex 
class I-restricted T cells. These could be boosted by a modified Ankara vaccine virus, 
expressing the same immunogen, to generate a memory capable of gamma interferon 
(IFN-y) production, proliferation, and lysis of sensitized target cells (Larke, Murphy et 
al.2005). 
The localisation of BTV NS 1 has been analysed in VIruS infected cells by 
immunofluorescence and electron microscopy. NS I was detected in high levels 
throughout the cytoplasm in a punctate pattern, and sometimes within the nucleus 
(Hyatt, Eaton et al. 1987; Eaton, Hyatt et al. 1988). Immunogold labelling and visual 
analysis of NS 1 tubules detected NS 1 in close proximity to VIB and associated with the 
cell cytoskeleton. Surprisingly when examined by immunogold electron microscopy 
virus particles also appeared to label with anti-NS 1 gold particles when visualised both 
in infected cells and when purified and fixed on to electron microscopic grids (Eaton, 
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Hyatt et al. 1987). Core particles purified from virus infected cells also labelled with 
anti-NS 1 gold particles. No NS 1 tubules are detected visually when the virus and core 
particles are examined by electron microscopy indicating that the form of NS I detected 
was monomer or was due to cross-reactive antibody. The interaction of NS 1 with virus 
cores, virus particles and the cytoskeleton may indicate that NS 1 plays a role in virus 
morphogenesis and transport from assembly sites to egress sites. No data is available on 
the interactions ofNSI in vitro with other BTV virus proteins to confirm the interaction 
of NS 1 with virus cores and particles. 
The role of NS 1 in BTV infection was examined usmg a single chain antibody 
expressed under the control of a Tet responsive promoter in a clonal mammalian cell 
line (Owens, Limn et al. 2004). The single chain antibody was derived from an NS 1 
specific monoclonal antibody, lOB I (Monastyrskaya, Gould et al. 1995), and used to 
knock down the amount of free NS I in virus infected cells when doxycycline was 
absent from the growth media. No NS 1 tubules could be detected by electron 
microscopy of cell sections or sucrose gradient purification when the antibody was 
expressed, although small amounts ofNS 1 were detected by western blot analysis. 
Strikingly less cytopathic effect (CPE) was detected in BTV infected cells where NS 1 
was knocked down, the mammalian cells appeared comparable to insect cells at the 
same time post infection. The change in visible CPE was not due to disruption in virus 
replication as the titre of cell associated virus is comparable to that produced during 
normal infection. However, a massive increase in the titre of virus released from the 
cells was observed indicating that production of infectious virus progeny is in fact up-
regulated by knock down ofNS 1. When examined by electron microscopy virions could 
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be detected budding from the plasma membrane as in insect cell infection rather than 
exiting via cell lysis, as detected in cells where no antibody was expressed, explaining 
the change in CPE yet increase in virus yield (Fig 1.7). 
a) 
TUBs 
b) 
No TUBs Virus particles 
Figure 1. 7: Ultrastructural EM analysis of BTV 10 infection in the presence and 
absence of an internally expressed single chain antibody against NSI. (a) Typical 
effects of BTV-I0 infection in BSR cells, including cytoplasmic inclusion bodies, 
tubules, mature virus particles and areas of severe morphological destruction near 
the plasma membrane consistent with lytic release of the virus. (b) BSR cells 
expressing the anti-NSI antibody, no cytoplasmic tubules are detected and virus 
particles are exiting the cells via budding from the plasma membrane (Owens, 
Limn et al. 2004). Bar represents 500nm. 
This data implicates a role for NS 1 in virus egress, which is supported in part by the 
apparent localisation of NS 1 with the cytoskeleton and virus and core particles. 
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However given the strong evidence in support of NS3 involvement in virus egress it is 
difficult to draw any conclusions as to how the knockdown of NS I has this effect or the 
possible mechanisms involved. Unlike co-expression of NS3 and VLP using 
recombinant baculovirus, co-expression of NS 1 and VLP in insect cells does not result 
in release of virus particles, indicating that NS 1 alone is insufficient to trigger particle 
release (Hyatt, Zhao et al. 1993). It is possible that interactions of NS 1 with cellular 
proteins, rather than the presence of NS 1 alone, help to regulate virus morphogenesis 
and egress. It is also probable that those interactions would differ in insect and 
mammalian cells, playing a part in the differential egress seen in BTV infection. 
1.4: Other viral tubules 
Many other viruses have proteins that form tubules, including some within the 
Reoviridae. A number of different viruses encode viral tubules for a variety of 
functions, many of which remain unknown. The variety of viral tubules makes it 
difficult to identify comparable features between the proteins and functions of the 
tubules within infected cells. Viral tubules can be assigned to two major types; the 
movement protein tubules of plant viruses and the storage tubules of excess viral 
proteins. Several viruses, including BTV, encode tubules that not within either of these 
categories; a lack of data on the active form of the protein prevents them from being 
classified as storage tubules, although this may indeed be the case. 
The first major type of virus tubules, and the most studied protein tubules, belongs to 
plant viruses. Plant viruses often encode one or more movement proteins that assemble 
into tubules and are involved in cell-cell spread of the virus within the plant. Plant cell 
walls are very rigid and do not allow viral spread from one cell to the next, movement 
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proteins modify the structure of plasmodesmata (pores in the cell walls allowing 
transport of nutrients etc) in such a way that viral transport is enabled from one cell to 
the next by transport of the viral particle through the movement protein tubule 
(Lazarowitz and Beachy 1999). 
Cauliflower mosaic Virus (CaMV), a double-stranded DNA VIruS, belonging to the 
family Caulimoviridae is one such plant ViruS that uses movement proteins. The 
movement protein, PI, accumulates in foci at the periphery of transfected protoplasts, 
and the tubules it forms extend beyond the cell wall (Perbal, Thomas et af. 1993; 
Huang, Han et af. 2000). A second viral protein, virion associated protein (V AP) also 
known as P3, is essential for CaMV movement between plant cells, V AP also mediates 
virus transmission by aphids through simultaneous interaction with both the aphid 
transmission factor and the virion. To form tubules PI oligomerizes as a trimer through 
a C-terminally located coiled-coil domain. PI interacts, via its C-terminal coiled-coil 
domain, with the N-terminal coiled-coil domain of V AP located on the virion surface 
(Stavolone, Villani et af. 2005), this interaction occurs within plasmodesmata that 
contain virus particles. MP also co-localises with the Arabidopsis thaliana MPI7 protein 
in the cell periphery foci, suggesting the possible involvement of host factors in virus 
movement (Huang, Andrianov et af. 200I).The interactions of YAP with PI and the 
virion by the coiled-coil domains, indicate a mechanism for movement in plant cells 
involving both proteins and possibly PI interaction with host proteins. 
The movement proteins of some plant viruses are efficient enough to allow cell to cell 
movement in viruses that are normally movement defective. The movement protein of 
Tomato spotted wilt virus (TSMV), NSm, can complement the movement deficient 
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Tobacco mosaic virus (TMV) allowing long distance transport to the upper leaves of the 
plant (Lewandowski and Adkins 2005). The C-terminus of NSm is necessary for its 
function as a movement protein; NSm does not directly interact with the plasma 
membrane indicating a possible interaction with a membrane protein for formation and 
function of tubules. 
There are also many plant viruses within the Reoviridae, of these some have been 
identified as expressing movement protein tubules. Rice dwarf virus (RDV) of the 
Phytoreoviruses, expresses a movement protein, Pns6, from the non-structural genome 
segment S6; this protein is also capable of complementing the movement deficient 
potato virus X (PVX) (Li, Bao et al. 2004). The S6 genome segment is equivalent to the 
S6 genome segment of BTV that encodes for NS 1; Pns6 is 56kDa which is only slightly 
smaller than BTV NS 1 at 64kDa. When the amino acid sequences of BTV NS 1 and 
RDV Pns6 are aligned they share 12% sequence identity, with a further 22% sequence 
similarity, i.e. the amino acids are changed to amino acids with similar properties, 
indicating that the 2 proteins are not particularly similar. 
The second major type of virus tubule is those tubules that are a form of storage for 
excess or misfolded viral proteins. The mammalian Rotavirus, also of the Reoviridae, 
expresses a capsid protein, VP6, which forms tubules that are thought to be either a 
form of storage for the capsid protein prior to virion assembly or due to misfolding of 
the protein (Lepault, Petitpas et al. 2001). The usual VP6 trimer, the subunit for capsid 
construction, is disrupted at an increased pH, and the protein assembles helically into 
tubules of 45nm or 75nm diameter. When VP6 is expressed both forms of tubules plus 
spherical virus like particles ofVP6 are detected. 
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Infectious bursal disease virus (lBOV) also encodes tubules used for protein storage, in 
fact it produces two distinct types of viral tubules type I and II. IBOV is an avian virus 
of the Birnaviridae family, possessing a bipartite double-stranded RNA genome (Van 
Regenmortel 2000; Fauquet 2005), and causes an immunosuppressive disease that 
affects juvenile chickens. Type I tubules are capsid mulitmers that stack up in a form 
similar to that seen in the virion subunit and possess the same diameter, 60nm, as the 
virus particle (Granzow, Birghan et al. 1997). 
The IBOV type II tubules may also act as storage for excess protein. Type II tubules are 
smaller, 24 to 26 nm in diameter, found in both cytoplasmic and intranuclear locations 
and contain the viral structural protein VP4, which is not found in the virus particle 
(Granzow, Birghan et al. 1997). VP4 is a protease responsible for cleavage of the VP2-
VP4-VP3 polyprotein encoded by the virus (Kibenge, Qian et al. 1997; Lejal, Oa Costa 
et al. 2000 Rodriguez-Lecompte, Nino-Fong et al. 2005). The role of these virus tubules 
in unknown, although since VP4 is a protease, aggregation might serve to inactivate 
excess protease preventing lethal damage to the virus. Surprisingly, although IBOV 
replicates in the cytoplasm of infected cells, these VP4-containing type II tubules were 
detected in both the cytoplasm and nucleus although it is unclear how VP4-containing 
tubules or their immature forms reach the nucleus; no obvious nuclear localization 
consensus signal has been found (Gorlich and Mattaj 1996). 
A different type of tubule entirely, that fits into neither the movement protein tubule or 
storage tubule groups, is encoded by the insect virus Autographa cali/arnica 
nuc1eopolyhedrovirus (AcMNPV). The very late protein pto is synthesised in high 
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levels and fonns fibrillar structures that spiral through the nucleus and the cytoplasm of 
AcMNPV-infected cells (Quant-Russell, Pearson et al. 1987; Van Oers, Flipsen et al. 
1994). The coiled-coil domain within the N-tenninus of pI 0 is responsible for the 
aggregation of pI 0 monomers (Van Oers, Flipsen et al. 1994; Alaoui-Ismaili and 
Richardson 1996). pi 0 and its tubules have no known function although it is thought to 
be involved in cell lysis due to the failure of cells to lyse when pI 0 was mutated/absent 
(Williams, Rohel et al. 1989), further evidence suggests that it may be involved in 
nuclear disintegration and subsequent cell lysis (Patmanidi, Possee et al. 2003). The pI 0 
tubules co-localise with cortical microtubules and a depolymersiation of tubulin via 
treatment with nocodazole leads to an abrogation of pi 0 tubule fonnation and a 
deposition of pi 0 in cytoplasmic foci (Patmanidi, Possee et al. 2003). It is thought that 
this interaction is ionic via the basic carboxy tenninal microtubule binding domain of 
pl0 and the acidic carboxy tenninus of tubulin. 
Similarly to AcMNPV pIO, BTV NSI does not fit into the movement protein tubule 
group and may not fit into the storage tubule group either, although this depends if the 
active fonn of NS 1 is monomers/dimers or tubules. BTV NS 1 does however share a 
number of similarities with the insect virus protein tubules described. The AcMNPV 
plO tubules have some structural similarities with NS I tubules; the amino tenninus is 
required for aggregation of the monomers whilst the carboxy tenninus is free to interact 
with other proteins. 
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1.5: Viral Non-Structural Proteins and Important Interactions 
Virus life cycles can be split into five main stages; entry, replication, trafficking of 
replication products for assembly, egress and transmission. Throughout their life cycle 
viruses interact with host cellular proteins at each of the five stages in addition to 
interacting with host proteins throughout their life cycle to abrogate anti-viral immune 
responses. Viral interactions range from having no significantly detrimental effects on 
the host to causing the shut down of protein synthesis and subsequent cell death. The 
effects of virus-host protein interactions can be localised to the cell that is infected or 
can have a multi-cellular effect on the host, especially in the case of abrogation of anti-
viral immune responses. 
1.5.1: Interactions during Virus Entry 
Interaction of virus and host proteins during virus entry usually involves viral structural 
proteins on the outer surface of the virion and cellular surface proteins which the virus 
uses as receptors. The virus then enters the host cell by receptor mediated endocytocis 
or membrane fusion in the case of enveloped viruses. As non-structural proteins are not 
present in virions they rarely have a role in virus entry although several viruses rely on 
non-structural proteins for inter-cell transmission (chapter 1.5.5). 
1.5.2: Interactions during Genome Replication and Protein Translation 
Most viruses hijack normal house keeping cellular processes such as the enzymatic 
machinery for DNA replication and the materials for DNA and RNA replication. All 
viral transcripts are translated using host cell ribosomes and materials; post translational 
modifications such as glycosylation are also achieved via normal cellular processing. 
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Viral non-structural proteins with enzymatic roles sometimes function to allow the virus 
to use cellular pathways. For example, to utilise the cellular translation machinery 
Influenza viruses, which lack 5'capped mRNA, have to hijack the 5' m7G caps of 
cellular mRNAs. The non-structural protein, PB2 endonuclease, of Influenza virus 
cleaves the 5' m7G cap plus 10-15 nucleotides from the termini (Ulmanen, Broni et at. 
1981), thus giving heterogeneous 5' termini to the viral RNA segments (Caton and 
Robertson 1980; Dhar, Chanock et af. 1980). By removing the 5' caps from host 
transcripts the virus has a detrimental effect on the cell reducing/abolishing cellular 
protein synthesis. Virus replication must therefore be completed rapidly and efficiently 
before virus induced cell death occurs. Other examples of viral non-structural protein 
interactions with transcription and translation machinery are detailed in table 1.3. 
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Virus Host Non-structural protein and its Interactions 
pathway 
The viral protease 3C(pro) cleaves and inactivates pol I 
transcription factors, SL-l (selectivity factor) and UBF 
Poliovirus Transcription (upstream binding factor), inhibiting RNA polymerase 
I host cell transcription (Banerjee, Weidman et al. 
2005). 
The viral proteases 2A and 3C cleave host factors 
eukaryotic translation initiation factor (eIF4G) and poly 
Poliovirus Translation A binding protein (PABP) shutting down host cell 
protein synthesis (Kuyumcu-Martinez, Van Eden ct al. 
2004). 
Viral reverse transcriptase binds to eukaryotic 
Murine translation release factor inhibiting translation 
leukaemia Translation termination and release of polyproteins from the 
virus ribosome. This enhances read through of the Gag-Pol 
polyprotein increasing the amount of reverse 
transcriptase in the cell (Goff 2004) 
NSSA inhibits phosphorylation of eIF2alpha and eIF4E 
exerting counteracting effects on mRNA translation, 
Hepatitis C this might maintain the global mRNA translation rate 
virus Translation during early VIruS infection while favouring cap-
independent translation of HCV mRNA during late 
infection (He, Tan et a/. 2001). 
Viral protein 2A translocates to the nucleus and helps 
to up-regUlate the synthesis of new and modified 
Encephalomyo Translation ribosomes that have an inherent preference for internal 
-carditis virus ribosomal entry site (IRES)-dependent viral genome 
translation over cap-dependent host mRNA translation, 
thus shutting down host protein synthesis (Aminev, 
Amineva et al. 2003; Aminev, Amineva et al. 2003). 
3A protein inhibits ER-Golgi protein traffic thus 
Poliovirus and Protein inhibiting host protein secretion. This inhibits secretion 
Coxsackie's secretion of various immune response proteins including IFN-P 
B3 virus and MHC I and TNF receptors (Choe, Dodd et a/. 
2005). 
Dengue virus Interferon Viral protein NS4b inhibits activation of ST A T1 and 
pathway blocks ISRE promoter activation in response to IFN-
alphalbeta (M unoz-J ordan, Sanchez-Burgos et al. 
2003). 
Table 1. 3: Interactions of viral non-structural proteins with proteins involved in 
host house keeping pathways. 
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1.5.3: Interactions during Trafficking of Viral Products to Sites of Assembly 
Viruses also make use of the complex trafficking networks within the cell to aid 
accumulation and movement of specific viral proteins. The golgi body and endocytic 
vesicles are used to process and traffic viral proteins and particles within the cell. The 
cytoskeleton network of microtubules, micro filaments and intermediate filaments are 
also used by many viruses to target viral proteins and virions. The structural proteins of 
several viruses, including West Nile virus and African swine fever virus, interact with 
cellular cytoske1etal proteins to traffic proteins and virus particles to egress sites. 
The non-structural protein NS3 of Japanese encephalitis virus (JEV), a multifunctional 
protein with activities of serine protease, triphosphatase and RNA helicase, interacts 
with microtubules and a Golgi associated protein that associates with microtubules, 
TsglOl (Chiou, Hu et af. 2003). Infection with lEV causes rearrangement of 
microtubules within the cell; this is caused by the NS2B-NS3 polyprotein. JEV NS2B 
or NS3 might induce microtubule reorganization in order to facilitate the transport of 
other viral proteins from the rER and Golgi apparatus to the CM (virus induced 
convoluted membrane) during JEV multiplication (Chiou, Hu et af. 2003). Furthermore, 
since tubulin exhibits the functions of a chaperone (Guha, Manna et al. 1998; Manna, 
Sarkar et al. 2001), it may help viral proteins to maintain their conformation in the CM. 
1.5.4: Interactions during Virus Egress 
Other cellular processes that are utilised by viruses include the exocytosis pathway for 
non-lytic release of virus. Recruitment, by specific viral protein interactions, of cellular 
protein complexes controlling budding from the plasma membrane are used by 
retroviruses and BTV (Garrus, von Schwedler et al. 2001; Wirblich, Bhattacharya et af. 
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2006). As described in chapter 1.3.4 the BTV non-structural protein NS3 interacts with 
TsgIOI and the calpactin light chain pII to aid virus release. 
The NS2 protein ofParvovirus minute virus of mice (MVMp) interacts with the nuclear 
export receptor protein, Crm 1, and plays a critical role at a late stage of the parvovirus 
life cycle involved in release of progeny viruses (Eichwald, Daeffler et al. 2002; Miller 
and Pintel 2002). NS2-Crm 1 interactions are essential for egress of the virus particles 
from the nucleus into the cell cytoplasm, without this interaction egress of progeny 
virus is severely inhibited. 
1.5.5: Interactions during virus transmission 
The interaction of viral non-structural proteins with host cellular proteins is vital for the 
non-circulative transmission of the arbovirus CaMV by aphids. As discussed in chapter 
1.4 the V AP non-structural protein, in addition to the non-structural protein A TF (aphid 
transmission factor), also known as P2, is essential for virus transmission in aphids. 
ATF is taken up from punctures in plant epidermal and mesophyll cells by the aphid and 
is retained in the aphid stylet by its interactions with cuticle proteins (Palacios, Drucker 
et al. 2002). Subsequently the viral particles are ingested from the plant phloem and 
interactions between A TF and V AP, which acts as a bridge between A TF and the 
virion, retain the virion in the stylets for transmission upon the next plant meal (Leh, 
Jacquot et al. 2001; Palacios, Drucker et al. 2002). Furthermore the interaction of V AP 
with the virion is necessary for the transmission of the virion between plant cells but not 
for infection of single cells (Kobayashi, Tsuge et al. 2002; Stavolone, Villani et al. 
2005). 
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1.5.6: Interactions with proteins involved in anti-viral immune responses 
The host immune response to virus replication is large and complex and many viruses 
have developed mechanisms to down-regulate or prevent this response from limiting 
virus replication. This can be as simple as is seen in BTV replication whereby viral 
genomic material, double-stranded RNA, is never present in the cell and is always 
contained within core particles preventing dsRNA activation of the interferon pathway. 
Table 1.4 gives a summary of some viral non-structural proteins that inhibit host 
Immune responses. 
Limitation of the host immune response can also be a more complex process involving 
protein interactions as is seen in flavivirus replication. The non-structural proteins 
NS4A, and to some extent NS4B and NS2A, of Dengue virus are known to inhibit 
interferon induced antiviral activities by interacting with a component of the interferon 
signalling pathway. Dengue virus and Japanese encephalitis virus (JEV) down-regulate 
both STATl (signal transducer and activator 1), STAT2 and STAT3 expression and 
activation in addition to disrupting the JAKJST AT pathway further by preventing Tyk2 
activation (Munoz-Jordan, Sanchez-Burgos et al. 2003; Lin, Liao et al. 2004; Ho, Hung 
et al. 2005). 
Simian VIruS 5 (SV5) links the abrogation of antiviral immune responses to an 
interaction with the ubiquitin pathway (Precious, Childs et al. 2005; Precious, Young et 
al. 2005). SV5 is a rubulavirus of the Paramyxoviridae; most viruses within the 
Paramyxoviridae at least partially circumvent the interferon response by blocking 
interferon signalling and reducing the production of interferon by infected cells. The 
SV5 V protein does not bind to STATl but does bind directly to both STAT2 and 
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DDB1 mediating degradation of STAT!. The SV5 V protein acts as an adaptor 
molecule linking a DDB lICullin 4a-containing ubiquitin ligase complex to 
ST AT2/ST A T1 heterodimers, which leads to the ubiquitination of ST A T1 and its 
subsequent degradation. 
Virus Host pathway Non-structural protein and its interactions 
Influenza Posttranscriptional NS 1 binds and inhibits the function of the 30-kDa 
A virus inhibition of IFN subunit of CPSF, a cellular factor that is required for 
and TNF induced the 3'-end processing of cellular pre-mRNAs, thus 
gene expression inhibiting posttranscriptional processing of antiviral 
mRNAs (Wang, Li et af. 2000; Noah, Twu et al. 
2003). 
Poliovirus Protein secretion 3A protein inhibits ER-Golgi protein traffic thus 
inhibiting host protein secretion. This inhibits 
secretion of vanous Immune response proteins 
including IFN-~ and MHC I and TNF receptors (Choe, 
Dodd et af. 2005). 
Hepatitis PKR inhibition NS5A inhibits the cellular interferon (lFN)-induced 
C virus protein kinase R (PKR) preventing mediation of the 
IFN induced anti-viral immune response (He, Tan et 
af.2001). 
Poxvirus Inhibition of Secretory protein NILmodulates the innate immune 
NFKB and IRF3 response by disrupting signalling to NF-kappaB by 
signalling T ollllL-l Rs and TNF superfamily receptors by 
pathways targeting the IKK complex for inhibition. Nt L also 
inhibits IRF3 signalling (DiPerna, Stack et al. 2004). 
Table 1. 4: Interactions of viral non-structural proteins with host proteins involved 
in anti-viral immune responses. 
1.6: Insect Transmission of Viruses 
In 1902 Yellow fever virus was documented as being transmitted by mosquitoes, since 
then numerous arboviruses have been identified. Today over 70% of plant and 40% of 
mammalian viruses are classified as arboviruses with over 100 different pathogens of 
humans (van den Heuvel, Hogenhout et af. 1999). Arboviruses are a diverse collection 
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of vlruses; the best known groups are within the Togaviridae, Flaviviridae, 
Bunyaviridae and the Reoviridae. The host ranges and diseases caused are also diverse 
ranging from Dengue virus, a human pathogen with a positive ssRNA genome vectored 
by mosquitoes to Tomato spotted wilt virus, a plant pathogen with a negative ssRNA 
genome vectored by thrips. BTV is vectored by insects of the Culicoides genus and in 
this respect the orbiviruses are unique to the other viruses within the Reoviridae that are 
not vectored by arthropods. 
Arboviruses are often classified within the even broader groupmg of emerging 
infections. As geographic boundaries are disrupted by world travel and transport, 
vectors and hosts increasingly contact each other in new areas changing the global 
distribution of disease. Changes in climate, ecological habitats and public health control 
and perception also add to this burden. BTV is a good example of an emerging infection 
that has spread from Africa where it was first described in the 18th century across 
America, Asia, Australasia and more recently Europe. BTV was first detected in Europe 
in 1956 in an outbreak in Spain and Portugal and, despite efforts to control the disease 
by vaccination, has since been detected in various European countries including Greece, 
Italy, Turkey, France and Bulgaria. This continued spread of BTV has been attributed to 
changes in European climate that have allowed increased virus persistence during 
winter and a northwards movement ofBTVs main vector Culicoides imicola. A shift in 
transmission to new strains of Culicoides native to Europe is also an important factor 
(Purse, Mellor et al. 2005). 
BTV belongs to the circulative, propagative classification of arboviruses, these viruses 
are both internalised and actively replicate within the vector species (Gray and Banerjee 
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1999; van den Heuvel, Hogenhout et al. 1999). The arthropod vector is extremely 
important in the life cycle of BTV as it is necessary for the transmission and long term 
survival ofthe virus. The mammalian host is a short tenn, limiting stage of the BTV life 
cycle due to the disease it causes. This stage does however provide a high titre source of 
virus allowing more efficient infection of the insect vectors which are capable of 
sustaining BTV replication for longer periods. During the BTV life cycle the virus must 
infect and replicate successfully in both hosts and effectively transmit between both 
hosts for the cycle to be maintained. 
Wildlife reservoir 
Domesti c livestock 
Figure 1.8: Transmission cycle of BTV. The Culicoides sp. midge is the BTV 
vector between the wildlife reservoir and domestic livestock. 
Many barriers exist in both the mammalian and arthropod stages of the life cycle which 
BTV must overcome to replicate and transmit efficiently and sustainably. Whilst a lytic 
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infection of mammalian cells allows rapid replication and spread of the virus within an 
organism it does not permit spread from one mammal to another and infection is 
therefore self-limiting. BTV requires the persistent non-lytic infection of insects for 
transmission to occur and the disease cycle to be maintained. The relationship between a 
virus and its insect vector is highly specific; BTV along with many arboviruses can only 
be transmitted by one or a limited number of closely related species of insect. BTV 
transmission is sustained by species within the Cu/icoides genus, although BTV is 
capable of infecting other genera of insect including the sand fly Lutzomyia longipa/pis 
(Jennings and Mellor 1987) it is unable to transmit using these insects. For a virus to be 
transmitted it must first infect the midgut of the insect that has ingested it and then be 
able to subsequently escape the cells of the midgut wall to disseminate. Once a systemic 
infection has been established within the insect, the virus must be able to infect and then 
escape the cells within the salivary gland. Only by doing so will the virus become 
present in the saliva of the insect for transmission during biting of the next mammalian 
host. All of these barriers must be efficiently overcome for the transmission cycle of the 
virus to continue. 
Co-evolution of the virus and vector allows specific interactions to occur where by these 
barriers on virus transmission can be escaped. Capsid genes of insect transmitted plant 
viruses are subject to greater selective pressure on amino acid sequence than those 
transmitted by other means (Chare and Holmes 2004). Even greater selective constraints 
exist for vector-borne animal viruses presumably due to a higher complexity of the 
hosts involved in circulative transmission of these viruses. Sindbis virus of the Alpha 
viruses is a well known arbovirus transmitted by mosquitoes, work has identified that 
the size of the envelope protein transmembrane domain is a key determinate of 
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infectivity in mammalian cells but has no effect on virus replication and infectivity in 
insect cells (Hernandez, Ferreira et al. 2005). 
Despite the huge economic impact of arboviruses little is known about the differences 
seen between the infections of viruses in insects and mammals. There are obvious 
biological differences between insects and mammals and yet whilst the interactions of 
the arboviral proteins with cellular proteins are extensively studied in mammals little 
work has been done to identify and address these in insects, with few documented 
results. 
1.7: Protein-Protein Interactions between virus and insect cells 
BTV protein NS3 interacts with the insect and mammalian homologues ofTsgl01, this 
is an important finding as it confirms that viral proteins may interact with the same 
proteins in both insect and mammalian cell infection, although it does not confirm that 
the function of the interaction is identical. The majority of documented research on 
arbovirus-insect protein interactions is in reference to cellular receptor proteins. A virus 
protein interaction with insect proteins was identified for Dengue Virus serotype 2 
(DEN-2). Virus overlay assays identified 5 C6/36 membrane proteins that interacted 
with DEN-2, identified by their differing sizes of 19, 65, 67, 79 and 80kDa. DEN-2 
binding to two of these proteins, 67KDa and 80KDa, is inhibited by the addition of 
antibodies specific to the C6/36 membrane indicating that these two proteins are 
receptors for DEN-2 (Munoz, Cisneros et al. 1998). In a different study two proteins of 
sizes 40 and 45 kDa were identified as putative DEN4 receptors in C6/36 cells (Salas-
Benito and del Angel 1997; Reyes-del Valle and del Angel 2004). Unfortunately the 
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specific interactions and identities of the putative receptor proteins have yet to be 
determined. 
Venezuelan equine encephalitis VIruS (VEEV), an alphavirus, is different to many 
arboviruses in that it is transmitted by a broad range of vectors, several genera of 
mosquitoes and ticks. VEEV binds to a 32-kDa polypeptide present in the C6/36 plasma 
membrane fraction, which is a laminin binding protein. VEEV binds and competes for 
binding to this polypeptide with homologous and heterologous alphaviruses, suggesting 
that this polypeptide binds virus via a receptor-ligand interaction and is a common 
receptor for alphaviruses. Laminin binding proteins are highly conserved and the broad 
vector range may be attributed to this (Ludwig, Kondig et al. 1996; van den Heuvel, 
Hogenhout et al. 1999). Laminin binding proteins have been identi fied as receptor 
proteins for Tick-borne encephalitis virus (TBE) in mammalian cells (Protopopova, 
Khusainova et al. 1996) and other enveloped RNA viruses including Dengue virus and 
Sindbis virus (Wang, Kuhn et al. 1992; Thepparit and Smith 2004) indicating that viral 
receptors may be common between insect and mammalian cells. 
The arbovirus Cucumber Mosaic virus infects over 800 plant species and is vectored by 
aphids (Palukaitis, Roossinck et al. 1992). Like many plant arboviruses it does not 
replicate inside its insect vector and so the barriers faced are different. Transmissible 
virus particles acquired from infected plants are retained only on the cuticle lining the 
food canal in the aphid stylets. From there, Cucumber mosaic virus is released when the 
vector probes on a new host plant. This interaction does not involve progression of the 
virus into the insect salivary gland and is therefore much simpler. The betaH-betaI loop 
of the capsid subunit is a potential key motif responsible for virus interactions with the 
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insect vector allowing retention and subsequent transmission of the virus (Bowman, 
Chase et al. 2002). 
Due to the lack of studies involving arbovirus-insect protein interactions, studies 
involving insect viruses also allow insight into the interactions that may be necessary 
for efficient replication and transmission in insects. Members of the Luteoviridae are 
transmitted by aphids in a circulative, non-propagative manner that requires the virus to 
be acquired through gut tissue into the aphid hemocoel and then exit through salivary 
tissues. This process is aphid species-specific and involves specific recognition of the 
virus by unidentified components on the membranes of gut and salivary tissues. Both 
structural proteins of the virus are involved in the transmission process, with multiple 
protein domains regulating the movement and survival of the virus in the aphid and 
plant (Young and Filichkin 1999; Gray and Gildow 2003). 
Recent work on a unique relationship between parasitic wasps (Cotesia congregata), the 
caterpillar Manduca sexta and a bracovirus, C. congregata bracovirus (CcBY), has 
identified an interaction between the expression of viral cystatins and a change in 
caterpillar susceptibility to the parasitic wasp infection (Espagne, Douris et al. 2005). 
The parasitoid wasp lays eggs in the caterpillar host and at the same time transmits 
CcBY into the caterpillar. Expression of viral genes alters the caterpillar's immune 
defence responses and developmental program, resulting in the creation of a favourable 
environment for the survival and emergence of adult parasitoid wasps in a bizarre and 
rare mutualism between viruses and eukaryotes. However the interesting interactions 
allowing this odd relationship to occur are found at protein level. CcBY encodes three 
proteins during infection of the caterpillar that have homology to members of the 
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cystatin superfamily of tightly binding, reversible inhibitors of cysteine proteases. 
Assays in vitro determined that CcBV viral cystatins are functional, having potent 
inhibitory activity towards the cysteine proteases papain, human cathepsins Land Band 
Sarcophaga cathespin B. CcBV cystatins are, therefore, likely to playa role in host 
caterpillar physiological deregulation by interacting with and inhibiting host target 
proteases in the course of the host-parasite interaction (Espagnc, Douris et al. 2005). 
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2: Aims 
To investigate the role of NS 1 in BTV replication via its interactions with cellular 
proteins. 
To investigate the interactions of NS 1 with other BTV proteins to identi fy a role for 
NS 1 in BTV replication. 
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3: Materials and Methods 
3.1: Cell Culture 
293T (Human embryonic kidney) cells were maintained in MEM (Sigma) supplemented 
with 10% FCS at 37°C, 5% CO2. 
BSR (baby hamster kidney cells), HeLa (Human cervical carcinoma cells) and Vero 
(African green monkey kidney cells) cells were maintained in DMEM (Sigma) 
supplemented with 10% FCS at 37°C, 5% CO2• 
Culicoides cells were maintained in Drosophila media-SFM (Invitrogen) supplemented 
with 10% FCS at room temperature. 
C6/36 (Aedes albopictus larvae cells) cells were maintained in at Leibovitz media 
(Sigma) supplemented with 10% FCS at 28°C. 
Sj9 cells were maintained in SF900 media (Invitrogen) supplemented with 2% FCS at 
28°C, 200 RPM shaking. 
Sj21 cells were maintained in TC 1 00 media (Sigma) supplemented with 10% FCS at 
28°C in spinner flasks. 
BSR ex NSI cells (Owens, Limn et al. 2004) were maintained in DMEM (Sigma) 
supplemented with 10% FCS at 37°C, 5% CO2• These cells contain the single chain 
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antibody against NS I under control of a Tet responsive promoter using the Tet off 
system (BD Clontech). To maintain the cells with no expression of the cassette, media 
was supplemented with 100Jlglml hygromycin, 100Jlglmi G418 and 1 ILg/ml 
doxyclycline, to give expression of the cassette, no doxycycline was added. 
Escherichia coli strains 
Genotype Methodologies used for 
Strain 
DH5a F',<p80dlacZ~MI5, Cloning, propagation and 
~(lacZYA-argF)UI69, maintenance of all plasmid 
deoR, recAI, endAI, stocks. 
hsdRI7(rk', mk+), phoA, 
supE44, t.:, thi-l, gyrA96, 
relAI 
XLI Blue recAl endAl gyrA96 thi-l Construction, propagation 
hsdR17 supE44 relA 1 lac and screening of the A 
[F'proAB lacf! ZL1M 15 Tn 1 0 phage libraries 
(Td)] 
BM25.8 supE44 , thi ,1(/ac-proAB) [F' Cre recombinase mediated 
traD36, proAB+, laclqZ ,1M15] recombination of A phage 
Aimm434 (kanR)P1 (camR) into plamsids 
hsdR (rk12- mk12-) 
3.2: Transfection of mammalian cells 
293T cells were grown in 24 well plates until 90% confiuent, washed in serum free 
MEM and incubated with 500Jll of serum free MEM. 50ILI of OPTIMEM (Sigma) was 
mixed with 2JlI of Lipofectamine 2000 transfection reagent (Invitrogen) and incubated 
at room temperature for 5 minutes. 0.5Jlg of plasmid DNA or 50-1 OOng of siRNA was 
added and incubated for a further 30 minutes (volumes given per well). The media was 
removed from each well and the transfection mix added drop wise, after 30 minutes at 
37°C 400Jll ofMEM plus 2% FCS was added to each well. 
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BSR and Vero cells were transfected as above but usmg the Lipofectamine Plus 
Transfection reagent (Invitrogen) and DMEM in place of MEM as per celI maintenance. 
3.3: Maintenance of BTV Stock 
BSR cells were grown to 80% confluency, washed in serum free DMEM and 5ml of 
serum free DMEM was added. BTV was then added at an MOl of 0.1 and left to adsorb 
at 35°C for I hour. 7ml DMEM 2% FCS was added and celIs were incubated at 35°C for 
3-4 days. Once 100% ePE was reached celIs and virus stock were stored at 4°C. 
3.4: Infection with BTV 
Cells were grown and maintained in the appropriate media until 80% confluent, washed 
in serum free media, infected with BTV at the appropriate MOl (MOl of I was used for 
most experiments giving almost synchronous infection of all celIs in the culture) and 
incubated at 35°e for 1 hour. The virus inoculum was removed, cells were washed in 
serum free media and then maintained until harvest in media supplemented with 2% 
FeS at 35°C. 
3.5: Maintenance of Baculovirus Stock 
Sj9 cells were grown in suspension to a density of 1 x 1 06 cells/ml and infected with 
recombinant baculovirus at an MOl of 0.01 then incubated with shaking at 200rpm at 
28°e for 5-6 days. Virus was harvested by centrifugation at 9500rpm and supernatant 
was stored at 4°C. 
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3.6: Infection with Baculovirus 
Sj9 cells were grown in suspension to a density of Ix 106 cells/ml and infected with 
baculovirus at an MOl of 0.1. Cells were then maintained for the 3-4 days until harvest 
for protein analysis. 
3.7: Virus Titration 
BTV 
BSR cells were grown, as in chapter 3.1, in 6 well plates to 100% con fluency. Cells 
were washed in serum free DMEM and Iml of serum free DMEM was added to each 
well. The virus stock was added in a serial dilution from 1 x 1 0. 1 to I X 10-6 across the 
wells and incubated at 35°C for 1 hour, with gentle rocking. The virus inoculum was 
removed and cells were washed gently in serum free DMEM. 2ml of agarose overlay 
(1.5% LMP agarose and 5% FCS in DMEM (minus phenol red» was added and set at 
4°C for 5 minutes; the plate was then incubated at 35°C for 3 days. Plaques were 
visualised by incubation with 2ml of 1120 neutral red (Sigma) in PBS solution for 5 
hours. 
Baculovirus 
Sj21 cells were seeded at a concentration of Ix 1 06 cells/well, in a 6 well plate, and left 
to adhere, at room temperature, for 30 minutes. The cells were washed with serum free 
TCI00 and then Iml of serum free TCIOO was added to each well. The baculovirus 
stock was added in a serial dilution from lxlO·2 to lxlO·7 across the wells and incubated 
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at 28°C for 1 hour, with gentle rocking. The virus inoculum was removed and cells were 
washed gently in serum free TCI00. 2ml of agarose overlay (1.5% LMP agarose, 5% 
FCS, and 50% TCIOO in SDW) was added and set at 4°C for 5 minutes before the 
addition of Iml ofTCIOO 10% FCS to the surface; the plate was then incubated at 28°C 
for 4 days. Plaques were visualised by incubation with 2ml of 1120 neutral red (Sigma) 
in PBS solution for 5 hours. 
3.8: RNA Extraction 
Total RNA was purified from T-75 flasks of cells (293T, BSR or Kc cells) only or cells 
infected with BTV-1O. Media was removed and centrifuged at 3000rpm for 5 minutes, 
the supernatant was discarded. The cell pellet and cells in the flask were combined and 
lysed by incubation with 10mls of TRl reagent (Sigma), a single step RNA isolation 
reagent, containing phenol and guanidine thiocyanate that immediately inactivates 
RNase activity, for 30 minutes. Iml of chloroform was added; using acidic 
phenollguanididium extraction, the aqueous phase, containing RNA, was harvested by 
centrifugation. Total RNA was then precipitated in isopropanol, washed with 70% 
ethanol and re-suspended in DEPC treated water. 
RNA was extracted from live, virgin Aedes aegypti mosquitoes by grinding them in TRI 
reagent using a pestle and mortar and then purifying as above. 
3.9: Purification of Poly A + RNA 
Poly A + RNA was purified from total RNA using the Oligotex mini kit (Qiagen). 
Briefly total RNA was added to the oligotex beads which have dClOT30 oligonucleotides 
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covalently linked to the surface. mRNA hybridises with high efficiency to this matrix, 
in high salt conditions, by base pairing interactions between its poly A + tail and the poly 
dT tail of the beads. After washing mRNA and can be eluted in pure form, from the 
beads by disruption of the hydrogen bonds using a low salt solution, without the need 
for ethanol precipitation. 
3.10: eDNA synthesis 
The SMART cDNA library construction kit (BD-Clontech) was used to synthesise 
double-stranded cDNA from Kc cell poly A+ RNA. The cDNA was synthesised, using a 
thermal cycler, with the appropriate termini, for use in the construction of a A library, 
provided by the sequence of the primers. Briefly the cDNA was amplified using primers 
that promote the inclusion of full length cDNA, including the 5' termini of the mRNA, 
giving specific ends with directional Sfi 1 sites used for ligation with the provided A. 
phage arms. The cDNA was size fractionated using chromaspin 400 size exclusion 
columns (BD-Clontech) and the larger and middle size cDNA (approximately IKb-
7Kb) was collected. 
The BD Matchmaker library construction kit was used to synthesise double-stranded 
cDNA from Kc cell poly A + RNA and A. aegypti poly A + RNA. The cDNA was 
synthesised as above but with the appropriate termini for use in the construction of a 
plasmid library that can be expressed in the yeast two-hybrid system, again the 
sequence was provided by the primers. The termini in this case are used for homologous 
recombination with the yeast plasmid giving directional inserts for expression in the 
yeast two-hybrid system. 
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3.11: cDNA library construction 
The HeLa cDNA library was purchased from Clontech. This was generated by 
directional cloning of HeLa cDNA into the two-hybrid DNA activating domain vector 
pGADGH. 
The Kc A library was constructed using the SMART eDNA library construction kit 
(BD-Clontech). cDNA was synthesised as above and the appropriate size fractions were 
digested with Sfi 1 and ligated directionally into the A phage arms which are pre-
digested with Sfi 1. This produces a A phage with a cDNA insert within the mUltiple 
cloning site situated between the two arms of the phage. The library was then tested 
using blue/white plaque screens to calculate the percentage of A phage with eDNA 
inserts, blue colouration of plaques identifies non-recombinant A phages, and then the 
resulting library was amplified before use. In this library the cDNA insert was 
expressed from a triple reading frame cassette that allowed all eDNA inserts to be 
expressed in the frame normally used by the host, in addition to the remaining two 
frames. 
A Kc cDNA library was constructed using the BD matchmaker library and screening kit 
(BD Clontech). Kc cDNA was produced as in chapter 3.10 and cloned into the two-
hybrid DNA activating domain vector pGADT7-Rec by recombination of homologous 
sites in the primer sequences. Recombination was carried out in the yeast strain AH I 09 
by co-transformation of the cDNA and linearised plasmid; recombination repaired the 
linearised plasmid and allowed expression of the transcription factors necessary for 
complementation of the yeast auxotrophisms. Successful recombination was selected 
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for on solid yeast media (see chapter 3.13) minus leucine, and positive colonies were 
amplified and washed off the media before use. The library in this procedure is present 
in yeast and screening is done via mating to limit amplification of the library. In 
contrast to the A phage library, the cDNA insert is only expressed in one frame which 
decreases the chance of it producing the same peptide as is produced from within the 
normal host. 
The BD matchmaker kit was also used to construct an A. aegypti eDNA library in the 
yeast strain AH109. 
3.12: A Library Screening 
The A library was screened using the plaque lift technique (Stratagene Picoblue 
immunoscreening kit). A plaque assay was performed with the A library in a lawn of 
XLI blue E. coli in NZY agar (5g NaC!, 2g MgS04, 5g yeast extract and 109 NZ amine 
per litre, pH 7.5. For bottom agar add I5g agar!l, for top agar add agarose to 0.7% w!v). 
Once small plaques were visible, approximately 8 hours post plating; cDNA expression 
was induced with IPTG, by overlaying the agar with a nitrocellulose filter and 
subsequent incubation for 4 hours at 37°C. The filters were first soaked in 10mM IPTG 
for 1 minute and then dried. The expressed cDNA proteins were bound to nitrocellulose 
filters, as they were released by lytic A phage replication. The filters were washed in 
TBS-T (20 mM Tris-HCI, pH 7.6, 137 mM NaCI. and 0.1% Tween-20) and then 
blocked with TBS-T 5% milk powder for I hour. After blocking the filters were then 
incubated for 2 hours with eSS-methionine] labelled NSI expressed from a recombinant 
baculovirus. The filters were washed 5 times in TBS-T. dried on blotting paper and 
viewed via radiography to identify positive plaques that bound NS 1; the corresponding 
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plaques were then purified with 3 rounds of plaque assays. BM25.8, an E. coli strain 
that expresses Cre recombinase, was infected with the purified phage ATripl Ex2 which 
contains loxP sites flanking the embedded plasmid pTripl Ex2 (containing the cDNA 
insert). The plasmid was excised using Cre-mediated site specific recombination at 
31°C, for 1.5 hours, and the resulting colonies containing the plasmid were selected for 
using ampicillin selection. The plasmids were then amplified and purified by normal 
DNA purification protocols. Any further studies with the purified plasmids were 
performed in DH5a strain E. coli to prevent further recombination. 
3' sequencing primer: T AA T ACGACTCACT A T AGGGC 
5' sequencing primer: CTCCGAGATCTGGACGAGC 
3.13: Yeast Two-Hybrid System 
3.13.1: Yeast strains 
The yeast strains of Saccaromyces cerevisiae routinely used for yeast two-hybrid 
analysis were propagated on complete nutrient media, YPDA (lOg yeast extract, 109 
bactopeptone and 20g dextrose per litre, pH 5.6. For solid YPDA add 15g agar), and 
kept at 4°C. AHlO9 and Y187 were used for the mating screen (AHI09 being the A 
strain and Y187 being the ex strain), PJ694A was used for the HeLa cDNA screen. These 
yeast strains are defective in various nutritional pathways which are complemented by 
the plasmids used in this system; without the plasmids these yeast strains can only be 
propagated on YPDA. 
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Yeast strain Auxotrophic requirements Plasmid complementin2 the mutation 
AHl09, trpl-90l genotype, requires pAS2-l and recombinant plasm ids e.g. 
Y187 and tryptophan for growth pAS-NSl and pAS-VP7 
PJ694A leu2-3, 112 genotype, pACT2 and pGAOT7-Rec plasmids e.g. 
requires leucine for growth library plasmids and pACT-VP7 
AH109 and ADE2 Interaction of the GAL4 transcription 
pJ694A factor domains, as a result of interaction 
HIS3 of the recombinant proteins fused to 
them, gives complementation. 
Table 3. 1: Table of all the auxotrophic properties of the yeast strains used and the 
plasmids that complement each mutation (for further information on 
complementation of Ade2 and His3 mutations see figure 3.1). 
3.13.2: Yeast transformation 
Yeast were grown in YPOA liquid culture over night and grown to an 00600 of 1.0. 
Yeast were pelleted and washed in 100mM LiOAc before re-suspension in 100mM 
LiOAc. Approximately 5.0 x 107 yeast were combined with 33% PEG 3350, 100mM 
LiOAc, 300JLM ssONA (from salmon testes) and lJLg of plasmid in a final volume of 
l80J.L1 and incubated for 30 minutes at 30°C. After a further 30 minute incubation at 
42°C yeast were centrifuged and re-suspended in SDW before plating on minimal media 
minus the appropriate amino acids to allow plasmid selection, see table 3.1 (SM 
minimal media (6.7g yeast nitrogen base, 20g dextrose and dried amino acid mix that 
does not contain adenine (A), tryptophan (W), histidine (H) and leucine (L» with H, A, 
Land Wadded to the appropriate concentrations when needed). 
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3.13.3: Yeast mating 
Approximately 1 x 10 10 YlS7 yeast containing the bait DNA-BD plasmid were 
combined with 1 x 108 AH109 yeast containing the prey DNA-AD plasmid on a 15cm 
plate of complete YPDA agar. This was incubated at 30°C for 12 hours before the yeast 
were washed off using PBS and sterile glass beads. Yeast were centrifuged and 
resuspended in SDW before plating on SM media minus the appropriate amino acids to 
select for the plasmid or the plasmid and protein interactions. 
3.13.4: Plasmid isolation 
Yeast were grown in liquid culture overnight, centrifuged and resuspended in lysis 
buffer (25mM Tris pHS, lOmM EDT A pH S, 1 % SDS, 1 % NLS and 0.3M NaOAc). 
Phenol: chloroform was added to 20% with sterile glass beads and the solution was 
vortexed for 3 minutes. The aqueous phase was recovered and isopropanol precipitated. 
The pellet was re-suspended in SDW and RNA was precipitated in 3M NaOAc on ice 
for 30 minutes, the resulting supernatant was isopropanol precipitated. Chromosomal 
DNA was removed from the pellet in 6.5% PEG SOOO, O.SM NaCI on ice for 10 
minutes. After centrifugation the resulting pellet of plasmid DNA was resuspended in 
SDW. 
3.13.5: Library Screening 
The HeLa yeast two-hybrid library was screened following the protocol supplied with 
the library by co-transfection of the bait plasmid (NS 1-DNABD) and the library 
plasmids. Yeast (PJ694A) containing pAS-NS 1 was transformed with the library 
plasmid and plated on SM media minus leucine and tryptophan, selecting for the 
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presence of both plasmids which complement the auxotrophic requirements of the yeast 
parent. Interacting bait and prey proteins were identified by replica plating onto a 
further selection of SM media minus histidine and adenine, in addition to leucine and 
tryptophan, on this media the yeast will only grow if the 2 proteins interact bringing 
together the GAL4 DNA binding and activation domains (Fig 3.1). This step was 
repeated to minimise the number of false positives. The library plasmids were extracted 
and re-transformed in parallel into yeast containing either pAS-NS 1 to confirm the 
interaction or pAS-VP7 to isolate non-specific interactions. The cDNA inserts identified 
as putative positives by interacting with pAS-NSI but not pAS-VP7, were sequenced 
using primers specific to the 3' and 5' flanking regions of the cDNA insert. 
3' sequencing plasmid: 
5' sequencing plasmid: 
5'------GAA GAT ACC CCA CCA AAC CC---------3' 
5'------GA AGG CCT GAA TTC AGA TCT GCC---3' 
The Kc and A. aegypti cDNA libraries were screened as above with the exception that 
the plasmids were not co-transformed. The library plasmid was constructed by 
recombination, in the yeast strain AHI09, of the cDNA insert and linearised plasmid, 
and then mated on YPD agar overnight with yeast strain Y 187 pre-transformed with 
pAS-NSl. Yeast containing both plasmids was selected for as above and then replica 
plated to select for interaction as above. The positives were sequenced using the 
primers, 3' sequencing plasmid and 5' sequencing plasmid, as described for sequencing 
of the HeLa cDNA library. 
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Figure 3. 2: Schematic of the yeast two-hybrid system screening process, detailing 
the interactions of the GAIA domains necessary for identification of the cDNA 
interactions to occur. 
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3.14: Construction of plasmids 
FLAG tag Constructs 
For expression in both E. coli and mammalian cells the vector pTriEx4 (Novagen) was 
used. Inserts were amplified by PCR using a 5' primer with the sequence for a FLAG 
tag contained within it to allow for easy identification of the proteins in suhsequent 
analysis. The primers also contained restriction enzyme recognition sites to allow 
products to be digested and inserted into the MCS region ofpTriEx4. 
5' primer: 
5' ---GA AGG CCT GAA TIC AGA TCT GCC ATG GAT TAT AAA GAT GAT GAT GAT AAA----3' 
MDYKDDDDK 
3' primer: 5'----GAA GAT ACC CCA CCA AAC CC-----3' 
Yeast Two-Hybrid Constructs 
The coding region of NSI was cloned into pAS2-1 (Clontech) giving a C-terminal 
fusion to the GAL4 DNA binding domain; pAS-NSl (Noad, R). 
The coding region of VP7 was cloned into pAS2-1 giving a N-terminal fusion to the 
GAL4 DNA binding domain; pAS-VP7 (Noad, R). 
3.15: Plasmid DNA Purification 
Plasmids were transformed into competent E. coli DH5a by heat shock at 42°C and then 
grown in 50ml liquid culture for approximately16 hours. E. coli was harvested via 
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centrifugation and re-suspended in 6ml 25mM Tris, 10mM EDT A. 9ml 0.2M NaOH , 
1% SDS to lyse the bacterial cells and denature DNA, the protein and chromosomal 
DNA was then precipitated by the addition of 7ml 4M KOAc and centrifugation. The 
supernatant was strained through 2 layers of wet muslin and nucleic acid was 
precipitated using isopropanol and centrifugation. The pellet was re-suspended in 185/1,\ 
SDW, and 555111 of 4M NaOAc pH 6.0 was added; the RNA was precipitated on ice for 
30 minutes. After centrifugation at 13000 rpm the supernatant was harvested and DNA 
was precipitated with isopropanol. The DNA pellet was re-suspended in 600111 SDW 
and 600lli 13% PEG 8000 1.6M NaCI was added; the centrifugation was repeated. This 
DNA pellet was re-suspended thoroughly in 700lli of SDW and 200lli of 
phenoVchloroform was added. The supernatant was clarified by centrifugation and the 
purified plasmid was precipitated by NaOAc/ethanol precipitation. 
3.16: Sequencing of DNA 
DNA was sequenced using Big Dye chain terminator reaction mix (Applied 
Biosystems) in a total volume of 10J1.1 (4.4J1.1 of DNA (50ng/IlI), 4111 of ABI version 3 
mix and 1.6J1.1 of primer (1 pmolllll)). The reaction was heated to 96°C for 2 minutes 
followed by 35 cycles of 96°C for 30 seconds, 50-58°C for 15 seconds and 60°C for 4 
minutes. The DNA was prepared for gel sequencing by NaOAc/ethanol precipitation (to 
the 10J1.1 reaction add 3111 NaOAc pH5.2 and 86111 70% ethanol, incubate at room 
temperature for 15 minutes and centrifuge at 13000 rpm for 20 minutes. Wash the penet 
twice in 500lli 70% ethanol to remove the excess salt and dry) and analysed on an ABI 
prism 337 DNA sequencer. 
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3.17: SDS PAGE and Western Blot Analysis 
Protein samples were analysed on 10% polyacrylamide SDS gels and then either 
visualised by coomassie staining or western blotting. To stain gels with coomassie blue, 
gels were fixed in destain buffer (450ml methanol, 100m I acetic acid and 450ml water 
per litre) for 20 minutes and then stained in coomassie blue buffer (450ml methanol, 
100m I acetic acid, 450ml water and 2.5g coomassie brilliant blue per litre) overnight. 
The excess staining was removed by washing in destain buffer until only the proteins 
were stained. 
For analysis by western blot proteins were transferred by western blotting at 100mAmp 
for 1 hour to nitrocellulose membranes. The membranes were blocked in PBS-T 5% 
milk powder (0.05% tween 20 in PBS (0.01 M phosphate buffer, 0.0027 M potassium 
chloride and 0.137 M sodium chloride) pH 7.4,) for 1 hour before being probed with 
primary antibodies at a 111000 dilution, in PBS-T milk, against the desired proteins over 
night. The membranes were washed then re-probed with secondary antibodies 
conjugated with alkaline phosphatase diluted at 1/10000 in PBS-T milk, and the protein 
bands were visualised using Lumiphos (Pierce) and chemiluminescence detection by 
film, or Sigma fast tablets (Sigma). 
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3.18: Antibodies 
Antibody Protein detected Techniques used for 
Rabbit anti-BTV-10 (R) BTV -10 proteins Western blot 
Mouse anti-VP2 VP2 Western blot 
Rabbit anti-VP3 VP3 Immunofluorescence 
Guinea pig anti-VP5 (GP) VP5 IImmuno fl uorescence, 
immunoprecipitation, 
Mouse anti-VP7 (MAb 11AlO) VP7 Immunofluorescence, 
immunoprecipitation, 
western blot 
Rabbit anti-NS 1 (R633) NSI Western blot 
Guineapiganti-NS1 (GP791) NS1 Immunofluorescence, 
immunoprecipitation 
Guinea pig anti-NS2 (GP 373) NS2 Immunofluorescence, 
immunoprecipitation 
Mouse anti-NS3 (AP 434) NS3 Immunofluorescence, 
western blot 
Rabbit anti-CBP (Upstate) Calmodulin binding Western blot 
protein 
Mouse anti- a tubulin (Sc 5286, a tubulin Immunofluorescence 
Santa Cruz Biotechnology) 
Goat anti-actin (Sc 1616, Santa Actin Immunofluorescence, 
Cruz Biotechnology) western blot 
Goat anti-vimentin (Sc 7557, Santa Vimentin Immunofluorescence, 
Cruz Biotechnology) western blot 
mouse anti -Caspase 3 (eBioscience, Caspase 3 Western blot 
San Diego, CA) 
Rabbit anti-SUMO-l (Sc 5308, SUMO-I Immunofluorescence, 
Santa Cruz Biotechnology) western blot, 
immunoprecipitation 
Mouse anti-FLAG (Sigma) FLAG peptide Immunofluorescence, 
western blot, 
immunoprecipitation 
Table 3. 2: Antibodies used in methods described in this thesis. 
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3.19: Confocal Immunofluorescence Microscopy 
Cells (BSR, 293T or Sj21) were cultured on glass cover slips in 24 well tissue culture 
plates and where necessary infected with BTV -10 and/or transfected with plasmids 
expressing various proteins (BTV -IONS 1, FLAG tagged cDNA inserts or SUMO-I). 
Cells were washed with PBS and fixed using cold PBS 4% parafonnaldehyde at room 
temperature for 30 minutes, the washes were repeated. Cells were penneablised with 
PBS 1 % Triton X-IOO for 10 minutes and then washed. Cells were incubated with 
primary antibody at a dilution of 11100 to 11300 for 20 minutes, washed and then 
incubated with secondary antibody conjugated to FITC or TRITC stains for 30 minutes. 
During staining with the secondary antibody the nuclei were also stained using Hoesch 
stain (Sigma-Aldrich), at a concentration of 10JLglmi. Cover slips were washed and 
mounted in 5JLI of mountant on slides, the edges were sealed with clear nail varnish and 
slides were examined using a Zeiss LSH 510 confocal microscope and images were 
elaborated using LSH 510 image browser software. 
3.20: Radio-labelling of Proteins 
Proteins under the control of the T7 promoter (cloned into plasmid pOcus or pTriEx4, 
both Novagen,) were transcribed and translated in vitro using the TNT T7 quick 
coupled transcription/translation kit (Promega). The plasmid was incubated with the 
rabbit reticulocyte lysate mix and esS] methionine at 30°C for 90 minutes and the 
labelled proteins were then analysed by SDS PAGE. The TNT kit combines T7 RNA 
polymerase to transcribe RNA from the T7 promoter, and rabbit reticulocytes, which 
provide the tRNA, ribosomes, amino acids, initiation, elongation and tennination 
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factors needed for translation. The labelled methionine is incorporated into the proteins 
as they are translated as it is the only source of methionine in the mix. 
Proteins expressed in the baculovirus system can also be labelled. Sj9 cells were grown 
in tissue culture plates and infected as described in chapter 3.7; 24 hours post infection 
cells were washed in SF900 II minus L-methionine (Invitrogen), and then incubated for 
30 minutes in this media. After this starvation period the media was supplemented with 
0.6MBq 35S labelled L- methionine and incubated at 28°C for 2 hours, proteins made 
during this time incorporated the labelled methionine as the non-labelled methionine 
was limited by the previous starvation step. Labelled proteins were harvested via cell 
lysis. 
3.21: Co-immunoprecipitation 
Test proteins were co-expressed and radio-labelled using co-infection of recombinant 
baculoviruses (Sj9 cells lysed using freeze thaw in 25mMNaHCOJ) or the in vitro TNT 
system (chapter 3.20). Protein A sepharose beads were prepared in IP buffer (50mM 
Tris pH 7.4, 150mM NaCl, ImM EDTA, 0.025% NP40) and incubated at 4°C, with 
rolling, for 1 hour with primary antibody (against one of the proteins being isolated e.g. 
anti-NS 1 antibody). The beads were then washed 4 times in IF buffer and a further 
twice in Native IP buffer (50mM Tris pH 7.4, 150mM NaC], ImM EDTA, 0.5% NP40, 
0.05% deoxycholate). The beads were re-suspended in Native IP buffer (0.05% 
deoxycholate for medium stringency) and the labelled proteins were added. After 1 hour 
incubation at 4°C, with rolling, the beads were washed three times and the samples were 
re-suspended in SDS PAGE loading buffer (removes any proteins from the beads for 
analysis as normal) and analysed by SDS PAGE and autoradiography. 
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3.22: TAP tag Construct and Purification 
NS I was cloned into pNTAP B (Stratagene) for expression of N-terminal TAP tagged 
NS I in mammalian cells. NS I was amplified by PCR from PNSS (a plasmid containing 
full length NS I already analysed for tubule production) to give Bam HI and Eco RI sites 
for directional cloning (primers NSI fwd and NSI rev below). NSI was digested and 
inserted into pNT AP B, which was digested with the same enzymes, giving 
pTAPBNSl. 
NSI fwd: 5'----CTG GAA TTC GGA TCC TCT AGT TGG CAA CCA CCA------3' 
Eco RI Bam HI 
NSI rev: 5'----CTG CTC GAG GAA TTC ATA CTC CAT CCA CAT CTG AG--3' 
Xho I Eco RI 
The TAP tag of pTAPBNSI contains a streptavidin binding site and a calmodulin 
binding site. NS I can be purified via both tags yielding NS I plus any proteins that 
interact with NS I in the mammalian cell culture system. 
Tandem affinity purification of T APBNS I was performed by joining two well known 
purification procedures together. The streptavidin purification protocol from the 
Stratagene Interplay mammalian TAP system was followed using buffers, SBB and 
SEB, and the calmodulin binding protein purification protocol from the Stratagene 
Interplay mammalian TAP system was followed using buffers, CBB and CEB. 
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SBB: 40mM Tris pH 8.0, 300mM KCI, 2mM EDT A, 0.1 % Triton X 100, 5mM .6ME, 
100jlg/ml BSA, 20jlllmi PIC (protease inhibitor cocktail, Sigma) and 1 mM 
pefabloc (Sigma). 
SEB: SBB plus 2mM biotin 
CBB: lOmM tris pH 8.0, 150mM NaCI, 0.1 % imidazole, 2mM CaCb, 5mM .6ME, 
20jlllmi PIC and ImM pefabloc (Sigma). 
CEB: 10mM Tris pH 8.0, 2mM EGTA, 0.1 % NP40, ImM imidazole and 10mM .6ME. 
Streptavidin beads were washed 5 times in SBB and then re-suspended in SBB. 
T APBNS 1 was expressed in 293T cells which were then lysed by dounce 
homogenisation in PBS 0.5% Triton X 100. Cell lysate was clarified by centrifugation 
and the supernatant was added to the streptavidin beads and incubated at 4°C for 2 
hours, with rolling. The beads were washed 3 times in SBB and then re-suspended in 
SEB (contains 2mM biotin which competes for the streptavidin, displacing the protein 
from the beads and into the eluate) and incubated at 4°C for 2 hours, with rolling. The 
supernatant was collected and CaCI2 (Ca2+ is needed for binding of the CBP tag to the 
calmodulin beads) was added to a final concentration of2mM, the supernatant was then 
added to the calmodulin beads in CBB (washed and re-suspended in CBB) and 
incubated at 4°C for 2 hours, with rolling. The beads were washed 3 times and re-
suspended in CEB (contains 2mM EGTA to chelate the Ca2+ ions dissociating the 
tagged protein from the calmodulin beads) and incubated at 4°C for 2 hours, with 
rolling. The eluate and beads were harvested and analysed via SDS PAGE and western 
blot alongside samples from each step of the protocol. 
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3.23: Caspase 3 Assay 
293T cells were transfected with plasmids expressing the yeast positive TY7 and NS I 
protein under the cytomegalovirus promoter (CMV), a pol II based promoter, and 
incubated for 20 hours. Cells were harvested by centrifugation and re-suspended in lysis 
buffer (PBS 0.5% Triton X 100) containing protease inhibitors (PIC Sigma). After 4 
cycles of freeze-thaw, cell debris was pelleted by centrifugation and the supernatant 
harvested. The supernatant was analysed by western blot using mouse Ig G anti-Caspase 
3 (eBioscience, San Diego, CA) and lumiphos (PIERCE). The blot was visualised using 
hyperfilm (Amersham-Pharmecia Biotech). 
3.24: DNA Fragmentation Assay 
293T cells were transfected with plasmids expressing the yeast positive TY7 and NSI 
protein under the CMV promoter and incubated for 20 hours. Cells were harvested by 
centrifugation and re-suspended in lysis buffer (PBS 0.5% Triton X 100) containing 
protease inhibitors (PIC Sigma). After 4 cycles of freeze-thaw, cell debris was pelleted 
by centrifugation and the supernatant harvested. The supernatant was incubated for 1 
hour at SO°C with RNase A at SOp.g/ml to remove RNA from the sample which affects 
the results when visualised by UV. The cell supernatant was then clarified by 
phenol/chlorofonn precipitation and the aqueous phase containing total cellular DNA 
was harvested. The DNA was precipitated in 3M NaOAc pH7.4 and 70% ethanol to 
concentrate it and washed twice in 70% ethanol to remove excess salt. The DNA pellet 
was air dried, re-suspended in SDW and analysed on a 2% agarose gel. 
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3.25: ELISA 
ELISA (enzyme linked immunosorbent assay) assays were performed by coating 96 
well plates with purified NS 1 tubules over night at room temperature. Wells were 
washed 3 times with PBS and blocked with either PBS 5% milk or PBS 5% BSA for 2 
hours at 37°C; washes were repeated. The test FLAG tagged protein was added to the 
wells and incubated for 90 minutes at room temperature; wells were washed 3 times 
with PBS and then primary antibody, mouse anti-FLAG antibody (Sigma), was added 
and incubated at room temperature for 2 hours. After washing a further 3 times 
secondary anti-mouse-HRP conjugate (Sigma) was added and incubated for 2 hours at 
room temperature. The wells were washed extensively (6 times) and 100111 of TMB 
liquid for ELISA (Sigma) was added, this produced a blue colour in wells that contained 
the FLAG tagged product binding both primary and secondary antibodies (this indicated 
an interaction between the FLAG tagged protein and NS1). Once the blue coloured 
product appeared the reaction was stopped immediately by the addition of 50111 I II 0 
HCI. The colour change product was read on a plate scanner, stronger signals indicated 
more binding of the FLAG tagged proteins to NSI. 
3.26: NSI Tubule Purification 
NS 1 expressed by baculovirus produces large amounts of tubules that can be purified by 
sucrose gradient. Cells expressing NS 1 (mammalian cells infected with virus or 
transfected with plasmid, or Sj9 cells infected with recombinant baculovirus) were lysed 
in STE buffer (l50mM NaCI, ImM EDTA, 10mM Tris pH 7.5) with 0.5% Triton X-
100 (Sigma) and dounce homogenisation. The cell lysate was clarified by centrifugation 
and the supernatant was loaded onto a 2ml 40% sucrose cushion in STE buffer. Tubules 
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accumulate in a pellet having passed through the sucrose cushion, leaving smaller 
cellular material above the sucrose cushion, by ultra-centrifugation at 35 OOOrpm for 2 
hours. The sucrose cushion was then diluted with STE buffer to a volume of 5ml and 
loaded onto a continuous sucrose gradient of 10-40% before ultra-centrifugation at 20 
OOOrpm for 1 hour. The gradient is collected in Iml samples and each sample is 
analysed by SDS PAGE and/or western blot, tubules are large and vary in length so 
should be present in middle to bottom fractions of the gradient. 
3.27: Disruption of Intermediate Filaments 
293T or BSR cells were grown in 6 well plates, or on cover slips as for confocal 
immunofluorescence microscopy, in MEM 10% FCS or DMEM 10% FCS respectively. 
Cells were infected with BTV-IO at an MOl of 1, and left to adsorb at 4°C for 1 hour. 
The inoculum was removed and fresh media was added. Cells were maintained until 
harvest in MEMIDMEM media supplemented with 2% FCS, containing OmM 
acrylamide as a negative control or 2mM acrylamide at 35°C, 5% CO2. Cells were 
harvested or fixed and the effects of acrylamide on virus replication and protein 
expression/distribution were examined by immunofluorescence, western blot and virus 
titre analysis. 
3.28: siRNA design and optimisation 
siRNA against NS 1 was designed as an RNA molecule, to be transfected directly into 
cells, using the design tool, siMAX™, supplied on the MWG website 
(http://www.mwg-biotech.comlhtmlls _synthetic _acids/s _rna.shtml). The tool ranks 
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potential siRNA according to their ability to fulfil 12 criteria including GC content, 
secondary structure and critical positioning of specific nucleotide bases in the siRNA 
sequence. The siRNA that achieved the highest rank for potential knockdown in the 
modelling design tool is aimed at region 347 - 365 ofNS 1. 
NS 1 siRNA; Sense strand 5'--- UGA UGG AGG CUA UUA ATT---3' 
siRNA against SUMO-l was pre-designed by Ambion (http://www.ambion.com). two 
siRNA were used with the fonowing sequences: 
siRNA 138970: 5'--- GGU GAG AGU AAU GAC UAA Ctt----3' 
3'--tt CCA CUC UCA UUA CUG AUU G------5' 
siRNA 13183: 5'--- GGA AGA AGA UGU GAU UGA Att----3' 
3'--ct CCU UCU UCU ACA CUA ACU U -----5' 
Fluorescein labened scramble siRNA (NEB) was used as a transfection efficiency 
control. The double-stranded siRNA is 21 bases in length (19 of these are 
complementary and base pair, the remaining 2 bases overhang at the 3' terminus) and 
has a fluorescein molecule linked to the 5' termini of both strands. This control has no 
sequence identity to any mammalian sequences in the database and has the fonowing 
sequence: 
Fluorescein-5'----AGG UCG AAC UAC GGG UCA AUC----3' 
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Fluorescein-5'----UUG ACC CGU AGU UCG ACC UAG----3' 
3.29: siRNA transfection in mammalian cells 
siRNA was transfected into 293T cells twice, once at 24 hours prior to infection and a 
second time 12 hours prior to infection with BTY-10. 100ng of siRNA was used per 
well on a 24 well plate and either Lipofectamine 2000 (Invitrogen) or simporter 
(Upstate) transfection reagent was used. 
293T cells were grown in 24 well plates until 90% confluent, washed in serum free 
MEM and incubated with 500JLI of serum free MEM. 100JLI of serum free OPTIMEM 
was mixed with IJLI of transfection reagent and incubated at room temperature for 5 
minutes. In a separate tube 100JLI of serum free OPTIMEM was mixed with 100ng 
siRNA (volumes given per well). The 2 tubes were mixed and incubated at room 
temperature for 30 minutes then added to one well of cells. FCS was not added to the 
wells after the first transfection but was added after the second transfection to a final 
concentration of 2%. Cells were not washed prior to the second transfection or prior to 
infection with BTY -10 as better transfection efficiencies were obtained if the 
transfection mix remained on the cells. 
Transfection efficiency was highly variable dependant upon cell condition, confluency 
of the monolayer and amount of siRNA used; some cell death was detected after the 
second transfection in every experiment performed. Cells were always transfected for 
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the first time, 24 hours prior to infection, at a confluency of approximately 90%; only 
fresh cells seeded the day prior to transfection were used. 
3.30: Preparation of Cells for Electron Microscopy 
293T and BSR a NSI cells were grown as in Chapter 3.1 in T-75 flasks. 293T cells 
were transfected with the appropriate siRNA, specific to NS 1 or control scramble 
siRNA, or left un-transfected as positive control. The flasks were infected with BTV -10 
at an MOl of 1, except for the negative control which was neither transfected nor 
infected, and incubated for 18 hours at 35°C, 5% CO2• The monolayer was washed with 
serum free DMEM pre-warmed to 37°C and then fixative 1 (3% gluteraldehyde in 
serum free DMEM pH 7.4) pre-wanned to 37°C was added. Cells were immediately 
scraped off the flask in large sheets and incubated for 15 minutes. Cell sheets were 
pelleted gently at room temperature for 5 minutes, 3000rpm and re-suspended in 
fixative 2 (3% gluteraldehyde in 0.2M sodium cacodylate buffer pH 7.4), pre-warmed to 
room temperature, and subsequently incubated at 4°C for 2 hours. 
The cells were washed in 0.2M sodium cacodylate buffer for 15 minutes, this step was 
repeated 4 times. Cells were then osmicated in 1 % OS04 for 90 minutes and the washes 
were repeated as above and then again using SDW. Cells were added to 2% LMP 
agarose in SDW and incubated at 45°C for 2 hours. The cell samples were then 
dehydrated, for 10 minutes in each solution, in ever increasing concentrations of 
methanol starting at 30% and continuing to 100%. The dehydrated cells were treated 
with propylene oxide at a 1: 1 ratio with 100% methanol for 10 minutes before treatment 
with propylene oxide only for 10 minutes. The propylene oxide was replaced with 
propylene oxide at a 1: 1 ratio with T AAB resin for 10 minutes and then incubated 
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overnight at room temperature with T AAB resin only. Fresh T AAB resin was added 
before the samples were embedded and polymerised at 60°C for 24-48 hours. 
Cell samples were fixed, sectioned and examined by Maria McCrossan and Dr David 
Ellis using transmission electron microscopy before digital capturing of the images. 
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4: Identification of Interactions between NSI and 
Mammalian Cellular Proteins 
4.1 Introduction 
Viruses encode few proteins in comparison to their complex mammalian hosts and 
therefore use host macromolecular machinery and materials to replicate successfully. 
This dependence means that viruses have adapted a variety of mechanisms for 
exploiting host cell functions. Since this is often detrimental to the cell, the virus must 
either replicate fast enough for this to be negligible or must evolve mechanisms of 
limiting damage and evading host immune responses until its replication cycle is 
complete. 
During virus infection there are continuous interactions between the virus and the host, 
some interactions are the use of housekeeping cellular processes such as DNA 
replication, RNA translation and protein maturation pathways. Other interactions are an 
interference of cellular functions providing more favourable conditions for virus 
replication, for example the interference of the interferon and related pathways by 
viruses with single-stranded RNA genomes allowing evasion of this cellular antiviral 
pathway (Diamond 2003). 
BTV has 4 non-structural proteins which do not have any enzymatic function assigned; 
it is therefore likely that they perform some other role in virus replication. NS2 is 
known to bind ssRNA and is present in large amounts at the site of virus replication 
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(Thomas, Booth et al. 1990); it is probable that NS2 is involved in recruiting and 
packaging of ssRNA before encapsidation, potentially using specific RNA structures or 
sequences to ensure that 10 different RNAs are packaged in each virion. NS3 has a role 
in virus egress from the cells which it achieves via interactions with several cellular 
proteins including the calpactin light chain (p 11) and TSG 101 (Beaton, Rodriguez et al. 
2002; Wirblich, Bhattacharya et al. 2006). 
NS 1 has no known role in BTV replication, although given that it is the most highly 
expressed viral protein it is likely to have an important role. It has been linked to virus 
egress although given that NS3 also has a role in this it can be assumed that NS 1 will 
have more than one function. There is no current explanation for the differences in 
pathogenesis and virus egress between insect and mammalian cells and little is known 
of the cellular proteins that BTV interacts with. 
The yeast two-hybrid system is well known for its use in identifying protein-protein 
interactions using a specified bait protein. Large numbers of potential interactions can 
be screened as the interaction is based on a powerful growth selection from the 
conditional expression of the yeast HIS3 reporter gene. A second conditional reporter 
gene ADE2 increases the stringency of this screening method. Using the specified 
protein fused to the GAL-4 DNA binding domain as bait, interacting clones fused to the 
GAL-4 activation domain can be quickly identified and processed for use in subsequent 
analysis. 
Another useful method for identifying protein-protein interactions is the TAP tag 
tandem affinity purification system. This method identifies proteins that interact in vivo 
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and therefore produces less false positives than the yeast two-hybrid system. The 
protein of interest is cloned with a TAP tag consisting of the streptavidin binding 
protein and the calmodulin binding protein. This dual tag is used for a double 
purification of the tagged protein without the use of harsh buffers; this ensures that any 
proteins that have a strong interaction with the tagged protein are co-purified. Co-
purifying proteins are identified by mass spectrometry and further analysis can be 
completed. 
Previous work on NS 1 interactions identified a putative interaction between SUMO-I 
and NSl, by yeast two-hybrid analysis using NS1 with an N-terminal tag to the GAL4 
DNA binding domain (pAS2-NS1) as bait (Noad, R and Roy, P; personal 
communication). SUMO-1 was isolated from this screen on 5 separate occasions and 
confirmed as a positive by retransformation into yeast containing pAS2-NS 1. Further 
confirmation of this interaction was provided by confocal immunofluorescence 
microscopy analysis indicating co-localisation between SUMO-1 and plasmid 
expressed, or BTV -10 expressed, NS 1 in mammalian cells. 
Basal levels of SUMO-l were not detectable by western blot or confocal analysis in 
uninfected cells. However BTV-IO infection readily induced SUMO-1 expression 
within 293T and BSR cells; sumoylated proteins were detected as early as 1 hour post 
infection. A variety of sumoylated products were detected by western blot analysis, 
these were 30, 43, 58, 70 and 80 kDa in size (Fig 4.1); none of these proteins were 
identified as BTV proteins. Confocal analysis of BTV -10 infected cells detected 
SUMO-l localising in distinct foci within the cell, not all of which co-localised with 
NSI. Further analysis showed SUMO-1 induction to be a specific response to BTV-10 
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infection as no SUMO-I could be detected by sUbjecting 293T or BSR cells to infection 
by Fowl pox virus or heat shock stress (Fig 4.1). 
BlV FPV HS 
BSR 293T BSR 293T BSR 293T 
""6"24 624 624""624 6'""24 "'6'24 k Da 
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- 24 
Figure 4. 1: Western blot comparison of sumoylation patterns following a variety 
of 'stresses' in 293T and BSR cells. Cells were treated with BTV-tO, Fowl pox 
virus (FPV) or heat shock at 42°C (liS) and harvested at 6 and 24 hours. Note the 
identical patterns of sumoylated proteins in BTV-t 0 infected 293T and BSR cells 
(Noad, R and Roy, P; personal communication). 
NS 1 alone was insufficient to induce expression of SUMO-l within mammalian cells 
and interaction in vitro was not proved as immunoprecipitation could not be achieved 
with either anti-NS 1 or anti-SUMO-l antibodies. It was hypothesised from this data that 
SUMO-l may be induced due to specific stresses caused by BTV -10 infection, and that 
since there is no covalent modification of NSI by SUMO-I , NSI may be binding 
sumoylated transcription factors and retarding their translocation to the nucleus. Thus 
NS 1 would be modulating the host response to BTV infection in a way that was 
advantageous for the virus. 
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This chapter describes the identification of mammalian proteins that interact with NS 1 
using the yeast two-hybrid system and the subsequent verification of the results by 
biochemical methods. This chapter also confirms the interaction of NS 1 with SUMO-l 
by biochemical methods; looks at SUMO-I induction in insect cells and analyses the 
impact of the interaction on BTV replication and pathogenesis. Finally this chapter 
studies the use of tandem affinity purification in identifying interactions and the 
drawbacks of this method. 
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4.2: Results 
Several approaches were employed to identify mammalian proteins that interact with 
NS 1. The main method used was a yeast two-hybrid screen using the coding region of 
NS 1 with the GAIA DNA binding domain tagged to the C- terminus (pAS-NS 1) as bait 
and a human HeLa cDNA library expressed with the DNA activation domain tagged to 
the N-terminus as prey. 
Mate pAS-NS I A strain 
and library IX strain yeast l Co-transform pAS-NS I and library plasrnids in to PJ694A 
Grow on SM Leu-Trp-to select F= .=:::, 
for both plasrnids ~ O()~ 
Replica plate on to M Leu-
Trp-Ade-His-selecting for 
both plasmids and interaction 
Replica plate on to SM Leu-
Trp-Adc-His- again to reduce 
the number of false positives 
Extract plasmid DNA from 
yeast and retransform in to 
yeast containing pAS-NSI , 
pAS2-1 orpAS-VP7 
Grow on SM Leu-
Trp-and SM Leu-
Trp-Ade-His-to 
confIrm plasmid 
presence and select 
for interaction 
l 
~ 
Positives interacting only with pAS-
NS 1 are used for further ana lysis 
Figure 4.2: Overview of the procedure used to identify putative positives in the 
yeast two-hybrid screen, indicating selective media at each stage. 
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Although humans are not the mammalian host for BTV, human cell lines are permissive 
to BTV infection in vitro. Many of the house keeping genes in human cells will show 
some homology to sheep genes, thus proteins identified in this screen, despite being 
human, may be extrapolated to sheep and other mammalian hosts. However it worth 
considering the strict host range displayed by BTV when extrapolating data between 
species where one is infected and one is not. A description of the yeast two-hybrid 
system is given in chapter 3.13, figure 3.1; an overview of the procedure used for yeast 
two-hybrid analysis is given in chapter 4.2 (fig: 4.2). 
4.2.1: Mammalian cDNA Library Screen 
1.3 X 106 cDNA clones from the HeLa Library were screened for interaction with BTV-
IONS 1 using the yeast two hybrid system. The transformed yeast were plated on media 
to select for both plasmids (minus leucine and tryptophan) and interaction of the two 
proteins (minus histidine), the colonies were then replica plated on media minus a 
further amino acid (adenine) giving a more stringent selection for interaction. The 
plasmid DNA was extracted from the positives and then transformed back into yeast 
containing the NS 1 plasmid to screen out wild type revertants. 20 cDNA with putative 
interactions with BTV -IONS 1 were identified (table 4.1). 
Number of positive colonies 
SM minus leucine, tryptophan and 1500 
histidine 
SM minus leucine, tryptophan and 300 
histidine and adenine 
Retransformants 20 
Table 4.1: Number of yeast colonies after each step in the screening procedure. 
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The 20 positives were verified as interacting in yeast with three bait constructs; pAS-
NSI to confirm the interaction, pAS2-NSI (N-terminal fusion to the DNA binding 
domain) to see if the position ofthe tag affected interaction and AS2-VP7 to screen out 
non-specific interactions. All of the yeast positives screened in this way interacted only 
with pAS-NSl , data for 3 separate positives is shown in figure 4.3. 
Positive 1 
Positive 2 
Positive 3 
Figure 4.3: Yeast re-transformation analysis of 3 putative positives with (a) pAS-
NSl, (b) pAS2-l and (c) pAS-VP7. 
4.2.2: Proteins and Peptides interacting with NSI 
Many of the 20 cDNAs isolated encode for short peptides from out of frame truncated 
proteins e.g. 15 amino acids of out of frame translated BAF155, peptide TY7 (Table 
4.2) . Four of the positives gave longer in-frame peptides from human genes, Nucleotide 
binding protein 1 (NUBPl), aldolase A, cathespin B and pyruvate kinase M2 (PKM2). 
Cathespin B is a proteolytic protein found in cellular lysosomes and is unlikely to 
represent a real partner for NS 1; it was therefore dismissed as a yeast two-hybrid 
artefact. PKM2 was not studied further as I was unable to produce a plasmid with this 
cDNA product fused to a FLAG tag. One of the two-hybrid positives that interacted 
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with NSI , the peptide TY7, was found to induce cell death only on co-expression with 
NS 1 in mammalian cells. 
Positive Number of times isolated Number of amino acids 
translated 
Out of frame truncation 10 6-20 
(various) 
TY7 truncation 1 15 
Pyruvate lcinase M2 2 238 iaa 191- 4291 
Aldolase A 1 2331aa 121- 354) 
Cathespin B 2 198 (aa 142- 3401 
Nucleotide binding protein 1 4 218 (aa 2- 220) 
Table 4. 2: Identification of the 20 putative positives from the yeast two-hybrid 
screen. 
4.2.3: Confirmation of Proteins Interacting with NSI 
Further confirmation of the interactions was necessary; an overview of the steps taken 
to achieve this is shown in figw·e 4.4. 
eDNA imerts from identified yeast two-hybrid 
positives arc al11>lified with N-terminal FLAG 
tag; an:! cloned in to TriEx 4 for further analysis 
Seqll::OCe analysis and 
dentification of insert ....... __ 
~ 
EUSA analysis of 
~ mteractlOn wIth 
"- pFLAG purified NS 1 
X 
ConfOcal 
e 
-'" :-LAG ~gg~ protein 
/ '" immunofluorescence 
with plasmid an:! 
virus expressed NS 1 
Immwnprecipitation 
with NS I using anti-NS I 
and anti-FLAG 
antibodies 
Figure 4. 4: Overview of the biochemical procedures used to confirm putative 
positives. 
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To further confirm the interaction of NUBPI and aldolase A with NS I the eDNA 
inserts were amplified by PCR from the eDNA library plasmid to give an N-terminal 
FLAG tag and then cloned into pTriex-4. The resulting plasmids (pFLAGNUBPI and 
pFLAGALDO) were co-transfected into 293T cells with a plasmid expressing NS I 
under the control of the CMV promoter and analysed 24 hours later by 
immunofluorescence. NSI was detected with poly clonal antisera GP69 1 and anti-guinea 
pig IgG FITC conjugate (Sigma), the test positives were detected with mouse 
monoclonal anti-FLAG antisera and anti-mouse IgG TRITC conjugate (both Sigma). 
Peptide TY7 was also analysed for further interaction with NS 1 as it was the first to be 
cloned with a FLAG tag (pFLAGTY7) due to its smaller size of267 bp, however due to 
the induction of cell death on co-expression ofNS 1, samples were harvested at 12 hours 
post-transfection. NUBPl, aldolase A and TY7 all show some co-localisation with NSI. 
which displayed a punctate localisation (Fig 4.5a). When examined by performing a Z-
stack of sections throughout the cell the proteins appeared to be localised towards the 
outer membrane of the cell. NS 1 displays denser staining in this data than previously 
documented, though this may be due to differences in the cell types used, 293T 
cOmpared to BSR cells. 
The localisation of NS 1 was similar to that seen in normal BTV infection, however to 
confirm that localisation was not due to the over expression of NS I the confocal was 
repeated with cells transfected with FLAG-tag constructs then infected with BTV -10 at 
an MOl of 1 and harvested 24 hours post infection (NB. Cells transfected with TY7 
were harvested 12 hours post infection when no cell death was detectable) (Fig 4.5c). In 
these experiments the distribution of both the FLAG-tagged constructs and NS 1 was 
similar to that detected with plasmid expressed NS 1 and co-localisation was retained. 
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(a) a FLAG aNSI Merge 
FLAGNUBPI 
FLAGALDO 
FLAGTII 
a FLAG aNSI Merge 
(b) 
FLAGNUBPI 
FLAGALDO 
FLAGTY7 
Figure 4. 5: Confocal analysis of NSI and pFLAGNUBPl, pFLAGTY7 and 
pFLAGALDO. (a) Confocal analysis of 293T cells transfeded with pFLAGNUBPl, 
pFLAGALDO or pFLAGTY7 and plasmid expressing NSl. (b) Confocal analysis 
of 293T cells transfected with pFLAGNUBPl, pFLAGALDO or pFLAGTY7 and 
then infected 24 hours later with BTV-tO. pFLAGNUBPI and pFLAGALDO 
colocalisation with NSl was analysed 24 hours post infection as in (a); pFLAGTY7 
colocalisation with NSI was analysed 12 h post infection. 
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BTV NSI and the FLAG-tagged positives, pFLAGNUBPl and pFLAGALDO, were 
transcribed and translated in vitro and an immunoprecipitation assay was then 
performed using sepharose beads conjugated to either Guinea Pig anti-NS 1 or mouse 
anti-FLAG monoclonal antibody. Many non-specific bands were present in the 
transcription/translation products (lanes 1 and 6 Fig 4.6), and the two main bands for the 
FLAG tagged products, at approximately 58 and 45 kDa, were weaker than expected. 
exFLAG precipitation gave no visible bands for FLAGNUBPI and NS 1 (lane 3) but a 
weak band of NSI was visible for FLAGALDO and NSI precipitation, although no 
FLAGALDO was visible (lane 8) . exNS 1 precipitates NS 1 for both reactions but no 
FLAGNUBPI or FLAGALDO was present (lanes 4 and 9 respectively) . The unlabelled 
r 
NSI 
FLAGNUBPI 
FLAGALDO 
FLAGNUBPI & NSI FLAGALDO & NS 1 
A 
~ _____ A'-__----. 
1 2 3 4 5 8 7 8 9 10 
o 
116 
84 
64 
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36 
26 
Figure 4. 6: Imrnunoprecipitation of NS1 and FLAGNUBP1 and NS1 and 
FLAGALDO. Lanes 1, 2, 6 and 7 are samples of the protein mix used in the puU-
down; the negative controls are unlabelled beads used for pull-down. 
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To confinn this data and further analyse the interactions of these proteins ELISA 
analysis was performed. NS 1 was bound to the wells and FLAG-tagged proteins 
(mammalian cell lysates of transfected cells) were added, positive interactions were 
identified by the presence of the FLAG-tag bound to the NS 1 within the well giving a 
colour change product above that identified in the negative control. Positive results were 
obtained for aldolase A, NUBPI and TY7 (Fig 4.7) confirming an interaction in vitro 
with NSI . 
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Figure 4.7: ELISA analysis ofNSl interactions with FLAGALDO, FLAG NUBPI 
and FLAGTY7. NSI was bound to the wells and positive colour product 
production was measured. Negative control was GFP transfected 293T cell lysate 
added to wells coated with NSI (sample 5) and the positive control was wells 
coated directly with FLAG-tagged protein (sample 1). Error bars represent 
standard deviation where n=5. 
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4.2.4: Examination of TY7 and NSl Induced Cell Death 
Surprisingly when 293T cells were transfected with both NS 1 and TY7 for 
immunofluorescence analysis (Fig 4.3, immunofluorescence performed at 12 hours post 
transfection), extensive cell death was observed within 24 hours (Fig 4.8) . This cell 
death was not seen in cells transfected with either TY7 or NS 1 (data not shown). 
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Figure 4. 8: Effect of pFLAGTY7 and NS1 expression on 293T cells. (a) 293T cells 
transfected with pFLAGTY7 and plasmid expressing NSl showing extensive cell 
death 16 hours post transfection compared to (b) non-transfected control cells. 
In order to determine if cell death was a programmed response in reaction to the co-
expression of NSI and FLAGTY7, a DNA fragmentation assay and Caspase-3 
activation assay were performed as these are both markers of apoptosis. During 
apoptosis Caspase-3 is activated from a 32 kDa protein to a 17 kDa protein and 
chromosomal DNA is fragmented and degraded into a ladder of DNA visible as a smear 
or ladder by gel electrophoresis. In cells exhibiting cell death the inactivated form of 
Caspase-3 is present at 32 kDa, and no band is seen at 17 kDa, indicating that Caspase-3 
has not been activated (Fig 4.9a) . All of the DNA remains in the wells indicating that 
chromosomal DNA has not started to fragment and is too large to run through the gel 
(Fig 4.9b) compared to the positive control of BTV infected cells (sample supplied by 
Eduardo Mortola, Roy lab) . 
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Figure 4. 9: Analysis of capase-3 activation and DNA fragmentation in cells 
expressing pFLAGTY7 and NSI. (a) Western blot analysis ofCaspase-3 activation 
in cells undergoing pFLAGTY7 and plasmid expressed NSI induced cell death. No 
band of activated Caspase 3 is visible at 17 kDa. (b) DNA fragmentation assay of 
cells undergoing pFLAGTY7 and plasmid expressed NSf induced ceO death. DNA 
fragmentation is detected in the BTV infected cell Iysates but not in the 
pFLAGTY7INSI transfected cell Iysates. (c) Kyle and Doolittle hydrophobicity 
plot of the peptide FLAGTY7. 
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4.2.5: Properties of Peptide FLAGTY7 
The sequence of TY7 was analysed and identified as a 15 amino acid peptide fused at 
the N-terrrunus to a FLAG tag: 
MDYKDDDDK - DLGPFVFVLDSWEWK 
~ "-...... --~y-------/ 
FLAG TY7 
The peptide FLAGTY7 was examined using the ExP Asy website 
(http://www.expasy.org/) proteomics tools to identify any defining features; TY7 alone 
was also examined as it is possible that this 15 amino acid peptide, not the 24 amino 
acid form of TY7 fused to the FLAG tag, which induces cell death. The subcellular 
localisation of the FLAGTY7 peptide could not be examined due to its size, but 
confocal data (Fig 4.5a) indicated it as cytoplasmic not nuclear localised. The 
FLAGTY7 peptide was hydrophobic, with the first 12 amino acids being patticularly 
hydrophobic, when analysed on a Kyle Doolittle plot (Fig 4.9c, entire peptide). The 
TY7 peptide alone was more hydrophilic, with 7 of the 15 amino acids being 
hydrophilic in nature (Fig 4.9c, amino acids 10-24). The termini of the peptide, the first 
3 and last 5 amino acids, were hydrophobic in nature. The secondary structure of 
peptide FLAGTY7 was analysed and found to be generally unstructured, consisting of 
coiled loop areas (C) and extended ~ sheets (E) (Fig 4.10). No a helices or structures of 
interest were located, though given the small size of this peptide it is not surprising. 
Peptide TY7 alone gave the same data as for the last 15 amino acids ofFLAGTY7. 
MDYKDDDDKDLGPFVFVLDSWEWK 
CCCCCCCCCCCCCEEEEECCCCCC 
Figure 4. 10: Predicted secondary structure of peptide FLAGTY7. 
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4.2.6: Effects ofFLAGTY7 on BTV-tO Infection 
To identify the effects ofthis interaction on virus infection 293T cells were transfected 
with TY7 then infected with BTY -10 which expresses NS 1. The rapid cell death 
occurring in the transfected cells was not easily distinguishable from CPE; cells treated 
with pFLAGTY7 prior to infection with BTY -10 showed CPE and cell death 
comparable to that in untreated BTY infected cells. To investigate if there was an effect 
on virus replication, and identify if the CPE seen was due to virus infection or 
pFLAGTY7 INS 1 induced cell death, titres of virus produced in cells transfected with 
pFLAGTY7 were assessed across a 24 hour period and compared to those of cells 
transfected with pFLAGNUBP1 (control for the possible effect of transfection and the 
FLAG tag on BTY replication) or non-transfected cells. 
pFLAGNUBPl expression had no effect on BTY replication with percentages, 94% and 
102% at 12 and 24 hours post infection, comparable to that of untreated cells (Fig 4.11). 
At 12 hours post infection the yield of virus in cells treated with pFLAGTY7 was 81% 
of that for untreated cells (Fig 4.11). At 24 hours post infection the difference was even 
more marked at 63% of normal virus yield. Treatment of cells with pFLAGTY7 greatly 
reduced the yield of virus, by approximately one third, despite no extra cell death being 
visible, thus indicating that the CPE, seen at 24 hours post infection, was potentially 
attributed to lesser levels of virus induced CPE in addition to FLAGTY7INS 1 induced 
cell death. 
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Figure 4.11: Analysis of the effect ofpFLAGTY7 on BTV-IO replication and virus 
yield. (a) Yield of BTV-10 at 12 and 24 hours post infection from cells transfected 
with pFLAGTY7, pFLAGNUBP1 or non-transfected cell control. (b) Percentage 
yield of virus progeny produced in cells treated with pFLAGTY7 or 
pFLAGNUBPl, where normal virus yield is taken as 100%. Error bars represent 
standard deviation where 0=3. 
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4.2.7: Confirmation that SUMO-1 Interacts with NS1 
To confinn the previously identified interaction of NS 1 with SUMO-I, confocal 
analysis of SUMO-l induction and co-localisation with NS 1 was repeated over a 24 
hour time period in 293T cells. SUMO-l co-localised with NSI and as described by R. 
Noad (personal communication) displayed a punctate distribution where not all SUMO-
1 co-localises with NSI (Fig 4.12). 
Hours post infection 
o 4 8 24 
NSI 
SUMO-l 
Merge 
Figure 4. 12: Confocal analysis of native SUMO-1 and NSI in BTV 10 infected 
293T cells. Guinea pig polyclonaJ and rabbit polyclonal antisera were used to 
detect NSI and hSUMO 1 expression respectively over a 24 hour period. 
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4.2.8: NS1 does not induce SUMO-1 Expression 
To confinn previous data indicating that NS 1 itself was not sufficient to trigger the 
sumoylation seen in BTV infected cells (No ad, R and Roy, P personal communication), 
293T cells were transfected with a plasmid expressing NS 1 under the control on the 
CMV promoter and harvested at 24 hours post transfection for confocal and western 
blot analysis. As identified previously SUMO-l is not detectable by confocal 
fluorescence microscopy or western blot upon the expression ofNS 1 only (Fig 4.13a & 
b) . g,'" NSI SUMO-l Merge ~ ~ 
(a) ~ ~ (b) 
.qf ~~ 
Plasmid 
.kDa 
expressed NSI 
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Figure 4. 13: Analysis of SUMO-1 expression following expression of BTv NS1 in 
the absence of BTY-10 infection. (a) Western blot analysis of SUMO-1 expression 
after transfection of 293T cells with a plasmid expressing NS1 or infection with 
BTY-10. (b) Confocal analysis of SUMO-l expression after transfection of 293T 
cells with a plasmid expressing NS1, control showing SUMO-l expression 24 hours 
after BTY infection of 293T cells. (c) Confocal analysis of SUMO-l expression in 
BSR NS1 a cells after infection with BTV-10. SUMO-1 was detected with rabbit 
polyclonal antisera. 
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In addition the expression of SUMO-l in BTV -10 infected cells where NS 1 expression 
levels have been reduced was studied. Confocal analysis of SUMO-I expression was 
carried out 24 hours post infection, in BSR a NSI cells infected with BTV-lO at an 
MOl of 1. BSR a NS 1 cells expressing an antibody against NS 1 also express GFP to 
confirm expression from the promoter, therefore GFP expression within a cell 
corresponds to knockdown ofNSI (see figure 6.2 for evidence ofGFP expression and 
figures 6.12 and 6.14 for confirmation ofNSI knockdown in this cell line). SUMO-I 
expression is detected and shows normal distribution patterns in BSR a NS 1 cells 
infected with BTV -10 and exhibiting GFP expression (not shown) (Fig 4. 13c). This data 
confrrms that high levels of NS 1, and NS 1 tubules (See Owens et al 2004 and figures 
6.12 and 6.13 for confirmation of tubule absence in BSR a NS 1 cells), are not necessary 
in BTV infection for the induction of SUMO-I. 
4.2.9: Effect of SUMO-l Knockdown on BTV Replication 
To further investigate the role of SUMO-I in BTV infection 293T cells were co-
transfected with 2 different siRNA against SUMO-I, 12 hours and again at 24 hours, 
prior to infection with BTV-IO. 293T cells were also transfected with a fluorescein 
linked scramble siRNA as a control. A transfection efficiency of 66% was achieved in 
293T cells and gave approximately 50% knockdown of SUMO-I in BTV infected cells 
(Fig 4.14). A slight knockdown was achieved with the scramble siRNA; this may be 
due to a lower infection rate in the transfected cells. 
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Figure 4. ]4. Western blot analysis of SUMO-t expression in 293T cells and 
knockdown with SUMO-t specific siRNA or scramble siRNA in comparison to un-
treated ceUs infected with BTY-tO. * Represents sumoylated proteins that are 
often detected by western blot with antibody against SUMO-t in BTY-tO infected 
cells. 
Virus yield in scramble transfected cells was lower than that in non-transfected celIs 
conftrming that transfection of siRNA lowers the production of BTV infection, 
probably due to a change in cell fitness , indicating that levels of NS I can not be 
compared between cells transfected with siRNA and untransfected cells. To analyse the 
effects of SUMO-l reduction on BTV-IO replication, virus was harvested from siRNA 
transfected, BTV infected cells and the yield was compared to that of cells transfected 
with the fluorescein linked scramble siRNA control (Fig 4.15). Released virus and cell 
associated virus were harvested and titrated separately. Total yield of virus in cells 
where SUMO-l levels were knocked down was drasticalIy reduced to 27% of the yield 
produced in cells transfected with scramble siRNA. Ratios of cell associated virus to 
released virus were comparable in both SUMO-l and scramble siRNA transfected cells. 
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Figure 4.15: Effect of SUMO-l knockdown on BTV-I0 replication and yield. (a) 
Yield of released and cell associated BTV-I0 in cells where SUMO-l is knocked 
down with siRNA, in comparison to the yield obtained in scramble siRNA 
transfected cells. (b) Yield of virus in cells with reduced levels of SUMO-l 
expressed as a percentage of virus yield in scramble transfected cells. Yield given 
for released, cell associated and total virus. Error bars represent standard 
deviation where n= 3. 
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4.2.10: Tandem Affinity Purification ofNS1 
NS 1 was cloned with an N-tenninal TAP-tag in the pNT AP B plasmid for expression in 
mammalian cells via the pol II promoter. Expression levels were tested in 293 T cells by 
western blot analysis with NS 1 antisera R633 or rabbit anti-calmodulin antibody 
(Upstate) . Good levels of expression were detectable, 75 hours after transfection, with 
both antibodies (Fig 4.16a); TAPBNSI migrated more slowly than plasmid and BTV 
expressed NSI, the migration shift was due to the addition of the 12 kDa TAP tag. The 
increase in size and the detection by anti-calmodulin binding protein antibody indicate 
that the TAP tag is present and correctly expressed. 
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Figure 4. 16: Confocal and western blot analysis of TAPBNS1 expression and 
distribution. (a) Western blot analysis of TAPBNSI expression in 293T cells 75 
hours after transfection, detected by both a NSI and polyclonal a calmodulin 
binding protein antibody. (b) Confocal analysis of TAPBNS1 expression in 293T 
cells 75 hours after transfection, detected by polyclooal a NS1. Note the differences 
in NSllocalisation with and without the N-tenninal TAP tag. 
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Expression and cellular localisation of T APBNS 1 was assessed by immunofluorescence 
using polyclonal antisera GP691 and anti-guinea pig IgG FITC conjugate (Sigma). NS 1 
expression is moderate (Fig 4.16b) but more diffuse than the normal punctate staining 
seen with BTV infected cells or plasmid expressed NS 1 . 
The TAP tag was placed at the N-terminus ofNSI and it was not known if this would 
effect tubule formation, given the slightly different distribution of T APBNS 1 tubule 
formation was analysed by purification of tubules on a sucrose gradient followed by 
western blot analysis. This was performed in tandem with plasmid expressed NS 1 and 
baculovirus expressed NS I. Baculovirus expressed NS 1 is present throughout the 
gradient sufficiently purified in high enough concentrations to be detected by coomassie 
staining (Fig 4.17a). Neither plasmid expressed NS 1 nor TAPBNS I was detected in the 
gradient by coomassie staining. When these samples were analysed by western blot (Fig 
4.17b) only a little NS 1 is detected in the cell lysate, once distributed in the sucrose 
gradient it is possible that the levels ofNS 1 would no longer be detectable. 
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Figure 4.17: Sucrose gradient purification ofNSI tubules. (a) Continuous sucrose 
gradient purification of baculovirus expressed NSI tubules visualised by coomassie 
staining, (b) Continuous sucrose gradient purification of plasmid expressed NSI in 
293T cells and TAPBNSI expressed in 293T cells visualised by western blot and 
R633 anti-NSI antisera. 
TAPBNS 1 was purified using two purification steps based on its two tags; Streptavidin 
purification followed by calmodulin binding protein purification. This purification 
protocol was first tested on 2 control proteins supplied with the Interplay TAP system; 
Tag 2 MEF 2c and TAP MEF 2a. These 2 proteins are known to interact strongly and 
the TAP tag on TAP MEF 2a was used to co-purify Tag 2 MEF 2c which was detected 
on western blot via its FLAG tag. Very little Tag 2 MEF 2c was detected in the 
insoluble fraction of cell lysate, the SN removed from the streptavidin beads after 
binding or the supernatant removed from the calmodulin beads after binding indicating 
that binding to both types of bead was successful (Fig 4.18). Less of the Tag 2 MEF 2c 
was present at the end of the procedure than was initially present and some degradation 
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occurred throughout the purification giving breakdown products (Fig 4.18). To resolve 
this problem in the tandem affinity purification of NS 1, the final concentration of 
protease inhibitors and pefabloc were increased reducing protease activity. 
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Figure 4. 18: Western blot analysis of tandem affinity purification of the control 
protein Tag 2 MEF 2c, detected by a FLAG antibody, co-purified by TAP MEF 2a. 
Samples were taken throughout the purification to assess the efficiency of the 
protocol. 
Very little NS 1 was present in the cell lysate compared to the insoluble pellet fraction 
indicating only partial cell lysis or the presence of an insoluble TAPBNSI protein. Of 
the small amount detected in the cell lysate a similar amount was detected in the 
supernatant removed from the streptavidin beads after binding indicating that binding 
was ineffective (Fig 4.19). No NS 1 was detected in the samples from the later stages of 
the purification. The protocol was repeated a second time to improve binding but again 
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much of the T APBNS 1 was detected in the insoluble fraction of cell lysate. It is likely 
that the addition of a tag at the N-terminus of NSI causes the protein to become 
insoluble, probably due to rnisfolding, and hence purification can not be achieved. The 
addition of a TAP tag at the carboxy terminus of NS 1 would not affect the folding of 
NS 1 or the assembly of tubules. However, due to the positioning of the C-terminus on 
the exterior surface of tubules it is likely that the C-terminus is necessary for NS I 
interactions with cellular proteins; therefore the addition of a tag on the C-terminus 
would disrupt or abrogate interactions. 
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Figure 4. 19: Tandem affinity purification of TAPBNS1. (a) Western blot and (b) 
SDS PAGE analysis oftandem affmity purification ofTAPBNSl. Cell lysates were 
harvested 75 hours post transfection and purified immediately by streptavidin 
beads and calmodulin beads. 
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4.3: Discussion 
The work in this chapter was undertaken to identify a possible role for BTY NS I In 
virus replication and pathogenesis via its interactions with mammalian cellular proteins. 
This chapter identifies 3 proteins; NUBP1, pyruvate kinase M2 and aldolase A, and I 
peptide, TY7, which interact with NS I both in vitro and in vivo. This chapter also 
confirms the interaction of NS 1 with SUMO-l and the importance of SUMO-l 
expression during BTV virus replication. 
Initially a yeast two-hybrid screen was performed with NS I fused to the DNA-BD at its 
C terminus. Screening of a BeLa cDNA library resulted in 20 putative positives. These 
positives were tested by plasmid extraction and re-transformation to rule out any false 
positives and confirm specific interaction with NS 1. The results showed that all of the 
20 positives grew under selection for interaction and were specific for interaction with 
NS 1. Having identified specific interactions the clones were sequenced before being 
subjected to further analysis. 
Positive clones were identified by BLAST analysis as aldolase A, NUBPI, pyruvate 
kinase M2, cathespin B and peptide TY7. A few other peptides were identified but were 
extremely short and were studied no further. Cathespin B is a proteolytic protein found 
in cellular Iysosomes, as NSI is extremely unlikely to play an active role inside 
lysosomes; this result was discarded as a yeast two-hybrid artefact. PKM2 was also not 
studied further due to being unable to produce a plasmid containing a FLAG tagged 
version of this gene. 
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NUBPl, Aldolase A and TY7 were cloned from the yeast two-hybrid plasmid using 
PCR to give a FLAG tag at the N terminus. Interactions in vivo were studied by 
expressing both NS 1 and the tagged positive in 293T cells and studying their co-
localisation. Results show that all proteins co-localised well with both plasmid and BTV 
expressed NS 1 indicating that an interaction could occur as both proteins were found 
localised in the same places at the same times. ELISA analysis confirmed an interaction 
in vitro between NUBP I, aldolase A and TY7 with NS 1; pull-down analysis was less 
conclusive indicating an interaction for aldolase A and NS 1 but no interaction for 
NUBPI and NS 1. In addition to this pFLAGTY7 and NS I interaction could not be 
analysed by immunoprecipitation as FLAGTY7 was too small to visualise by SDS 
PAGE. 
Expression of FLAGTY7 and NS 1 in 293T cells resulted in extensive cell death within 
16 hours of plasmid transfection. The mode of cell death was analysed and results 
showed that it was not due to programmed cell death. Chromosomal DNA 
fragmentation and activation of Caspase 3 are markers characteristic of cells undergoing 
apoptosis, neither of these indicators were present. Proteomic analysis of FLAGTY7 
detected a high level of hydrophobicity (reading ofless than 0) within the first 12 amino 
acids and the last 3 amino acids, an overall hydrophobicity of -0.9. 
When FLAGTY7 was expressed in cells infected with BTV -10 the amount of CPE was 
comparable to that in untransfected cells infected with BTV -10. The virus yield of cells 
treated with FLAGTY7INSI before infection with BTV-IO was 63% of normal virus 
yield, a 3-fold reduction. The decrease in BTV yield is almost certainly due to the 
increased speed of cell death meaning less virus progeny are formed. The lack of 
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apparent increased CPE in FLAGTY7INS 1 treated cells 24 hours post infection, may be 
attributed to less CPE caused by virus replication in addition to extra cell death caused 
by FLAGTY7INSI, overall this would appear comparable to normal CPE at 24 hours 
post infection, where many cells are dead. Given the data it can be assumed that if no 
programmed response is occurring upon the co-expression of NS I and FLAGTY7 from 
either plasmid or virus expressed NS I the cell death may be caused by a toxic effect of 
a complex formed by the two proteins and not due to a specific effect on part of the 
BTV replication cycle or cellular response to infection. 
Specific polyclonal antibodies against SUMO-I allowed further studies to be carried out 
against native SUMO-I in BTV infected cells. Data had already identified and 
confirmed a putative interaction between NSI and SUMO-I, by both yeast two-hybrid 
and confocal immunofluorescence microscopy analysis (Noad, R and Roy, P; personal 
communication). Repetition of aspects of this work confirmed co-localisation of 
SUMO-I and NS 1 in BTY infected cells. 
NS I alone was insufficient to stimulate SUMO-I expression and down regulation of 
NS I using Tet-off ex NS I BSR cells did not effect the distribution of SUMO-I in BTV 
infected cells. This data further confirms that BTV infection, but not the expression of 
NSI, can induce SUMO-I in mammalian cells. 
The interaction of SUMO-I with NS I was of great interest and two different siRNA 
were used to knockdown SUMO-I in BTV infected mammalian cells to examine if any 
of the characteristics of BTV infection were modified. Results indicated a dramatic 
reduction in virus yield to 27% of the yield produced in cells transfected with scramble 
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siRNA. Ratios of cell associated VlruS to released virus were comparable in both 
SUMO-l siRNA, and scramble siRNA transfected cells. The mechanisms by which this 
occurs require further investigation. 
SUMO-l is a small ubiquitin related modifier that post-translationally modifies cellular 
proteins. It has diverse roles within the cell including regulation of transcription, 
chromatin structure, DNA repair and differential protein localisation. SUMO-l can 
covalently modify proteins with distinct functional consequences; this modification can 
be reversible and in some cases is necessary for the cyclic activity of individual 
proteins. SUMO-l is well known for its role in Herpes virus infections and is used to 
regulate the function of many herpesvirus encoded proteins; such as enhancing the 
transactivation activity of the Rta protein encoded by Epstein Barr virus (Chang, Lee et 
al. 2004; Izumiya, Ellison et al. 2005). 
Recently SUMO-I has been identified as a partner in interactions where the protein is 
not covalently modified but interacts transiently with SUMO-I. One such interaction is 
that of SUMO-l with the GTP binding protein dynamin. Dynamin mediates endocytosis 
by assembling around the necks of lipid vesicles and controlling the pinching off step of 
endocytosis. When SUMO-l was up-regUlated in mammalian cells there was a down 
regulation in dynamin mediated endocytosis (Mishra, Jatiani et al. 2004) by inhibition 
of the lipid dependant oligomerisation of dynamin necessary for its role in pinching off 
vesicles. Data suggests that dynamin may act as scaffold that concentrates sumoylation 
machinery thereby facilitating the sumoylation of other proteins. 
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SUMO-1 has been identified as interacting with viral proteins previously via non-
covalent modifications; the best example is that of Hantaan virus (HTNV) nucleocapsid 
protein (NP). SUMO-I and its conjugating enzyme Ubc9 interact with NP via a specific 
region of NP, residues 101-125, the MKAE motif within this region is a putative 
SUMO-I binding site. The interaction of Ubc9 is necessary for the peri-nuclear 
localisation of NP and subsequent assembly of HTNV-NP (Lee, Yoshimatsu et al. 
2003; Maeda, Lee et al. 2003). 
NS I has two putative sumoylation sites at residues 194-198 (lKRE) and 370-374 
(VKIE). However this does not confirm the interaction of NS I with SUMO-1 as it is 
possible that these residues are not positioned in an accessible conformation once NS I 
is folded. 
One proposed role of NS I interaction with SUMO-1 is that NS 1 is a virus response to 
the up-regulation of SUMO-1 in infected cells. NS 1 could act as an inhibitor of SUMO-
I interaction with dynamin with subsequent consequences for virus trafficking and 
egress. If this is the case it is expected that interference of the ratios of dynamin and 
SUMO-I in BTV infected cells would elicit a change in virus yield and potentially in 
virus sub-cellular distribution. Therefore it is also likely that alteration of the ratios of 
dynamin and SUMO-I in cells where NS1 is knocked down should elicit an attenuated 
difference in virus yield. 
Another possible role of NS 1 is that NS I may be binding sumoylated transcription 
factors and retarding their translocation to the nucleus. Thus NS 1 would be modulating 
the host response to BTV infection in a way that was advantageous for the virus. It is 
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also possible that NS 1, like many other viral proteins, fOnTIS part of an E3 ligation 
complex and is involved in the targeting of SUMO-l onto specific cellular targets. This 
would also allow modification and control of host responses to BTV infection. 
Continuing studies within this area are needed to further elucidate the importance of 
NS 1 and SUMO-1 in BTV replication. 
In conclusion whilst it is difficult to draw direct conclusions from the work carried out I 
believe that the interaction of NS I with pFLAGTY7 produces an extremely interesting 
effect during BTV -10 infection and requires further study. It is unlikely that this 
interaction OCcurs during BTV-lO infection since peptide FLAGTY7 is not a naturally 
expressed protein, however further study in this area may elucidate how the addition of 
a peptide with no defining characteristics has such a large impact on cellular health 
when expressed in conjunction with NS 1. 
The interaction of SUMO-I with NS 1 needs further characterisation. This is the most 
promising interaction identified in this study and data on the role of SUMO-l in BTV 
infection may help identify differences/similarities between BTV and other viruses that 
interact with this protein. Analysis of the mechanism of this interaction and the affects it 
causes may also help to define a role for NS 1 in BTV infection and increase 
understanding of virus interactions and hijacking of host pathways. 
Aldolase A is a cellular house keeping protein and is therefore difficult to study with 
siRNA technology. It has not been possible to identify any importance in this 
interaction from literature regarding other virus interactions with this protein and it is 
therefore likely that this interaction may be an artefact of the yeast two-hybrid system. 
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NUBPI is a hypothesised open reading frame discovered during human genome 
sequence analysis. The lack of infonnation on this protein makes it difficult to assess 
the possible importance of an interaction with NS 1 in virus infected cells and therefore 
further study of this protein is unlikely. 
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5: Identification of Interactions between NSI and Insect 
Cellular Proteins 
5.1: Introduction 
As described in chapter 1.5, the interactions of a virus with its insect vector may help to 
detennine transmissibility and aspects of viral replication. BTV replicates in its insect 
vector, Culicoides, and its mammalian host to high titres. It is likely that BTV proteins, 
in particular NS 1, may interact with both insect and mammalian proteins to create a 
more advantageous environment for BTV replication. 
The balance between BTV and its insect and mammalian hosts is critical, ifit causes too 
severe a disease in either one the virus would no longer be transmitted, but if too little 
virus replication occurs transmission would be severely limited. BTV replication in its 
insect vectors of the Culicoides genus, causes little damage to the insect allowing 
continuing virus replication and excellent transmission of the virus. In contrast BTV 
replication in its mammalian host causes significant amounts cellular damage and 
overall disease. This infection is self limiting, limited by either death or clearance of the 
virus by the immune system; however it is enough to maintain a reservoir of BTV for 
insect transmission. 
Several differences exist between BTV infection in insect cells and mammalian cells 
including the varying amounts of NS3INS3A expression, the varying levels of virus 
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induced CPE and the different methods of virion egress (budding and cell lysis) 
displayed in the two cell types. Recent work has identified that NS3 interacts with both 
the insect and mammalian homologues of certain cellular proteins, including Tsg 101, 
indicating that viral proteins may play comparable roles within the two host systems 
(Wirblich, Bhattacharya et al. 2006). No data is currently available for interactions of 
other BTV proteins with insect cell proteins. 
There are few reagents with which to study insect protein interactions and yet an 
approach similar to that taken in chapter 4 is possible with the synthesis of insect cDNA 
libraries. Unfortunately many insect proteins are uncharacterised although genetic 
databases do exist for several insects including Aedes aegypti and Drosophila 
melanogasta, and although these are not complete genomic sequences many protein 
homologues are already identified. 
This chapter discusses the construction of several insect cDNA libraries and identifies, 
by use of A phage plaque screening and yeast two-hybrid analysis, insect proteins that 
interact with BTV NS I in vitro. 
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5.2: Results 
Given the lack of reagents available to screen protein-protein interactions involving 
insect proteins it was necessary to first construct cDNA libraries for such analysis. 
Several insect cell lines were available within the lab including the Kc cell line derived 
from the BTV vector Cu/icoides sonorensis. It is highly likely that different cellular 
genes will be switched on during virus infection and this is an important consideration 
for studying the interactions of BTV with its vector. Given the wide variety of barriers 
within the insect vector that the virus must overcome it was important to represent as 
many different mRNA species as possible, no live Culicoides were available within our 
laboratory but live mosquitoes were. Though A. aegypti is evolutionary distinct from C. 
variipennis it is likely that most house keeping genes and many other genes will possess 
homology between the two genera. Also with the published A. aegypti genome 
database, analysis of positives would be more conclusive. 
5.2.1: Insect eDNA Library Construction 
Two cDNA libraries were constructed to generate two independent methods of 
screening. The benefits of the yeast two-hybrid system were discussed in the previous 
chapter; however the major drawback of this method is the lengthy screening process 
and high number of false positives. A A phage library is quicker to screen since it relies 
on expression within E. coli which is inducible using the Lac operon in 4 hours, 
allowing more cDNA to be screened and more rounds of screening to be performed, 
thus minimising the number of false positives. 
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To address the issues regarding virus induced gene expression and to ensure that all 
potential protein interactions were examined, poly A + RNA was harvested from both 
uninfected and infected Kc cells. Total RNA was harvested at early, mid and late time 
points of virus infection; 0, 2, 27 and 72 hours post infection with BTY -10 at an MOl of 
1. 
In addition to addressing virus induced gene expression it was vital to ensure that poly 
A+ RNA species from as many representative cell types as possible were represented 
within the screen. Live virgin A. aegypti mosquitoes were used for RNA extraction 
providing poly A + RNA from all tissue types. 
cDNA was synthesised from the poly A+ RNA using primers that promote the inclusion 
of full length cDNA, including the 5' termini of the mRNA. Different primers were 
used to construct the two-hybrid library and A library (as described in chapter 3) giving 
either specific ends with directional Sji 1 sites used for ligation with the provided A 
phage arms or giving sites for homologous recombination with linearised yeast plasmid. 
The cDNA was size fractionated and the larger and middle size cDNA (approximately 
1 Kb-7Kb) was collected to represent poly A+ RNA species. 
Two Kc cDNA libraries were constructed, one for use in the yeast two-hybrid system 
and one for use in the A phage system. The A. aegypti cDNA was used to construct a 
library for use in the yeast two-hybrid system. 
Inserts from 10 random Kc cDNA library yeast two-hybrid plasmids were amplified 
using peR and primers targeted to the termini of the plasmid outside the region of 
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homologous recombination (5' and 3' primers used in FLAG tag construct synthesis 
chapter 3). 8 out of 10 positives analysed had strong bands from PCR when visuali sed 
by electrophoresis; insert sizes ranged from 300 to 900 base pairs and were different in 
all 8 samples (Fig 5.1). 
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Figure 5. 1: peR amplification of inserts from 10 random Kc cDNA library 
plasmids. Inserts are present in 8 of the library plasm ids and range from 300-900b 
in length. All of the inserts visualised are different in length suggesting that each 
plasmid contains a different cDNA species. 
5.2.2: Yeast two-hybrid cDNA Library Screen 
The yeast two-hybrid Kc library was screened using pAS-NS 1 as in chapter 4 with the 
exception that Ct strain yeast containing pAS-NS 1 were mated with A strain yeast 
containing the library to give co-expression of the bait and prey plasmids in diploid 
yeast. Co-transformation of pAS-NS 1 and library plasmids could not be performed as 
the library was constructed within the A strain yeast. Amplification and purification of 
the library plasmids from the yeast would result in amplification of the library and 
disproportionate levels of some eDNA species. 
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Initially I used the mating procedure described in the library manual (BD-Clontech). 
However, this gave a very low mating efficiency of less than 2% resulting in very little 
diploid yeast colonies; this meant only 2.1 x 104 cDNA had been screened. Therefore a 
different, more efficient approach for yeast mating was required. The mating efficiency 
of yeast in liquid and on solid media was assessed. (l yeast containing pAS-NSI were 
combined with library containing A strain yeast and subjected to mating over night in 
liquid or on solid YPDA media. The yeast were collected by centrifugation and plated 
on SM Leu-Trp- media selecting for diploid yeast, i.e. those containing both plasmids. 
Mating on solid media gave a higher percentage of diploid yeast, 5%, and was therefore 
more effective allowing 4.68 x 105 cDNA to be screened. However, a comprehensive 
screen of cDNA species requires the screening of at least 5 x 106 cDNA, therefore the 
current mating efficiency was insufficient. The ratio of bait to prey yeast was analysed 
as it is possible that this may affect the mating efficiency of the yeast on solid media. 
The optimal ratio of bait: prey yeast was very low at 0.01: 1 giving a mating efficiency 
of just under 40% (Fig 5.2). The mating efficiency decreased rapidly as the ratio was 
increased, dropping to just 5% for a ratio of 0.1: 1 bait: prey yeast. 
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Figure 5. 2: The ratio of bait Y187 yeast: prey AHI09 library yeast required for 
the fonnation of diploid yeast colonies possessing both plasmids. Yeast were 
counted with a haemocytometer and combined at the appropriate ratios on YPDA 
agar plates over night. 
The yeast two-hybrid screen (see fig 4.1 for overview of process) yielded 23 putative 
positives displaying strong interactions with NS 1 i.e. growth on SM Leu-Trp-His-Ade-
media. These were isolated and analysis for strong interactions was repeated; 3 positives 
were identified. After plasmid purification and retransforrnation analysis to limit the 
number of false positives, one cDNA plasmid was confirmed as positive, this was 
tenned pUb-A. 
5.2.3: Analysis of Yeast Two-Hybrid Positives 
The positive pUb-A, plasmid DNA was extracted from yeast liquid culture and 
purified. The insert was amplified by peR as above (5.2.1) and the resulting insert was 
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approximately 200bp long. The insert was sequenced using primers described in chapter 
3.12 and sequence data (Fig 5.3) was analysed by BLAST software 
(http://www.ncbi.nlm.nih.gov/BLAST/). The insert showed little homology to any 
sequences within the database. When the BLAST search was rerun with specificity for 
identity to Drosophila melanogaster genes, there were many matches but each section 
of homology was a maximum of 40bp; it is likely that none of these represents true 
sequence identities. D. melanogaster may be too distantly related to C. sonorensis for 
the BLAST analysis to identify fun length sections of homologous DNA sequence. 
TTTTCGTAATCTTCCTAATGATCACATTTTATTACATAATCAAAGAATCGTACGAATATTATA 
AAACAATTGATTTGTTATTTTAAAAACTATTCATTTACTTGGAACTGCGTTTACCACGACGAG 
CGTCTGAAAATATAACATAAATTATTAAATTAAGGGAATCGGCATTACGGCCGGGTAAATTA 
TTAM 
Figure 5. 3: Sequence data for the 193bp cDNA insert ofpLib-A. 
The predicted protein sequence of pLib-A was generated using SIXFRAME software 
(SDSC Biology workbench, http://workbench.sdsc.edu/) (NB this plasmid expresses the 
cDNA in one frame only as a read through from the GAU AD). pLib--A encodes a 27 
amino acid peptide fused at the amino terminus to the carboxy terminus of the GAL4 
activation domain (Fig 5.4). 
GAL4 DNA AD----FVIFLMITFYYIIKESYEYYKTIDLLF 
Figure 5.4: Amino acid sequence of pLib-A insert that encodes for a 27 amino acid 
peptide fused at the amino terminus to the GAIA DNA activation domain. 
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No amino acid sequence identity could be detected for peptide Lib-A when sequence 
alignment was performed using the D. meianogaster protein database. The properties of 
this peptide were analysed using the ExPAsy website (http://www.expasy.org/) 
proteomics tools to identify any defining features. The peptide was mainly hydrophilic 
with hydrophilic termini and a short hydrophobic area in the centre (amino acids 14-22) 
when analysed on a Kyle Doolittle plot (Fig 5.5). No other features of interest were 
detected for this peptide; cellular localisation and secondary structure analyses were 
inconclusive due to the small size of the peptide. 
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Figure 5.5: Kyle and Doolittle hydrophobicity plot of the peptide Lib-A. 
5.2.4: A cDNA Library Screen 
The Kc cDNA A. library was screened using a method based around the plaque lift 
technique. The library was expressed after IPTG induction during lytic replication of the 
A. phage; the proteins expressed were released by bacterial cell lysis and bound to 
nitrocelIulose filters for subsequent interaction analysis. 
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Approximately 1 x 107 pfu were screened giving a screen of 1 x 107 individual clones. 
In the first round of screening approximately 70% of plaques showed binding of NS 1 to 
the nitrocellulose membrane, these were identified by formation of radiolabelled spots, 
corresponding to the position of a plaque, when the filters were examined by 
autoradiography or phosphoscreen analysis. By comparison the control plate, where 
expression of the inserts was not induced, had few plaques that displayed interaction 
and binding with NSl. 10 plaques that showed greater levels of binding to NS1 
(identified by the formation of more intense radiolabelled spots) were purified by 
isolating the phage from an individual plaque and repetition of the screening stage. This 
phase was repeated 3 times until all of the plaques produced bound NS 1 on the 
nitrocellulose membrane replica (Fig 5.6); this was achieved for 5 out of 10 purified 
phage samples. 
(a) (b) (c) (e) 
(I) (g) (h) (i) 
'. 
Figure 5.6: Interaction of 3SS met labelled NSl to plaques after 3 rounds of plaque 
purification. 5 of the filters show binding of NSI to every plaque, a, b, c, f and g, 
the remaining 5 show binding of NSl to very few plaques. 
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Once purified a single plaque was picked from each plate and subjected to ere mediated 
site-specific recombination. Plasmid was recovered for all 5 phage positives that 
underwent excision; pTripl Ex2 A, B, C, D and E. 
S.2.S: Analysis of A screen positives 
The 5 positive plasmids pTripl Ex2 A-E were analysed by restriction digest to 
determine the insert sizes of the cDNA in each. Each plasmid was digested with Sfi r, 
Eco RliSac I and Eco RIlNot I; the resulting fragments were analysed by 
electrophoresis and UV visualisation. The restriction sites are positioned either side of 
the insert within the multiple cloning site of pTripl Ex2. No insert was detected for 
pTripl Ex2 A, C or E, whi lst pTripl Ex2 Band D had inserts of approximately 350b, 
and 300b respectively (Fig 5.7). 
2690 
925 
305 
Figure 5. 7 : Restriction enzyme analysis of the 5 putative positive eDNA plasmids, 
pTripl Ex2 A-E. Each plasmid was digested with Sfi I, Eco RlISac I and Eco 
RIlNot I and fragments were visualised by electrophoresis. Inserts of 350bp and 
300bp were detected for pTripl Ex2 Band D respectively, the other 3 plasmids had 
no inserts. 
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The plasmids were sequenced using primers described in chapter 3.12 and the results 
were subjected to BLAST analysis. All cDNA inserts are expressed in the frame used 
by the host, in addition to the remaining two frames, due to the presence of a triple 
reading frame cassette in the plasmid. Sequence data confirmed the absence of inserts 
in pTripl Ex2 A, C and E. Sequence data was obtained for pTripl Ex2 Band D covering 
the entire length of the inserts, 335bp and 216bp respectively (Fig 5.8). Very little of the 
insert sequence for pTripl Ex2 Band D showed homology to any sequences in the 
BLAST database. Small sections of sequence, 25 and 40 bases, showed homology to 
Drosophila proteins but these were not arranged in the same consecutive order as the 
comparative sequence in the Drosophila genome, thus it is likely that none of these 
represents true sequence identities. 
pTripl Ex2 B: 
GGGAACGGTCATTAGTTTTTGAAATTTGCTGTAATGATGAAGAAGGCGAAGATGTTGAAGTTCCATATGT 
GCAGTACACTCTTCCTTAAACGAAATCAGAAAATTAAAGGATGTCCCTAAGCTTGATTTAATGATGATTA 
TATGATAATGTTTTTTTTTTCATCATCAAACTTTTTTTTATGTTAATCGCGCCGTAATTAACTGTATTTA 
TTTTATAAAACACTCGCCTCTCACTCAATTTTTTCAAATGTGTAGACAATTATCCGTACTTTTAAAATAA 
TAAGAATTTCAATCATGACAAAA~~VV~~AA~~~~~~CATGTC 
pTripl Ex2 D: 
TCGGGACCGCATGTGTGGTCCGGGAATCGGCATTACGGCCGGGTATAATGTAGTAAAAATTTTTTTCTCG 
TAAAAGTTAAAGTAGATGATTTTATATTAAATTTAAAAAAAAAAATACCCAATATAACATAAATTATTAA 
ATTAAATAACAAAACAAGGGATTGCTTAAGGTCTCTCAG·~~~~~~~~~~~~~~A 
CATGTC 
Figure 5. 8: DNA sequence data for the 335bp and 216bp inserts of plasmids 
pTripl Ex2 Band D respectively. 
129 
5.2.6: NSl putatively interacts with the C-terminus ofUBA-l (EI) 
The open reading frames for each insert were studied and translation products for each 
identified using SIXFRAME software (SDSC Biology workbench). pTripl Ex2 B has 
no long ORF, the longest is 28 amino acids long, and the longest ORF for pTripl Ex2 D 
is 23 amino acids long. 
pTripl Ex2 B longest ORF 
pTripl Ex2 D longest ORF: 
ERSLVFEICCNDEEGEDVEVPYVQYTLP 
RDRMCGPGIGIT AGYNVVKIFFS 
The inserts were analysed for any sequence identities to known protein finger prints, 
which may help define their functions and properties, using Interproscan (EMBL, 
http://www.ebi.ac.ukllnterProScanl). pTripl Ex2 B showed similarity to the finger print 
of the UABl gene from the ubiquitin ligase activating family, no finger prints were 
found in pTripl Ex2 D. BLAST analysis of pTripl Ex2 B using the protein databases 
showed that the peptide had 89% homology to the 28 C-terminal amino acids of 
Drosophila melanogaster ubiquitin activating enzyme 1 (UBA-l or E 1). The properties 
of the three amino acids that do not share homology, positions 13, 14 and 24, were 
compared. The D to E (aspartate to glutamate) change at position 14 does not greatly 
change the overall properties of the peptide, changing from one acidic amino acid to 
another, whilst the change from R to Q (arginine to glutamine) at position 24 confers 
some changes; both Rand Q are hydrophilic amino acids but R is a basic amino acid 
whilst Q is acidic. The V to E change at position 13 confers the largest difference, this 
swaps an uncharged aliphatic amino acid for an acidic amino acid; a change from 
hydrophobic to hydrophilic. 
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pTripl Ex2 B ERSLVFEI EDVEVPyv!YTLP 
981- 1008 of D. melanogaster UBAI ERSLVFEI 
Figure 5. 9: Sequence alignment of the longest ORF of pTripl Ex2 B with C-
terminal amino acids 981-1008 D. meianogaster UBAL Amino acids highlighted in 
pink are those that are not identical but possess similar properties, the amino acids 
high lighted in blue are those which are not identical and do not have similar 
properties. 
The insert sequences were examined further for any defining features that may help to 
characterise them, usmg the ExP Asy website proteomics tools 
(http://www.expasy.org/) . Neither sequence was long enough to predict the subcellular 
localisation; pTripl Ex2 B has no predicted transmembrane domains whilst pTripl Ex2 
D has 1 predicted transmembrane domain in the centre of the sequence. There is a 
hydrophobic region in the centre of pTripl Ex2 B; pTripl Ex2 D has a small 
hydrophobic region at the N terminus with the rest ofthe peptide being hydrophilic. 
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5.3: Discussion 
The work in this chapter was undertaken to provide reagents to study the interactions of 
NS 1 with insect cellular proteins and to identify and characterise these interactions with 
the aim of elucidating the role of NS 1 in BTV replication and pathogenesis. This work 
identifies 2 peptides that putatively interact with NS 1, one of which displays homology 
to the E1 ubiquitin acitivating enzyme (UAB1) of Drosophila melanogaster. 
Initially cDNA was synthesised from two sources of RNA, RNA extracted from Kc 
cells infected with BTV -10 over a 72 hour time course and RNA from live virgin A. 
aegypti mosquitoes. The sources of RNA were chosen to give a representative 
population of mRNA providing as many cellular proteins as possible that may be 
present during BTV infection. The cDNA was synthesised using two different sets of 
primers to yield cDNA compatible with two different library plasmids, one for use in 
the yeast two-hybrid system and one for use in phage display. 
The phage display library was quicker and more efficient at generating positives than 
the yeast two-hybrid screen. Subsequent analysis of the positives was also more 
efficient when using the phage display library due to the fast process of plasmid 
isolation. Of the two systems used for cDNA screening the phage display library gave 
more reproducible results and allowed more data to be generated in a set time period. 
A yeast two-hybrid screen was perfonned with NS1 fused to the DNA-BD at its C 
terminus. Screening of 1.52 x 106 independent clones from the Kc cDNA library 
resulted in 3 putative positives. One of the positives, pLib-A, was specific for 
interaction with NS 1 and was sequenced before being subjected to further analysis. 
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The DNA sequence of the 193b cDNA insert of pLib-A showed little homology to any 
sequences within the BLAST database. The peptide encoded by the insert is 27 amino 
acids in length and mainly hydrophilic, except for a small patch of hydrophobic amino 
acids in the centre of the peptide. The Lib-A peptide has no other defining 
characteristics or sequence homology that indicate possible roles or identities of the 
cDNA insert. Although Drosophila and Culicoides are not closely related it can be 
expected that they would share some sequence similarity. The lack of sequence data for 
the Culicoides genus makes positive identification difficult, and the A. aegypti cDNA 
library may be of more use, despite the fact that this insect does not vector BTV. 
A screen of the phage Kc cDNA library was performed using plaque lift technology and 
subsequent interaction analysis with radio labelled NS I. After the first round of 
screening many plaques were positive, after 3 rounds of plaque purification 5 of the 
clones produced plaques that showed complete binding with NS 1. Cre recombination 
allowed excision of a plasmid containing the insert from the A phage particle, this was 
used to analyse the size and identity of the insert. 
Three of the five plasmids, pTripl Ex2 A, C and E, had no insert, this is unexpected as it 
is unlikely that the plaques would show such extensive binding to NS 1 if they were 
empty. It is likely that the inserts were lost during ere recombination due to continued 
recombination between loxP sites. This is supported by the observation that 
approximately 10% of the original library consists of empty phage vector. If the three 
positive plasmids were empty during screening and NS 1 was therefore interacting with 
proteins from either the A phage or E. coli almost one tenth of the plaques screened 
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would have shown the increased levels of binding detected for these 3 plaques. Also 
when comparing the plaque lifts for induced and none induced expression of the cDNA 
insert, many more plaques showed binding when the inserts were expressed. This 
indicates that though there is a high a level of background much of the binding detected 
for NS I is with insect cDNA expressed proteins not proteins found in normal lytic 
phage replication. 
pTripl Ex2 Band D had inserts of approximately 335bp and 216bp respectively. These 
were sequenced using primers at either side of the multiple cloning sites giving read 
across the entire insert and 5' and 3' ends of the plasmid DNA. As with pLib-A, the 
yeast two-hybrid positive, very little sequence homology was detected for the inserts in 
these plasmids. 
Despite the length of each insert sequence and the presence of a triple reading frame 
cassette the longest open reading frames for each clone are very small giving maximum 
reads of 28 amino acids and 23 amino acids for pTripl Ex2 Band D respectively. 
Analysis of the peptides using proteomics software did not detect anything of interest 
for the peptide encoded by pTripl Ex2 D; however the finger print study of pTripl Ex2 
B was extremely interesting. The peptide sequence was identified as having similarity to 
the finger print of the UABI mouse gene from the ubiquitin ligase activating family. 
When the sequence was analysed in BLAST using protein databases the peptide showed 
89% sequence homology to UBAI of D. melanogaster. No confirmation of the 
interaction between NS I and UBA-I has been carried out in vitro due to the time 
restrictions of this project; though future work within the laboratory is expected to 
analyse this interaction further. If this putative interaction is confirmed it is also 
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necessary to carry out studies of the effects of this interaction on virus replication and 
pathogenicity by over expression studies and siRNA analysis. 
Ubiquitin activating enzyme 1, E 1, is one of three essential genes necessary for the 
activation of ubiquitin for ubiquitination of proteins in the cell cycle and degradation 
pathways. UBA1 is thought to consist of an adenylation domain, a catalytic cysteine 
domain, a four-helix bundle, and possibly, an ubiquitin-like domain (Szczepanowski, 
Filipek et al. 2005). The adenylation domain ofUBAl is homologous to the adenylation 
domains of the activating enzymes for the small ubiquitin-like modifier (SUMO) 
(Szczepanowski, Filipek et al. 2005). The E1 enzyme hydrolyses ATP and forms a 
complex with the resulting ubiquitin adenylate; this is followed by transfer of ubiquitin 
to the active site cysteine ofEl to form a thiol ester between the C-terminus of ubiquitin 
and the thiol group of the E 1. The ubiquitin is transferred from E1 to one of the 
ubiquitin ligase family enzymes, E2 and from there is conjugated to the protein targeted 
for ubiquitination via interaction with E3; this marks the protein for degradation by the 
26S proteasome (Fig 5.10). 
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Figure 5.10: Overview of the role ubiquitin (Vb) and enzymes E1, E2 and E3 play 
in protein degradation. Adapted from a schematic produced by Sigma AJdrich. 
Many viruses use the ubiquitin pathway during replication to their advantage, whether 
by mimicry of proteins or interaction with proteins involved in the ubiquitination 
pathway. The majority of these interactions are used to degrade cellular proteins that 
interfere with virus replication such as factors of the immune response or to affect the 
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cell cycle in a way which is advantageous for virus replication. KSHV uses two viral 
encoded E3 proteins to destroy MHC class I molecules (Ye, Shibata et al. 2005) by 
hijacking the pathway used to eliminate misfolded proteins from the ER to the cytosol 
by retrotranslocation. HSV -1 ICPO protein also mimics a protein from the ubiquitin 
pathway changing the state of virus infection by regulation of the initiation of lytic 
infection and reactivation of quiescent viral genomes (Boutell, Canning et al. 2005). 
Simian VIruS 5 (SV5) V protein facilitates the ubiquitination and subsequent 
proteasome-mediated degradation of ST A Tl by forming an E3 ligase complex with 
DDB1, thereby effecting host immune responses to SV5 infection. The V protein binds 
directly to both DDBI and STAT2, two cellular proteins known to be essential for SV5-
mediated degradation of STATl, acting as an adaptor molecule linking DDBI to 
STAT2/STATI heterodimers. The VI DDBlISTAT2/STATl complex, in the presence 
of additional accessory cellular proteins, including Cullin 4a, can ubiquitinate ST AT1 
facilitating its degradation (Precious, Childs et al. 2005; Precious, Young et al. 2005). 
The L domain of Rous sarcoma virus interacts with proteins from the Nedd4 family of 
E3 ubiquitin protein ligases, these selectively interact with specific E2 ubiquitin 
conjugating enzymes involved in the ubiquitin pathway, to carry out ubiquitin 
dependent modification of cellular proteins. The interactions of the L domain with 
proteins from the Nedd4 family are necessary for Gag budding of particles from the cell 
(Kikonyogo, Bouamr et al. 2001). Interestingly BTV-tO NS3 also interacts with a 
protein from the Nedd 4 like family of ubiquitin ligases (Wirblich et al. 2006) to aid 
virus particle release in addition to its interaction with TsgI0l (see chapter 1.7). Data 
identified that the knockdown of TsgI0l in cells infected with BTV reduced the virus 
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yield though did not completely abolish virus replication and release indicating that 
other pathways are involved in BTV release. The interaction of BTV NS I with proteins 
involved in the ubiquitin pathway and sumoylation pathway, and the interaction of BTV 
NS3 with Nedd4 like ubiquitin ligases, gives rise to a number of interesting possibilities 
for virus release and perceived pathogenicity. Since NS3 has a proven role in virus 
release and interactions with Tsg 101, that is involved in controlling virus budding, it is 
easy to speculate the importance of this in virus egress (Hyatt, Zhao et ai. 1993; 
Wirblich, Bhattacharya et al. 2006). However given the apparent involvement of NS I in 
non-lytic virus egress (Owens, Limn et al. 2004) and its interaction with both SUMO-l 
and possibly UBA 1 it is possible that NS 1 and NS3 function together, either 
dependently or independently, to regulate virus egress. Further more, given the 
differences in the ratio of NS 1: NS3 between insect and mammalian cell infections it is 
possible that more budding is seen during insect cell infection due to a di fferential 
balance of interactions with cellular proteins via NS 1 and NS3. 
A study of the localisation and possible interaction of NS 1 with NS3 and other BTV 
proteins may help to elucidate the role both proteins play in BTV egress in addition to 
other roles of NS 1 in virus replication. 
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6: Identification of Interactions between NSI and BTV 
Proteins and analysis of the role ofNSI in virus infection 
6.1: Introduction 
BTV NS 1 is identified in BTV infected mammalian and insect cells as tubules; 
purification of NS 1 from infected cells or recombinant baculovirus expression favours 
the purification of tubules as opposed to monomers/dimmers. Nevertheless, smaller 
material that is confirmed as NS 1 is always present at the top of the sucrose gradient. It 
is possible that tubules are a storage state for NS 1 and that the active form is the NS I 
monomer or dimer as is seen with Infectious Bursal disease virus (!BDV) tubules. 
Conversely it is also possible that NS 1 tubules are the active form of NS I and play an 
important role in virus infection, this may be related to their distinctive structure as seen 
with AcMNPV pI 0 tubules. 
For many viruses, non-structural proteins are involved in the enzymatic processes of 
virus replication and/or are responsible for the interference with cellular processes such 
as abrogation of the host immune response, shutting down host protein synthesis and 
hijacking host pathways (Lyles 2000; Fontoura, Faria et al. 2005; Hengel, Koszinowski 
et al. 2005). For the Reoviridae the enzymatic functions required for virus replication 
i.e. the helicase, guanyltransferase, triphosphatase and RNA-dependent RNA 
polymerase are performed by structural proteins. The non-structural proteins of viruses 
within the Reoviridae are likely to be involved in modulation of host responses to virus 
infection. In addition to the role many non-structural proteins play in virus-host 
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interactions, it is probable that they interact specifically with other viral proteins. 
Elucidation of these relationships may allow the identification of the role they play in 
virus replication. 
When NS 1 was knocked down using a single chain antibody against NS I (BSR anti-
NS I cells), virus titres were increased in comparison to those produced from normal 
mammalian cell infection by BTV and the amount of virus released into the culture 
medium, unusually by budding rather than cell lysis, increased by lO-fold (Owens, 
Limn et al. 2004). During this experiment no tubules were detected, presumably due to 
the low amounts of free NS 1 available to multimerise into tubules. However, it is 
impossible to confirm whether the change in egress is due to a lack of tubules or a lack 
ofNS! monomer/dimer. On closer analysis of the data for the BSR anti-NSI cells, the 
pulse-chase analysis of protein expression and stability within these cells indicates a 
reduction in several other proteins, in addition to NSl, including VPI, VP4, VP5 and 
VP6. It is possible that this is due to the reduced amount of virions within the cell due to 
increased virus egress, though this is unlikely as the expression and stability of VP2/3 
and VP7 appear unchanged. No information on the expression levels of the other two 
non-structural proteins, NS2 and NS3, is available. 
Data from the knock down ofNSI, using BSR anti-NSI cells, also implicated NSI in 
the egress ofBTV, when BTV NSI was knocked down there was a change in the mode 
of virus egress from lytic to non-lytic. However due to the decreased 
expression/stability of some of the viral structural proteins and lack of data on the 
expression and stability of the other non-structural proteins this phenotype may not be 
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due to the reduction of NS 1. NS 1 is not essential for virus egress and the presence of 
NS3 is sufficient for the egress ofVLP from Sf cells (Hyatt, Zhao et al. 1993). 
The analysis of NS 1 interactions with mammalian and insect cell proteins identified a 
putative interaction ofNSl with ubiquitin activating El enzyme, a protein involved in 
the ubiquitin pathway of Drosophila melanogaster, and the small ubiquitin-like 
modifier of the sumoylation pathway, SUMO-I. NS3 interacts with proteins of the 
Nedd4 like group of ubiquitin ligases that facilitate ubiquitination of target proteins, but 
are not involved in the classic ubiquitin pathway (Wirblich, Bhattacharya et al. 2006). It 
is therefore possible that NS 1 may have a role that is complementary to that of NS3 and 
hence the mode of virus egress is different in insect cells and mammalian cells where 
the ratio ofNS 1 :NS3 is different. 
The BTV outer capsid protein VP2, along with NSl, was detected in close association 
with cellular cytoskeletal fibres (Eaton, Hyatt et at. 1987). Recent data identifies a direct 
interaction ofVP2 with the intermediate filament protein vimentin (Bhattacharya, Band 
Roy, P; personal correspondence). Viruses frequently traffic structural proteins, 
immature virions and mature virions using the cellular cytoskeleton (Bearer and 
Satpute-Krishnan 2002). The AcMNPV non-structural protein pi 0, forms tubules that 
interact with a-tubulin microtubules of the cytoskeleton, this interaction may be 
involved in cell lysis for efficient virus egress (Williams, Rohel et at. 1989; Patmanidi, 
Possee et al. 2003). It is possible that NS 1, like VP2, associates directly with the 
cytoskeleton and its role in virus replication is linked to this. 
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This chapter describes the interactions of BTV NS 1 with other BTV proteins and the 
implications of these interactions. It also examines a possible role of NS 1 in trafficking 
and virus assembly via interaction with cytoskeletal proteins. Finally the importance of 
NS I in virus replication was investigated using siRNA to knock-down NS 1. 
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6.2: Results 
6.2.1: NS1 interactions with Structural Proteins 
To identify if NS 1 was involved in trafficking of core particles or vi rus particles the 
interactions ofNSl with the outer capsid proteins VP2 and VP5, and the outer layer of 
the core, VP7, were analysed by biochemical methods. The interactions ofNS 1 with the 
VP2, VP5 and VP7 were first analysed by immunoprecipitation, using antibodi es 
against both NS 1 and the test protein. No co-precipitation occurred for NS I and VP2 or 
NS 1 and VP5 with either antibody. NS I and VP7 co-precipitated with beads labe lled 
with both anti-NS 1 and anti-VP7; neither protein precipitated with the negative control 
(Fig 6.1). This experiment gave consistent reproducible results. 
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Figure 6.1: Immunoprecipitation of NSI with BTV structural proteins (a) VP2, (b) 
VPS and (c) VP7. Proteins were precipitated with antisera against both NSI and 
either anti-VP2, anti-VPS or anti-VP7 antisera. NSI was precipitated in all 3 
experiments with anti-NS1 antisera and was also precipitated with anti-VP7 
antisera. NSI was not precipitated with either anti-VP2 or anti-VP5 antisera. 
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To further confinn the interaction identified between NS 1 and VP7, co-localisation of 
NS 1 with VP7 was examined by confocal immunofluorescence microscopy. BSR cells 
were infected with BTV -10 at an MOl of 1 and analysed 24 hours post infection by 
immunofluorescence. NS 1 was detected with polyclonal antisera GP691 and anti-guinea 
pig IgG FITe conjugate (Sigma), VP7 was detected with monoclonal mouse antisera 
MAb IIAlO and anti-mouse IgG TRITe conjugate (Sigma) and the nucleus was stained 
using Roesch stain. NS 1 and VP7 show some co-localisation within BSR infected cells 
but both proteins are also found independently in other areas of every cell examined, 
possibly due to a non-synchronous cell population (Fig 6.2a). 
A more in depth study was carried out examining co-localisation of NS 1 and VP7, in Sf 
cells co-infected with recombinant baculovirus expressing VP3 and VP7 (Le. core-like 
particles) and NSI, during a 36 hour time course. To identify ifNSl co-localises with 
virus particles this experiment was also performed using VLP (VP2, VP5, VP3 and 
VP7) co-expressed with NS 1, by recombinant baculovirus in Sf cells across the same 
time course. VP2 was detected using monoclonal mouse antisera and anti-mouse IgG 
TRITe conjugate (Sigma). eLP expression and NS 1 expression was excellent in the Sf 
cells and good co-localisation was detected between NS I and VP7, though again this 
was not exclusive and both proteins were also found independently (Fig 6.2b). VP7 
expression was less punctate than that observed in BSR cells though this may be due to 
the lack of NS2 since VP7 is often found accumulated in the periphery of inclusion 
bodies. In Sfcells expressing VLP and NSI expression of both VP2 and NSI was lower 
than that observed in cells expressing VP7 and NS 1. NS 1 showed minor co-localisation 
with VP2; the distribution of NS 1 and VP2 is mainly at the outer periphery of the 
cytoplasm (Fig 6.2b). 
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Figure 6. 2: Confocal analysis ofNSl and VP7. (a) Co-localisation ofNSl and VP7 
in BSR cells infected with BTV-IO. (b) Confocal studies of NSI and VP7 
localisation, and NSI and VP2 localisation, over 36 hours in SIll cells co-infected 
with recombinant baculovirus expressing VP3, VP7 (i.e. core-like particles) and 
NSI or VP2 , VP5 (VLP) and NSl. (c) Expression of VP7 in BSR a NSI cells 
expressing a single chain antibody against NSl at 24 hours post infection with 
BTV-lO (GFP expression is indicative ofNSl knockdown (Owens et aL 2004». 
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Expression and localisation of VP7 was also examined in BSR ex NS 1 cells (expressing 
the single chain antibody against NS 1), 24 hours post infection with BTV -10. VP7 
expression and localisation was comparable to that detected in BSR cells infected with 
BTV-IO that do not express the single chain anti-NSI antibody (Fig 6.2c). Western blot 
analysis confirms that VP7 expression is the same in cells that do and do not express the 
single chain anti-NSI antibody (Fig 6.2c). 
6.2.2: Yeast Two-Hybrid Analysis ofNSl and VP7 
Plasmids pAS-NSl, pAS-VP7 ,pACT-NSl and pACT-VP7 (for descriptions see table 
6.1), were used to confirm the interactions of NS 1 and VP7 in the yeast two-hybrid 
system. One bait, and one prey plasmid were co-transfected into yeast strain PJ694A 
and plasmids were selected for on SM Trp'Leu'. A single colony was replicated onto 
media minus all 4 amino acids selecting for a stringent interaction and again onto media 
selecting for both plasmids proving viability of the yeast colony. NS 1 and VP7 
interacted regardless of which domain was fused to the proteins, growing on both SM 
Trp'Leu'and SM His' Ade' Trp' Leu' (Fig 6.3). 
Plasmid Description 
,RAS-NSI NS 1 with the GAL4 DNA binding domain fused at the C-terminus 
2.,AS-VP7 VP7 with the GAL4 DNA binding domain fused at the N terminus 
,RACT-NSI NS 1 with the GAL4 DNA activation domain fused at the C terminus 
.E.ACT-VP7 VP7 with the GAL4 DNA activation domain fused at the N terminus 
Table 6. 1: Descriptions of plasmids used to confirm specific interactions in the 
yeast two-hybrid system. 
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SM l.eu- TrJr 
SM l.eu- Trp-
Ade- His-
pAS NSI & pACTVP7 
pAS VP7 & pACT NSI 
Figure 6. 3: Yeast two-hybrid analysis of VP7INSI interaction. pAS-VP7 interacts 
with pACT-NSl, pACT-VP7 also interacts with pAS-NSl indicating that the 
different GAIA domains have no effect on the interaction. All yeast transformants 
grow on media selecting for both plasmids (SM Leu- Trp-) proving viability. 
6.2.3: NSl interactions with Non-Structural Proteins 
The interactions of NS 1 with one of the other two non-structural proteins NS2 was 
examined by immunoprecipitation. Due to the transmembrane domains within NS3 it 
was not possible to study its interaction with NS 1 using immunoprecipitation as the 
protein must first be separated from the membrane which may affect both the 
conformation of NS3 and its interactions. Both NS 1 and NS2 precipitated with their 
respective antibodies but no co-precipitation was detected for NS 1 and NS2 indicating 
that NS 1 does not associate with NS2 at the periphery of inclusion bodies (Fig 6.4) . 
-66 
Figure 6. 4: Immunoprecipitation of NSI and 
NS2. NSI was precipitated by polyclonal antisera 
-45 against NSlj NS2 was precipitated by poJyclonal 
antisera against NS2j neither protein co-
30 precipitated with the other. 
147 
Co-localisation studies were carried out for NS 1 with NS2 and NS3 in BSR cells 
infected with BTV -10 at an MOl of 1 and harvested 24 hours post infection. NS 1 was 
detected with GP791 and anti-guinea pig JgG FITC conjugate (Sigma) in studies with 
NS3, which was detected with monoclonal 44411 and anti-mouse IgG TRITC conjugate 
(Sigma). NS2 was detected with GP373 and anti-guinea pig IgG FITC conjugate 
(Sigma), in this study NS I was detected with polyclonal R633 and anti-rabbit IgG 
TRITC conjugate (Sigma). NSI displayed a normal distribution with disperse punctate 
pattern throughout the cytoplasm, NS2 also displayed the normal punctate distribution 
of several large patches within the cytoplasm (Fig 6.5a) with little to no co-localisation 
with NS 1. NS3 displayed a normal distribution with much of it being located at the 
periphery of the cell; some NS3 staining is visible in the main body of the cell 
presumably associated with internal membranes (Fig 6.5b), some co-localisation 
between NS 1 and NS3 is visible though this may be due to the excessive cytoplasmic 
staining 0 f NS 1. 
Expression and localisation of NS2 and NS3 was also examined in BSR ex NS 1 cells 
expressing the single chain antibody against NS 1, 24 hours post infection with BTV -10. 
NS2 expression and distribution was identical to that in cells not expressing the 
antibody, NS3 expression was lower than that detected in the control cells not 
expressing the antibody; however the distribution was comparable to that of nornlal 
BTV infection (Fig 6.5c). 
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(a) NSI NS2 Merge NS3 NSI Merge (b) 
(c) NS2 GFP Merge 
NS3 GFP Merge 
Figure 6.5: Confocal localisation analysis of NSl with the other non-structural 
proteins NS2 and NS3. (a) BSR cells 24 hours post infection with BTV-lO stained 
for NSl and the distinct inclusions of NS2. (b) BSR cells 24 hours post infection 
showing NSl and membrane associated NS3. (c) Distribution of NS2 and NS3 in 
BSR a NSl cells expressing the single chain antibody, comparison to (a) and (b) 
confirms normal localisation though a slight decrease in NS3 levels (GFP 
expression is indicative of NSl knockdown (Owens et al. 2004». 
6.2.4: NSI and Interactions with the Cellular Cytoskeleton 
From the observation that NS 1 interacts with VP7 but does not interact with VP2, and is 
found in close proximity to VIBs and the cytoskeleton (Eaton, Hyatt et al. 1987; 
Brookes, Hyatt et al. 1993), where VP2 and virus particles accumulate, it is possible 
that NS 1 may be involved in trafficking virus cores from VIB to the cytoskeleton for 
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subsequent assembly and egress. To address this hypothesis, first it was necessary to 
identify an interaction between NS 1 and the cytoskeleton. Confocal analysis of NS 1 
with three proteins of the three different types of filament that make up the 
cytoskeleton, was performed in BSR cells infected with BTV-IO at an MOl of I and 
harvested 24 hours post infection. Vimentin was chosen as a marker for intermediate 
filaments, whilst actin and a tubulin were chosen as markers for microfilaments and 
microtubules respectively. NS 1 was detected with polyclonal antisera GP691 and anti-
guinea pig IgG FITC conjugate (Sigma), Vimentin and actin were detected with 
polyclonal goat antisera Sc 7557 and Sc 1616 respectively (Santa Cruz Biotechnology) 
and anti-goat IgG TRITC conjugate (Sigma) and a tubulin was detected with 
monoclonal antisera Sc 5286 (Santa Cruz Biotechnology) and anti-mouse IgG TRITC 
conjugate (Sigma). Vimentin shows an extensive network of staining with a perinuclear 
distribution, in some cells this is mainly to one side of the nucleus, in others it is 
throughout the cytoplasm; a tubulin and actin show extensive staining throughout the 
cytoplasm. Given the diffuse distribution of staining detected for both NS I and the 
cytoskeletal markers it was not possible to draw conclusions about possible interactions 
of the proteins (Fig 6.6). 
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Figure 6. 6: Confocal localisation analysis of NSl and cytoskeletal components in 
BSR cells 24 hours post infection with BTV-IO. A diffuse and extensive tubular 
network of staining is visible for all three cytoskeletal markers, vim entin, a tubulin 
and actin. NSl shows a nonnal punctate distribution that extends throughout the 
cytoplasm. 
6.2.5: NSI co-localises with Intermediate Filament Vimentin 
Severa] drugs exist that allow disruption of each type of filament, the disruption of 
intermediate filaments, vimentin, is possible using low concentrations of acry]amide 
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added to the media in cell culture. Since VP2 was shown to interact with only the 
intermediate filaments and not the microfilaments or microtubules, the interaction of 
intermediate filaments with NS 1 was tested in both 293T cells and BSR ccIIs. A 
negative control staining for NS2 and vimentin was also performed in BSR cells. Cells 
were infected and stained as above and examined using confocal microscopy, NS2 was 
detected using polyclonal antisera GP373 and anti-guinea pig IgG FITC conjugate 
(Sigma). Very little staining of vimentin was observed in 293T cells, with some cells 
showing no staining at all, in comparison to the excellent staining observed in BSR ceIIs 
(Fig 6.7a), therefore the remaining work was completed in BSR cells. Vimentin showed 
a dense network of fibres that were detected as diffuse staining across the cytoplasm in 
both infected and uninfected BSR cells. In infected cells, dense foci of vimentin were 
also visualised. These foci do not correspond to VIB as there was no co-localisation 
with NS2 (Fig 6. 7c). Areas of co-localisation were visible for NS I and vimentin 
although, as described previously, staining was so diffuse it was not possible to confirnl 
whether the proteins were co-localised (Fig 6.7bi). However, with the addition of 2mM 
acrylamide to the media a distinct change is detected in the distribution of both NS 1 and 
vimentin (Fig 6.7bii). Vimentin condensed into small punctate localised patches, these 
patches showed good, though not complete, co-localisation with NSI. The pattern of 
NS I did not alter to the same extent as that of vimentin; some condensation was seen 
though a significant proportion of NS 1 was not co-localised with vimentin, indicating 
not all NS 1 was able to associate with vimentin. 
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Figure 6. 7: Effect of drug disruption on vimentin networks and NSI distribution. 
(a) Expression ofvimentin in uninfected 293T cells and BSR cells. (b) Distribution 
of vim en tin and NSI in BSR cells 24 hours post infection with BTV-IO treated with 
(i) OroM acrylamide or (ii) 2mM acrylamide. (c) Distribution ofvimentin and NS2 
in BSR cells 24 hours post infection with BTV-IO treated with (i) 0 roM acrylamide 
or (ii) 2 roM acrylamide. 
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To confirm that the addition of acrylamide was not affecting the amount of vimentin in 
the cell, and to confirm that expression ofNS 1 remained the same, western blot analysis 
of cell lysates was performed. BSR cells were infected with BTV -10 at an MOl of 1, 
virus was adsorbed at 4°C for 1 hour and then the inoculum was removed. The cells 
were washed with fresh media and then maintained until harvest in DMEM 2% FCS, 
2mM acrylamide at 35°C, 5% C02. A negative control was prepared in the same way 
though the fresh media contained no acrylamide. The amount of vimentin detected by 
western blot analysis was comparable in both the 2mM acrylamide and un-treated cells, 
and was also similar in the uninfected un-treated control (Fig 6.8a) . NSI expression was 
also comparable for both the acrylamide and un-treated control cells. As expected, no 
NSI was detected in the uninfected cell control (Fig 6.8b) . 
(a) 
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Figure 6. 8: Western blot analysis of expression of (a) vimentin and (b) NSI in 
uninfected, infected and infected 2mM acrylamide treated BSR cells. 
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To analyse the importance of vimentin in BTV infection the titre of virus produced 
during infection was studied. BSR cells were prepared as above. Samples were 
harvested at 6, 8 and 24 hours post infection; titres of virus in the supernatant, i.e. 
released virus, and cell associated virus were measured independently. The total virus 
yield was similar for both the acrylamide and non-acrylamide treated cells at 6 and 8 
hours post infection, at 24 hours post infection the total yield was slightly lower for the 
acrylamide treated cells (Fig 6.9d). At 6 and 8 hours post infection the percentage of 
virus in the cell associated sample was higher for the acrylamide treated samples than 
the un-treated samples, by 16% and 11% respectively (Fig 6.9 a & b), though the 
difference is not statistically significant. Conversely the percentage of released virus 
was higher for the un-treated samples than the 2mM treated samples at both 6 and 8 
hours post infection, though again not significantly. At 24 hours post infection the 
percentage of virus in the cell associated sample and released virus sample, was almost 
identical in both acrylamide and un-treated samples 91% compared to 92% (Fig 6.9c). 
The data for the effect of vimentin on BTV yield was reproducible. The differences in 
virus yield when vimentin filaments are disrupted with acrylamide are not significantly 
increased, indicating that although vimentin may be involved in BTV replication and 
trafficking, it is not essential. 
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Figure 6. 9: Effect of acrylamide induced vimentin disruption on virus replication 
and release at (a) 6 hours, (b) 8 hours and (c) 24 hours. (d) Yield oftotal virus from 
2mM acrylamide treated cells expressed as a percentage of normal virus yield. 
Error bars represent standard deviation where n= 4. 
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6.2.6: Effects of siRNA against NSI on NSI expression 
This thesis has so far gathered information to analyse the function of NS 1 via its 
interactions with cellular and viral proteins. To further analyse the function of NS 1 and 
its necessity for virus replication, NS 1 was down-regulated in virus infected cells using 
siRNA. A comparison could then be carried out using the BSR a NS 1 cells that also 
knockdown NS 1 using an inducible cell line expressing a single chain antibody against 
NSI. 
An siRNA was designed against NS 1 using the siMAXTM software on the MWG site 
(http://www.mwg-biotech.com/html/s _synthetic _ acids/s _ rna.shtml), the siRNA that 
achieved the highest rating for potential knockdown in the modelling design tool is 
aimed at region 347 - 365 of NS 1 (Chapter 3.27). 293T cells were transfected twicc 
with 100ng of siRNA, once at 24 hours prior to infection and a second time 12 hours 
prior to infection with BTV 10. Transfection efficiency was determined using a 
fluorescein labelled scramble siRNA control (NEB) and was on average approximately 
30-40% when cells were transfected once with siRNA and approximately 50-65% when 
cells were transfected twice (data not shown). Two different transfection reagents, 
Lipofectamine 2000 (Invitrogen) or simporter (Upstate), were used and both gave 
similar results (data not shown). 
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Figure 6.10: Western blot analyses of (a) NS1 knockdown and (b) actin expression, 
in 293T cells transfected with NS1 specific siRNA or control scramble siRNA and 
infected with BTV-10. A negative control ofuninfected 293T cells indicates normal 
actin levels. (c) Confocal analysis ofNSl knockdown and NS2 expression in 293T 
cells transfected with NSl specific siRNA and BSR a NSl cells which were 
subsequently infected with BTV-lO. 
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In cells where the transfection efficiency exceeded 50% the expression of NS I was 
studied by western blot analysis, NS I was detected with R633 polyclonal antisera. 
Expression of NS I was lower in cells transfected with the NS 1 specific siRNA 
compared to the scramble siRNA control (Fig 6.1 Oa) and there was no apparent visual 
difference in the amount of CPE caused by virus infection. When the same samples 
were analysed for expression of a cellular protein, actin, as a control, detected with 
polyclonal goat anti-actin (Santa Cruz Biosciences), comparable amounts of actin were 
present in all lanes including the uninfected 293T cells (Fig 6.1 Ob). The results for BSR 
ex NS I knockdown of NS 1 and expression of actin were comparable to those of NS I 
knockdown using siRNA. 
Knockdown of NS 1 was confirmed by confocal immunofluorescence microscopy 
analysis for NS2 and NSI in 293T cells at 24 hours post-infection with BTV-IO at an 
MOl of 1. NS2 expression was used to identify infected cells expressing either reduced 
or unchanged amounts ofNS!. NS2 was detected with GP373 and anti-guinea pig IgG 
FITC conjugate (Sigma), NS I was detected with R633 and anti-rabbit IgG TRITC 
conjugate (Sigma). In BSR ex NSI cells OFP expression confirmed the expression of 
the single chain antibody against NS 1. NS 1 and NS2 expression in BSR a NS 1 cells 
was detected independently as above, except that both proteins were visualised with 
TRITC conjugated antibodies. NS 1 expression levels were visibly knocked-down in 
cells expressing the single chain antibody against NS 1 whilst NS2 expression and 
distribution appeared unchanged. In cells treated with siRNA against NS I, NS2 was 
detected presenting a normal punctate pattern of large cytoplasmic patches and was 
comparable to cells transfected with scramble control siRNA (data not shown). NSI 
was detectable in all cells expressing NS2. However the levels of NS I expression 
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relative to NS2 varied significantly from normal to barely detectable; many cells 
expressed intermediate levels ofNS 1 (Fig 6.1 Oc). 
6.2.7: Presence of Tubules in siRNA treated cells 
It was necessary to establish the presence of tubules in cells treated with the NS I 
specific siRNA and displaying a reduction in NS 1 concentration since it is not known if 
tubules are the active form of NS I or not. Cells were transfected and infected as 
previously (Chapter 6.2.7) giving samples 1) Non-transfected positive control 293T 
cells, 2) NSI siRNA transfected cells, 3) scramble siRNA transfected cells and 4) BSR 
a. NS 1 cells expressing the single chain antibody specific to NS 1. All samples were 
harvested 40 hours post infection and were examined for tubule presence. NS 1 was 
visible in the cell lysates of all 4 samples though less was visible in the lysate of 293T 
cells treated with NSI siRNA (Fig 6.11). In the 293T non-transfected control a little 
NS 1 was detected in sample 5, collected from the top of the gradient; a high amount of 
NS 1 was detected in the mid to lower parts of the gradient, fractions 20 and 30 (Fig 
6.11a). The distribution of NSI within the gradient for the cells transfected with 
scramble control siRNA was comparable to the positive control with the exception that 
more NS 1 was detected in fractions 10 and 15 (Fig 6.11 c). The cells treated with NS I 
siRNA showed a different distribution of NS 1 throughout the gradient; NS 1 was 
detected only in fractions 5 and 10 and in lesser amounts than in the positive control 
(Fig 6.11b). This indicated that any NSI present was assembled as smaller multimers, 
not particular tubule structures. Similarly, NS 1 from the BSR a. NS 1 cells was 
distributed more towards the top of the gradient with NS 1 detected in samples 5, 10 and 
a little in fraction 15; no NS 1 was detected in fractions 20 and 30 again indicating the 
presence ofNS! multimers but not particular tubule structures (Fig 6.11d). 
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Figure 6. 11: Western blot analysis of NSI in sucrose gradient fractions from NSI 
tubule purification for (a) 293T cells, (b) 293T cells treated with NS] siRNA, (c) 
293T cells treated with control scramble siRNA and (d) BSR a NSI cells. All 
samples were infected with BTV-IO and harvested after 40 hours. 
It is evident from the western blot data that knockdown levels of NS 1 vary from 
experiment to experiment. In Fig 6. II a no NS 1 is detected in the samples treated with 
siRNA where as in Fig 6.1 I b NS 1 is detected although at lesser levels than detected in 
control transfections. In addition to this it is probable that the transfection efficiencies 
also vary, if transfection efficiency was 50% then 50% of the cells would still be 
producing tubules yet Fig 6.11 b indicates that this is not the case since no NS 1 is 
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detected in the lower fractions of the gradient suggesting a transfection efficiency much 
higher than 50%. 
To further analyse the presence of tubules in knockdown experiments samples 2,3 and 
4 were examined by cell sectioning and subsequent electron microscopy. In addition a 
negative control of uninfected 293T cells was included. Proof of virus infection was 
determined by identification ofVIB, virus particles and core particles; in addition to this 
the presence of tubules and use of celllysisibudding for virus egress was determined for 
each sample. Previous data showing examples of each structure were used for 
identification and cross reference (Roy and Gorman 1990; Roy 2005). 
In the negative control normal cellular structures such as mitochondria, cell junctions 
and the nucleus were clearly visible. No cell lysis, virus particles or NS I tubules were 
detected (Fig 6.12a). Sample 3, 293T cells transfected with control siRNA, clearly 
showed all signs of virus infection including VIB, virus particles and core particles. 
Localised patches of NS I tubules were also detected; many cells showed areas of lysis 
though no virus egress was visible (Fig 6.12b). Clear evidence of virus infection was 
also identified in BSR ex. NS 1 cells though no tubules could be detected confirming the 
knock down of NS 1 within these cells. In contrast to previous pictures of these cells 
(Owens, Limn et al. 2004) no evidence was found of virus budding from the plasma 
membrane; cells showed amounts of lysis comparable to those with normal levels of 
NS 1, though again no direct evidence of virus egress was observed (Fig 6.l2c). The test 
sample ofNS 1 siRNA transfected cells was comparable with the BSR ex. NS I cells. VIB, 
virus particles and core particles were all detected as was some cell lysis. No tubules 
were detected within the cells examined in this sample, though it is possible that 
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although no tubules were fonned, oligomers of NS 1 with no distinct structure were not 
detectable by this method (Fig 6.l2d). Again it is probable that transfection efficiencies 
of siRNA are higher than 50% in this experiment as no NS 1 tubules were detected in 
any of the cells. 
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Figure 6. 12: Cell sectioning transmission electron micrographs. NB all samples 
were analysed 'blind' by the EM operator to ensure that all samples were searched 
equally for the presence of tubules. 
(a) uninfected 293T cells, indicating some cellular structures. 
164 
VlB 
Tubules 
Virus particles 
SOOnm 
(b) 293T cells treated with control scramble siRNA and infected with BTV-IO 
indicating NSJ tubules and virus particles. 
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(c) BSR a NSI cells infected with BTV-IO indicating cell lysis and virus particles. 
Note no NSI tubules are detected. 
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(d) 293T cells treated with NSI siRNA indicating virus particles and areas of cell 
degradation. Note no NSI tubules are detected. 
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6.2.8: Effects of NSI specific siRNA on BTV Protein Expression 
To confirm that the siRNA was specific to NS 1 and that the expression levels of no 
other BTV protein were affected levels of whole virus protein expression were 
examined by western blot analysis using rabbit polyclonal anti-BTV -10 antisera. Ratios 
of all proteins, except NS 1, appeared unchanged in cells exhibiting NS 1 knockdown in 
comparison to non-transfected, infected cells with a normal level of NS 1 (Fig 6.13). 
This data indicated that any changes in BTV replication can be attributed to knockdown 
of NS 1. As with other experiments the amount of NS 1 knockdown detected is variable 
and in Fig 6.13 NS 1 expression levels appear comparable with the control. Confocal 
data in Fig 6.10 and EM data in Fig 6.12 suggest normal levels of NS2 in cells which 
show high levels ofNS 1 knockdown. 
As a comparison, protein samples of BTV proteins expressed in BSR a NS 1 cells were 
analysed by western blot using rabbit polyclonal anti-BTV -10 antisera. Strikingly the 
expression of several proteins in addition to NS 1 appeared to be reduced (Fig 6.13b). 
This confirms the observations made about the altered expression levels of BTV 
proteins in the pulse-chase analysis performed on these cells (Owens, Limn et al. 2004). 
Separate western blot analysis of the sample confirmed knockdown of NS3, VP3 and 
VP5 (Fig 6.13c). 
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Figure 6.13: Western blot analysis, using polyclonal anti-BTV-10 antisera, ofBTV 
proteins in (a) NSI specific siRNA treated cells and (b) BSR a NSI cells, all 
infected with BTV-IO. (c) Western blot analysis of specific BTV protein expression 
in BSR a NSI cells detected with anti-NS2, anti-NS3, anti-VP3 and anti-VP5 
poly clonal antisera. 
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6.2.9: Effects of NSl knockdown on BTV Replication 
To analyse the importance ofNS 1 in BTV infection and identify potential roles for NS 1 
the titre of virus produced during infection by BTV -10 was studied under normal and 
knockdown expression of NS 1. BSR cells were transfected as previously described, 
with siRNA specific to NS 1 or scramble control siRNA at 12 and 24 hours prior to 
infection with BTY -10 at an MOl of 1. Samples were harvested at 24 hours post 
infection; titres of virus in the supernatant, i.e. released virus, and cell associated virus 
were measured independently. Overall the yield of virus was comparable for the cells 
treated with NSI siRNA and control scramble siRNA, 6.16 x 104 and 4.78 x 104 
respectively (Fig 6.14). In both samples the percentage of released virus was higher than 
the percentage of virus that was cell associated. Amounts of BTV induced CPE were 
comparable in both samples. However, expression levels ofNSl were not tested for in 
these samples as doing so would have resulted in an altered virus yield, therefore it is 
possible that NS 1 expression was not reduced as significantly in these samples as it was 
in the samples analysed by Owens et al (2004) where virus yield increased lO-fold in 
the absence ofNS 1 tubules. 
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Figure 6. 14: Effect of NSI specific siRNA on virus replication and release at 24 
hours post infection with BTV-IO. Yield of (a) ceU associated virus and (b) released 
virus was analysed separately; (c) total virus yield of ceUs treated with NSI siRNA 
expressed as a percentage of scramble siRNA treated ceUs virus yield. Error bars 
represent standard deviation where 0=3. 
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6.3: Discussion 
The experiments perfonned in this chapter were undertaken to detennine a possible role 
for NSI in virus replication by examining its interactions with other viral proteins and 
cytoskeletal proteins. Also the overall effect of NS 1 on virus replication and egress was 
studied through the use of an NSI specific siRNA to knockdown expression levels of 
NS 1 in virus infected cells. An interaction between NS 1 and VP7 was identified, as was 
a potential interaction between NS 1 and the intennediate filament protein vimentin. 
Knockdown of NS 1 in virus infected cells was confinned to abrogate tubule assembly 
and appeared to have no detectable impact on virus replication and release. 
Initially the interactions of NS 1 with structural proteins VP2, VP5 and VP7 were 
analysed via immunoprecipitation of in vitro labelled proteins. In all three experiments 
the NSI was clearly precipitated by anti-NSI antisera; VP2, VPS and VP7 were also 
precipitated by their respective antisera. The only proteins that co-precipitated were 
NSI and VP7, precipitating with both anti-NSI and anti-VP7 antisera thus indicating an 
interaction in vitro and the potential for an interaction in vivo. 
As further confinnation of the biochemical interaction of NS 1 and VP7 in vitro, yeast 
two-hybrid analysis of the interaction was perfonned in tandem using proteins fused to 
both GAL4 domains independently. NS 1 and VP7 demonstrated interaction regardless 
of the GAL 4 domain they were fused to confirming the immunoprecipitation data. 
To analyse the interactions ofVP7 and NSI in vivo in BTV-IO infected cells BSR cells 
were examined by confocal immunofluorescence microscopy. NS 1 and VP7 co-
localised with each other, although each protein was also found localised independently. 
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This may be due to non-synchronous cell and virus populations. In nearly all cases co-
localisation was towards the outer edge of the VP7 staining which was in large punctate 
foci that co-localised perfectly with NS2 (data not shown). This was expected as VP7 is 
found in high quantities in the periphery of VIB, with core particles detected inside the 
VIB, and NS I tubules are frequently detected by electron microscopy in close proximity 
to the VIB. In Sf cells expressing CLP (VP3 and VP7) and NS I from baculovirus co-
infection, the distribution of VP7 was different forming large patches rather than 
distinct inclusions. However the co-localisation pattern was similar, with localisation 
occurring on the periphery of VP7 patches. 
The data presented within this chapter identifies a robust biochemical interaction 
between the outer-most core protein, VP7, and NSl. It is unclear from this data what the 
interaction of NS I and VP7 contributes to virus replication. In BSR (l NS I cells 
exhibiting knockdown levels of NS 1 and absence of NS 1 tubules, VP7 distribution is 
unchanged. Furthermore in the study performed by Owens et ai, overall virus yield was 
increased when NS 1 tubules were not present; in the NS I siRNA studies virus yield 
appeared unchanged when NS 1 tubules were not present. This data suggests that the 
interaction of VP7 with NSI does not rely on tubule formation and may even be 
enhanced by the lack ofNSI tubules, increasing virus replication. Work by Eaton et al 
1987, supports this observation that NS 1 and VP7 interaction may not involve tubules; 
anti-NSI labelled gold particles were detected on the surface of core particles when no 
tubules were visually detected (Eaton, Hyatt et al. 1987). 
NS I does not interact with NS2 in virus infected cells; no co-immunoprecipitation 
could be detected and confocal data did not show co-localisation of NS 1 and NS2. This 
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was not surprising since NS 1 tubules were not detected within the VIB and previous 
gold labelling electron micrograph studies of VIB showed no staining for NS I 
indicating the absence of NSI monomers/dimers from the VIB (Eaton, Hyatt et al. 
1987). However, NS 1 tubules were found in close proximity to VIBs (Eaton, Hyatt et 
al. 1987; Brookes, Hyatt et al. 1993); NSI interacts with VP7 which is found localised 
with NS2 in VIBs, and this may explain the close proximity ofNSI to VIBs but lack of 
interaction with NS2. 
Immunoprecipitation was not performed for NS 1 and the remaining non-structural 
protein NS3 due to the membrane spanning nature ofNS3. Confocal studies identified 
areas of co-localisation within the cell cytoplasm though this does not confirm an 
interaction. Much of the NS3 detected within the virus infected cells is localised at the 
plasma membrane where NSI is not routinely localised. NS3 is associated with virus 
egress and NS 1 knockdown has been linked to a change in virus egress (Owens, Limn 
et al. 2004; Wirblich, Bhattacharya et al. 2006). Both NS 1 and NS3 interact with 
proteins involved in the ubiquitination and sumoylation of target proteins as discussed 
in chapter 4 and 5 (Wirblich, Bhattacharya et at. 2006). It is possible that an interaction 
occurs between NSI and NS3, though this need not be direct, and is possibly most 
important via a supportive/opposing effect on aspects of ubiquitin and SUMO-l control 
of protein expression and distribution. 
NS 1 tubules are often found in close proximity to the cytoskeleton where both VP2 
(Bhattacharya B and Roy, P; personal communication) and virus particles are located 
(Eaton, Hyatt et al. 1987), and in close proximity to VIB (Eaton, Hyatt et al. 1988; 
Brookes, Hyatt et al. 1993). In addition to this, the observation that NSI interacts with 
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VP7 gives a hypothesis for the role of NSI in virus infection. BTV core-like particles 
are soluble and not associated with the cytoskeleton; previous investigations have also 
demonstrated that CLPs synthesised either in the presence of VP2 or VP5 fail to attach 
to the cytoskeleton (Hyatt, Zhao et al. 1993). This indicated that both the outer coat 
proteins are required for stable virus-cytoskeletal interaction. One hypothesis for the 
role of NS 1 in virus infection is that NS 1 helps core particles to accumulate near to VP2 
since NS 1 is associated with intermediate filaments. It is possible that NS 1 either as 
tubules or monomers/dimers transports virus cores, from the VIB where they assemble 
(Kar, Iwatani et al. 2005), to the cytoskeleton where VP2 is located thus helping in 
virus maturation and subsequent egress. It is also possible that NSI serves merely as an 
anchor for virus cores allowing the build up of cores in close proximity to VP2 before 
subsequent maturation and egress. To test this hypothesis the interaction of NS I with 
cytoskeletal proteins was first confirmed. 
Confocal analysis of NS 1 with cytoskeletal markers vimentin, a tubulin and actin was 
inconclusive. Staining of the cytoskeletal networks was comprehensive and throughout 
the cytoplasm indicating areas of co-localisation when in fact this may be overlap of 
localisation due to the cytoskeleton occupying so much of the cell. 
Studies were targeted to the intermediate filaments, vimentin, of the cytoskeleton since 
if the hypothesis is true NS 1 would be expected to localise with the same filaments as 
VP2 as it does not directly interact with VP2. Acrylamide is a known disrupter of 
vimentin filaments and has been well documented. In PtK.2 cells acrylamide causes 
aggregation of vimentin filaments in a concentration-dependent fashion; these effects 
occurred at a lower concentration than alterations in other cytoskeletal filaments and 
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were fully reversible causing no cytoskeletal cross linking (Sager 1989). In LLC-MK2 
cells acrylamide specifically disrupts intermediate filaments in a short period of time 
and cells recover their normal morphology and functionality in only a few hours after 
the removal of the drug (Arcangeletti, Pinardi et al. 1997). A more recent study has also 
shown that acrylamide disrupts the intermediate filament network and results in the 
formation of cytoplasmic aggregates of vimentin in the cell, a distinct change from the 
perinuclear cap distribution (Cordo and Candurra 2003). 
Vimentin expression was easily detectable and displayed a normal perinuclear network 
with some cells showing a cap like distribution and others showing a more diffuse 
network. The distribution of vimentin in BTV infected cells appeared unchanged in 
comparison to that in uninfected cells. BTV vm are not the same as the viral 
aggresomes, formed by other viruses, whereby vimentin forms a dense area for virus 
replication and assembly similar to that formed by NS2. 
Addition of 2mM acrylamide to BTV -10 infected BSR cells resulted in the expected 
change in vimentin distribution, vimentin appeared in perinuclear aggregates rather than 
the network normally detected. NS 1 distribution also changed in a similar way, though 
to a lesser extent than vimentin. This indicates that some NS I remained unaffected by 
vimentin distribution indicating that not all NS 1 interacts with vimentin. As a negative 
control NS2 localisation was also studied, no co-localisation was detected for NS2 and 
vimentin, this further confirms the absence of viral aggresomes and the distinct separate 
identification of Vffi. An earlier investigation using the same concentration of 
acrylamide showed that cellular protein synthesis was not significantly altered in Vero 
cells in the presence of the acrylamide (Cordo and Candurra 2003). The distribution of 
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NS I and vimentin in the acrylamide treated BSR cells could be explained on the basis 
of selective primary collapse and disassembly of vimentin in the cells, and not on the 
drug induced reduction or change in the synthesis of vimentin. Confirmation of this was 
achieved by western blot analysis indicating that the expression levels of vimentin and 
NS 1 remained comparable to those in cells un-treated with acrylamide. 
The effect of vimentin and NS I distribution, in acrylamide treated cells, on ViruS 
replication and egress over a 24 hour time course was examined by a study of virus 
yield, both cell associated and released virus yield. Total virus yield was comparable for 
both 0 and 2mM acrylamide treated cells at 6, 8 and 24 hours post-infection. This data 
indicates that although vimentin may be involved in virus replication and release it is 
not essential. It is possible that the change in distribution of vimentin and subsequently 
VP2 and some NSI, has a small effect on virus assembly or trafficking along the 
cytoskeleton, due to an altered cellular localisation, that is not detectable in this 
experiment. Also it is important to note that the optimum concentration of acrylamide 
for disruption of vimentin is 2mM (Sager 1989; Arcangeletti, Pinardi et a1. 1997; Cordo 
and Candurra 2003). This is much higher than the concentration most pharmacological 
inhibitors are used at, and although cells return to healthy normal morphology after 
removal of acrylamide it can not be assumed that acrylamide is not having an effect on 
overall cell health in a way other than disruption ofvimentin. 
Vimentin is involved in the replication of other viruses from different families; 
acrylamide has an inhibitory effect on Junin virus replication in a dose dependent 
manner without modifying the cellular viability (Cordo and Candurra 2003). It does not 
affect virus entry but significantly decreases virus protein expression and overall titre 
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indicating that vimentin has a role in the early stages of JUNV replication. Many other 
viruses such as poxviruses and African swine fever virus (ASFV) rearrange vimentin 
during virus replication to create viral aggresomes. Viral proteins accumulate in the 
aggresomes before assembly and release of the virus (Heath, Windsor et al. 2001; 
Risco, Rodriguez et al. 2002; Stefanovic, Windsor et al. 2005). 
An siRNA against BTV -IONS 1 was designed to knockdown NS 1 in BTV infected 
cells. This technique was used to identify and analyse any changes lack of NS 1 causes 
in BTV replication and to examine if it was possible to draw conclusions about the 
function of NS 1. Previous data produced using BSR a NS I cells to knockdown NS 1 
had indicated that tubules could not be detected in these cells though some NS 1 was still 
present. This data suggested that the lack of, or severe reduction of NS 1 tubules causes 
a change in virus egress. 
Western blot analysis determined that NS1 knockdown varied greatly between 
experiments but was on average NS 1 expression was reduced by approximately 50%, in 
cells treated with siRNA. This was expected since on average 50-65% of cells were 
transfected and siRNA is not 100% efficient, especially against a protein as highly 
expressed as NS 1. Detection of actin within cells displaying a reduced expression of 
NS I indicated that the expression levels of cellular proteins were not affected by siRNA 
transfection. Confocal immunofluorescence microscopy analysis confirmed that NS 1 
levels were reduced in 293T cells treated with NSI siRNA and that NS2 expression and 
distribution were normal. BSR a NS I cells were confirmed by western blot and 
confocal analysis to have comparable levels ofNS 1 as cells treated with NS 1 siRNA. 
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To address the study of knockdown with regards to lack/reduction of tubules it was 
necessary to confirm that NS I tubules were absent or reduced. Biochemical analysis of 
tubule presence by sucrose gradient purification indicated that less NS 1 was present 
overall and that the majority ofNSI was detected in the upper quarter of the gradient as 
is the case for BSR (l NS I cells NS I purification. NS I tubules are normally detected in 
the mid to lower fractions of the gradient, with lesser amounts towards the top. This 
indicates that in cells treated with NS I siRNA there are no particular tubule structures 
and NS I exists as oligomers of an undetermined size. The absence of NS I in the lower 
fractions also indicates a much higher transfection efficiency than achieved in some 
experiments; the absence of detectable tubules suggests a transfection rate of higher 
than 70%. 
NS 1 tubules were easily detectable by electron microscopy of BTV infected cells and 
the cellular distribution was comparable to previous studies (Eaton, Hyatt et al. 1988; 
Brookes, Hyatt et al. 1993; Monastyrskaya, Gould et al. 1995; Owens, Limn et al. 
2004). To confirm the absence of tubules in NSI siRNA treated cells and BSR anti-NSI 
cells EM studies were performed. Positive signs of virus infection were identified; these 
included the presence of VIB, virus particles and core particles. NS I tubules were not 
detectable in cells displaying knocked down expression of NS I, again this indicates a 
transfection efficiency much higher than 50%. In this experiment no virus particles 
could be detected egressing from the cell membrane via budding as was seen in the 
previous study of BSR (l NS 1 cells (Owens, Limn et at. 2004), though this may be due 
to different methods of analysis. 
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To ensure that any changes detected in virus replication were due to knockdown of NS 1 
and not due to an effect on another BTV protein, expression of BTV -10 proteins was 
examined by western blot analysis in 293T cells treated with NS 1 siRNA. As expected 
less NS 1 was visible though knockdown was not as successful as in previous 
experiments, although all other proteins appeared present in the same ratios and 
amounts as in the control. As a cross reference this experiment was also carried out in 
BSR a NSI cells. Previous data on these cells indicated a decreased stability/expression 
of certain proteins (Owens, Limn et al. 2004); western blot analysis confirmed 
reproducibly lower expression levels of VP3, VP5 and NS3. The knockdown of other 
BTV proteins may have serious consequences regarding virus infection; effects 
previously attributed to NS I knockdown must be reconsidered in this cell line. This 
may explain the apparent differences in virus egress between cells displaying NS 1 
knockdown due to siRNA and knockdown due to internally expressed single chain anti-
NS 1. However, it is also possible that the differences detected between the two cell 
lines may be due to differences in the levels of NS 1 knockdown or differences in 
analysis methods. 
Finally the effect of reduced NSI expression and absence of tubules were analysed with 
respect to the ability of the virus to replicate and release to normal titres. Previous 
western blot analysis indicated that viral protein expression was normal, thus any 
changes detected in virus yield may be due to changes in virus assembly and the later 
stages of virus maturation. Cell associated and released virus yield were measured 
separately providing information on virus egress, the total yield gives an indication of 
overall virus fitness. Total virus yield in NS 1 siRNA treated cells was comparable to the 
control yield, indicating that viral fitness was not detectably affected by NS 1 
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knockdown and tubule absence. In BSR a NS 1 the knockdown of NS I gave a IO-fold 
increase in virus yield. Differences in methodologies and knockdown levels of NS 1 
between the two experiments may explain this difference. 
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7: Conclusion 
This thesis set out to identify cellular proteins from mammals and insects that interact 
with NSI and to investigate the role ofNS1 in BTV replication by its interactions with 
these cellular proteins and other BTV proteins. 
BTV NSI was identified as interacting with aldolase A, NUBPl, pyruvate kinase M2, 
cathespin B and peptide TY7 from mammalian cells and ubiquitin activating E I enzyme 
from insect cells. The interaction of NS I with SUMO-I was confirmed and the 
importance of SUMO-I in BTV infection was established. Knockdown of NS 1 in 
mammalian cell BTV infection indicated a possible role for NS I monomers/dimers in 
BTV infection as absence of NS 1 tubules did not result in a detectable change in virus 
replication and yield. 
Expression of peptide FLAGTY7 and NSI in 293T cells resulted in extensive cell death 
within 16 hours of plasmid transfection, which was not apoptosis. Proteomic analysis of 
FLAGTY7 detected a high level of hydrophobicity; no other features were identified. 
The virus yield of cells treated with FLAGTY7 INS 1 before infection with BTV -10 was 
63% of normal virus yield, a 3-fold reduction. The decrease in BTV yield is likely to be 
due to the rapid cell death and consequently less virus progeny are synthesised. It can be 
assumed that if no programmed response is occurring upon the co-expression of NS 1 
and FLAGTY7 from either plasmid or virus expressed NSl, the subsequent cell death 
may be caused by a toxic effect of the two proteins and not due to a specific effect on 
part of the BTV replication cycle or cellular response to infection. 
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Two main roles have been identified for NSI in virus replication; one involves the 
interaction of NS 1 with cellular proteins involved in control of protein expression and 
degradation. The other involves the interaction ofNSl, probably in free monomer/dimer 
form, with BTV core protein, VP7, and vimentin intermediate filaments of the cellular 
cytoskeleton. 
BTV NS 1 interacts with human SUMO-I. BTV -10 infection, but not NS 1 alone, was 
sufficient to induce SUMO-l expression in mammalian cells. When SUMO-l 
expression in BTV infected cells was knocked-down by specific siRNA, a dramatic 
reduction in virus yield was observed. Only 27% of the normal virus yield was detected. 
SUMO-l has diverse roles within the cell including regulation of transcription, 
chromatin structure, DNA repair and differential protein localisation. 
It is possible that the interaction of NSI with SUMO-l leads to a modulation of host 
response to BTV infection in one of two ways. NS 1 may be binding sumoylated 
transcription factors and retarding their translocation to the nucleus, thus NS 1 would be 
preventing induction of BTV induced gene expression in a way that was advantageous 
for the virus. It is more probable that NS 1, like many other viral proteins, forms part of 
an E3 ligation complex and is involved in the targeting of SUMO-l onto specific 
cellular targets. This would also allow modification and control of host responses to 
BTV infection creating a more advantageous environment for BTV replication. 
Knockdown of SUMO-l would prevent NS 1 targeting specific proteins for 
sumoylation, altering the expression levels of various cellular proteins, which may 
account for the significant reduction in virus yield. 
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NSI also putatively interacts with the ubiquitin activating EI enzyme of Culicoides. A 
Culicoides protein with homology to the Drosophila melanogaster E 1 protein was 
identified as interacting with BTV NS 1 in vitro. E 1 is one of three essential genes 
necessary for the activation of ubiquitin for ubiquitination of proteins in the cell cycle 
and degradation pathways. Many viruses interact with enzymes from the ubiquitin 
pathway to degrade cellular proteins that interfere with virus replication such as factors 
of the immune response or to affect the cell cycle in a way which is advantageous for 
virus replication. It is possible that NS 1 interacts with E 1 to target specific cellular 
factors for ubiquitination, thus effecting the degradation of cellular factors, again 
modulating the host response to BTV infection. 
Knockdown of NS 1 is variable between experiments due to apparent differences in 
transfection and knockdown levels; this system therefore requires further 
standardisation for continutaion of this work. Knockdown of NS I inhibits tubule 
formation with no apparent effect on virus replication, indicating that NS I in its 
monomeric or oligomeric form may interact with SUMO-l and ubiquitin activating E 1 
to modulate the host response to BTV infection. It is possible that NS 1 tubules are more 
important in BTV replication and transmission in vivo where these processes are more 
complex. 
The interaction of BTV NS 1 with proteins involved in the ubiquitin pathway and 
sumoylation pathway, and the interaction of BTV NS3 with Nedd4 like ubiquitin 
ligases, gives rise to a number of interesting possibilities for virus release and 
pathogenicity. It is possible that NS 1 and NS3 function synergistically, either 
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dependently or independently, to regulate virus replication and egress; NS 1 by its 
interactions with proteins that modulate host protein expression, targeting and 
degradation, and NS3 by its interaction with host proteins that effect budding of virus 
particles by targeting host proteins for ubiquitination. Furthermore, given the 
differences in the ratio ofNS1: NS3 between insect and mammalian cell infections, it is 
possible that more budding is seen during insect cell infection due to the relative 
balance of interactions with cellular proteins via NS I and NS3. 
BTV NSI interacts reproducibly with VP7 in vitro. In BSR (l NSI cells exhibiting 
knockdown levels of NS I and absence of NS 1 tubules, VP7 distribution is unchanged. 
Further more in the siRNA NS 1 studies inhibition of tubule formation did not detectably 
effect virus replication. This data suggests that the interaction of VP7 with NS 1 does not 
rely on tubule formation. Work by Eaton et al1988, supports this observation that NS 1 
and VP7 interaction may not involve tubules; anti-NSI labelled gold particles were 
detected on the surface of core particles when no tubules were visually detectable 
(Eaton, Hyatt et al. 1988). 
NS 1 interacts to some extent with vimentin intermediate filaments. When vimentin 
fibres were disrupted with acrylamide a change was detected in the distribution of NS 1 
which mirrors, but to a lesser extent, the change in vimentin distribution, indicating that 
not all NS 1 within the cell interacted with vimentin. Disruption of vimentin filaments 
did not significantly alter virus replication or release indicating that vimentin is not 
essential. It is possible that the change in distribution of vim en tin and subsequently VP2 
and some NSl, has some effect on virus assembly or trafficking along the cytoskeleton 
due to an altered cellular localisation that was not detectable. 
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NS 1 tubules are often found in close proximity to the cytoskeleton where both VP2 
(Bhattacharya, B and Roy, P; personal communication) and virus particles are located 
(Eaton, Hyatt et al. 1987) and in close proximity to vm where VP7 is located in high 
quantities (Eaton, Hyatt et al. 1988; Brookes, Hyatt et al. 1993). One hypothesis for the 
role of NS 1 in virus infection is that NS 1 helps core to accumulate near to VP2 since 
NS1 is associated with intermediate filaments. It is possible that NS1 either as tubules 
or monomers/oligomers transports virus cores, from the vm where they assemble, to 
the cytoskeleton where VP2 is located thus helping in virus maturation and subsequent 
egress. It is also possible that NS 1 serves merely as an anchor for virus cores allowing 
the build up of cores in close proximity to VP2 before subsequent maturation and 
egress. 
Down regulation of BTV NS 1 in mammalian cell infection has no apparent effect on 
virus replication in vitro. Down regulation of SUMO-1 leads to a huge reduction in 
virus yield in vitro. Absence of NS 1 tubules, but presence of NS 1 monomer/oligomer, 
does not lead to a change in VP7 or SUMO-l distribution and expression, therefore it is 
probable that the function of NS 1 does not rely on the formation of tubules and that 
NS1 tubules are a form of storage for the active monomer/dimer form ofNSl. NS1 may 
be more essential during BTV infection in vivo where transmission and propagation are 
more complex. 
This project has generated some interesting data much of which is incomplete and 
requires further studying. The most promising aspects of this work involve NS 1 
interactions with host cell environment regulators, SUMO-1 and possibly UBA-I. More 
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work is required into this area to confion the interaction of NSI and UBA-I and to 
identify the mechanisms and outcomes of these interactions. Also further analysis of the 
involvement of NS3 with a similar set of proteins including TSGlOl and Nedd4, in 
addition to the role of NSI with SUMO-I and UBA-I may help to identify 
cumulative/antagonistic affects of these two non-structural proteins in BTY infection. 
The interaction of NS 1 with pFLAGTY7 produces an extremely interesting effect 
during BTY -10 infection. Further study in this area may elucidate how the addition of a 
peptide with no defining characteristics has such a large impact on cellular health when 
expressed in conjunction with NS 1. However it is unlikely that this interaction occurs 
during BTY-I0 infection since peptide FLAGTY7 is not a naturally expressed protein 
and is therefore unlikely to be studied further. It is also unlikely that the interactions of 
Aldolase A and NUBPI with NSI will be studied further due to a lack of literature 
suggesting their possible importance, it is not clear why NS I would interact with these 
two proteins and it is possible that they are yeast two-hybrid artefacts rather than true 
positives. 
187 
References 
Alaoui-Ismaili, M. H. and C. D. Richardson (1996). "Identification and characterization 
of a filament-associated protein encoded by Amsacta moorei entomopoxvirus." 1 
Virol 70(5): 2697-705. 
Aminev, A. G., S. P. Amineva, et al. (2003). "Encephalomyocarditis viral protein 2A 
localizes to nucleoli and inhibits cap-dependent mRNA translation." Virus Res 
95(1-2): 45-57. 
Aminev, A. G., S. P. Amineva, et al. (2003). "Encephalomyocarditis virus (EMCV) 
proteins 2A and 3BCD localize to nuclei and inhibit cellular mRNA 
transcription but not rRNA transcription." Virus Res 95(1-2): 59-73. 
Arcangeletti, M. C., F. Pinardi, et al. (1997). "Modification of cytoskeleton and 
prosome networks in relation to protein synthesis in influenza A virus-infected 
LLC-MK2 cells." Virus Res 51(1): 19-34. 
Attoui, H., F. Mohd Jaafar, et al. (2005). "Expansion of family Reoviridae to include 
nine-segmented dsRNA viruses: Isolation and characterization of a new virus 
designated aedes pseudoscutellaris reovirus assigned to a proposed genus 
(Dinovernavirus)." Virology 343(2): 212-23. 
Baker, T. S., N. H. Olson, et al. (1999). "Adding the third dimension to virus life cycles: 
three-dimensional reconstruction of icosahedral viruses from cryo-electron 
micrographs." Microbiol Mol BioI Rev 63(4): 862-922, table of contents. 
188 
Banerjee, R., M. K. Weidman, et al. (2005). "Modifications of both selectivity factor 
and upstream binding factor contribute to poliovirus-mediated inhibition of 
RNA polymerase I transcription." J Gen Virol 86(Pt 8): 2315-22. 
Bearer, E. L. and P. Satpute-Krishnan (2002). "The role of the cytoskeleton in the life 
cycle of viruses and intracellular bacteria: tracks, motors, and polymerization 
machines." Curr Drug Targets Infect Disord 2(3): 247-64. 
Beaton, A. R., J. Rodriguez, et al. (2002). "The membrane trafficking protein calpactin 
forms a complex with bluetongue virus protein NS3 and mediates virus release." 
Proc Nat! Acad Sci USA 99(20): 13154-9. 
Boutell, C., M. Canning, et al. (2005). "Reciprocal activities between herpes simplex 
virus type 1 regulatory protein ICPO, a ubiquitin E3 ligase, and ubiquitin-
specific protease USP7." J Viral 79(19): 12342-54. 
Bowman, V. D., E. S. Chase, et al. (2002). "An antibody to the putative aphid 
recognition site on cucumber mosaic virus recognizes pentons but not hexons." I 
Viral 76(23): 12250-8. 
Boyce, M., J. Wehrfritz, et al. (2004). "Purified Recombinant Bluetongue Virus VPl 
Exhibits RNA Replicase Activity. " J Viral In Press. 
Brookes, S. M., A. D. Hyatt, et al. (1993). "Characterization of virus inclusion bodies in 
bluetongue virus-infected cells." J Gen Virol74 (Pt 3): 525-30. 
Brussaard, C. P., A. A. Noordeloos, et al. (2004). "Discovery of a dsRNA virus 
infecting the marine photosynthetic protist Micromonas pusilla." Virology 
319(2): 280-91. 
189 
Caton, A. J. and J. S. Robertson (1980). "Structure of the host-derived sequences 
present at the 5' ends of influenza virus mRNA." Nucleic Acids Res 8(12): 2591-
603. 
Chang, L. K., Y. H. Lee, et al. (2004). "Post-translational modification of Rta of 
Epstein-Barr virus by SUMO-I." J BioI Chern 279(37): 38803-12. 
Chare, E. R. and E. C. Holmes (2004). "Selection pressures in the capsid genes of plant 
RNA viruses reflect mode of transmission." J Gen Virol 85(Pt 10): 3149-57. 
Chiou, C. T., C. C. Hu, et al. (2003). "Association of Japanese encephalitis virus NS3 
protein with microtubules and tumour susceptibility gene 101 (TSGIOl) 
protein." J Gen Virol84(Pt 10): 2795-805. 
Choe, S. S., D. A. Dodd, et al. (2005). "Inhibition of cellular protein secretion by 
picomaviral3A proteins." Virology 337(1): 18-29. 
Cordo, S. M. and N. A. Candurra (2003). "Intermediate filament integrity is required for 
Junin virus replication." Virus Res 97(1): 47-55. 
Dhar, R., R. M. Chanock, et al. (1980). "Nonviral oligonucleotides at the 5' terminus of 
cytoplasmic influenza viral mRNA deduced from cloned complete genomic 
sequences." Cell 21(2): 495-500. 
Diamond, M. S. (2003). "Evasion of innate and adaptive immunity by flaviviruses." 
Immunol Cell Bioi 81(3): 196-206. 
DiPerna, G., J. Stack, et al. (2004). "Poxvirus protein NIL targets the I-kappaB kinase 
complex, inhibits signaling to NF -kappaB by the tumor necrosis factor 
190 
superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-
like receptors." J BioI Chern 279(35): 36570-8. 
Eaton, B. T., A. D. Hyatt, et al. (1987). "Association of bluetongue virus with the 
cytoskeleton." Virology 157(1): 107-16. 
Eaton, B. T., A. D. Hyatt, et al. (1988). "Localization of the nonstructural protein NS I 
in bluetongue virus-infected cells and its presence in virus particles." Virology 
163(2): 527-37. 
Eichwald, V., L. Daeffler, et al. (2002). "The NS2 proteins of parvovirus minute virus 
of mice are required for efficient nuclear egress of progeny virions in mouse 
cells." J Virol 76(20): 10307-19. 
Espagne, E., V. Douris, et al. (2005). "A virus essential for insect host-parasite 
interactions encodes cystatins." J Virol 79( 15): 9765-76. 
Fauquet, C. (2005). Virus taxonomy: classification and nomenclature of viruses : eighth 
report of the International Committee on the Taxonomy of Viruses. San Diego, 
Calif. ; London, Elsevier Academic Press. 
Fillmore, G. C., H. Lin, et al. (2002). "Localization of the single-stranded RNA-binding 
domains of bluetongue virus nonstructural protein NS2." J Virol 76(2): 499-506. 
Fontoura, B. M., P. A. Faria, et al. (2005). "Viral interactions with the nuclear transport 
machinery: discovering and disrupting pathways." IUBMB Life 57(2): 65-72. 
Forzan, M., C. Wirblich, et al. (2004). "A Capsid Protein of Nonenveloped Bluetongue 
Virus exhibits Membrane Fusion Activity." Peoc Nat! Acad Sci USA 101(7): 
2100-2105. 
191 
French, T. J., S. Inumaru, et al. (1989). "Expression of two related nonstructural 
proteins of bluetongue virus (BTV) type 10 in insect cells by a recombinant 
baculovirus: production of polyclonal ascitic fluid and characterization of the 
gene product in BTV -infected BHK cells." J Virol 63(8): 3270-8. 
Garrus, J. E., U. K. von Schwedler, et al. (2001). "TsgI01 and the vacuolar protein 
sorting pathway are essential for HIV-l budding." Cell 107(1): 55-65. 
Ghosh, M. K., M. V. Borca, et al. (2002). "Virus-derived tubular structure displaying 
foreign sequences on the surface elicit CD4+ Th cell and protective humoral 
responses." Virology 302(2): 383-92. 
Ghosh, M. K., E. Deriaud, et al. (2002). "Induction of protective antiviral cytotoxic T 
cells by a tubular structure capable of carrying large foreign sequences." 
Vaccine 20(9-10): 1369-77. 
Goff, S. P. (2004). "Genetic reprogramming by retroviruses: enhanced suppression of 
translational tennination." Cell Cycle 3(2): 123-5. 
Gorlich, D. and I. W. Mattaj (1996). "Nucleocytoplasmic transport." Science 271(5255): 
1513-8. 
Gouet, P., J. M. Diprose, et al. (1999). "The highly ordered double-stranded RNA 
genome of bluetongue virus revealed by crystallography." Ce1197(4): 481-90. 
Granzow, H., C. Birghan, et al. (1997). "A second fonn of infectious bursal disease 
virus-associated tubule contains VP4." J Virol 71(11): 8879-85. 
Gray, S. and F. E. Gildow (2003). "Luteovirus-aphid interactions." Annu Rev 
Phytopathol41: 539-66. 
192 
Gray, S. M. and N. Banerjee (1999). "Mechanisms of arthropod transmission of plant 
and animal viruses." Microbiol Mol BioI Rev 63(1): 128-48. 
Grimes, J. M., J. N. Burroughs, et al. (1998). "The atomic structure of the bluetongue 
virus core." Nature 395(6701): 470-8. 
Grimes, J. M., J. Jakana, et al. (1997). "An atomic model of the outer layer of the 
bluetongue virus core derived from X-ray crystallography and electron 
cryomicroscopy." Structure 5(7): 885-93. 
Guha, S., T. K. Manna, et al. (1998). "Chaperone-like activity oftubulin." J Bioi Chern 
273(46): 30077-80. 
Guirakhoo, F., J. A. Catalan, et al. (1995). "Adaptation of bluetongue virus in mosquito 
cells results in overexpression of NS3 proteins and release of virus particles." 
Arch Viro1140(5): 967-74. 
Hassan, S. H., C. Wirblich, et al. (2001). "Expression and functional characterization of 
bluetongue virus VP5 protein: role in cellular permeabilization." J Virol 75(18): 
8356-67. 
Hassan, S. S. and P. Roy (1999). "Expression and functional characterization of 
bluetongue virus VP2 protein: role in cell entry." J Virol 73( 12): 9832-42. 
He, Y., S. L. Tan, et al. (2001). "Regulation ofmRNA translation and cellular signaling 
by hepatitis C virus nonstructural protein NS5A." J Virol 75( 11): 5090-8. 
Heath, C. M., M. Windsor, et al. (2001). "Aggresomes resemble sites specialized for 
virus assembly." J Cell Bioi 153(3): 449-55. 
193 
Hengel, H., U. H. Koszinowski, et al. (2005). "Viruses know it all: new insights into 
IFN networks." Trends ImmunoI26(7): 396-401. 
Hernandez, R., D. Ferreira, et al. (2005). "Single amino acid insertions at the junction of 
the sindbis virus E2 transmembrane domain and endodomain disrupt virus 
envelopment and alter infectivity." J Virol 79(12): 7682-97. 
Hewat, E. A., T. F. Booth, et al. (1992). "Structure of bluetongue virus particles by 
cryoelectron microscopy." J Struct Bioi 109(1): 61-9. 
Hewat, E. A., T. F. Booth, et al. (1992). "3-D reconstruction of bluetongue virus tubules 
using cryoelectron microscopy." J Struct Bioi 108(1): 35-48. 
Hill, C. L., T. F. Booth, et al. (1999). "The structure of a cypovirus and the functional 
organization of dsRNA viruses." Nat Struct Bioi 6(6): 565-8. 
Ho, L. J., L. F. Hung, et al. (2005). "Dengue virus type 2 antagonizes IFN-alpha but not 
IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the 
human dendritic cell." J ImmunoI174(12): 8163-72. 
Huang, Z., V. M. Andrianov, et al. (2001). "Identification of arabidopsis proteins that 
interact with the cauliflower mosaic virus (CaMV) movement protein." Plant 
Mol Bioi 47(5): 663-75. 
Huang, Z., Y. Han, et al. (2000). "Formation of surface tubules and fluorescent foci in 
Arabidopsis thaliana protoplasts expressing a fusion between the green 
fluorescent protein and the cauliflower mosaic virus movement protein." 
Virology 271(1): 58-64. 
194 
Huismans, H. (1979). "Protein synthesis in bluetongue virus-infected cells." Virology 
92(2): 385-96. 
Hyatt, A. D. and B. T. Eaton (1988). "Ultrastructural distribution of the major capsid 
proteins within bluetongue virus and infected cells." J Gen Virol 69 ( Pt 4): 805-
15. 
Hyatt, A. D., B. T. Eaton, et al. (1987). "The grid-cell-culture technique: the direct 
examination of virus-infected cells and progeny viruses." J Microsc 145 ( Pt 1): 
97-106. 
Hyatt, A. D., Y. Zhao, et al. (1993). "Release of bluetongue virus-like particles from 
insect cells is mediated by BTV nonstructural protein NS3INS3A." Virology 
193(2): 592-603. 
Izumiya, Y., T. J. Ellison, et al. (2005). "Kaposi's sarcoma-associated herpesvirus K-
bZIP represses gene transcription via SUMO modification." J Virol 79(15): 
9912-25. 
Jennings, D. M. and P. S. Mellor (1987). "Variation in the responses of Culicoides 
variipennis (Diptera, Ceratopogonidae) to oral infection with bluetongue virus." 
Arch ViroI95(3-4): 177-82. 
Kar, A. K., N. Iwatani, et al. (2005). "Assembly and intracellular localization of the 
bluetongue virus core protein VP3." J Virol 79(17): 11487-95. 
Kar, A. K. and P. Roy (2003). "Defining the structure-function relationships of 
bluetongue virus helicase protein VP6." J Virol 77(21): 11347-56. 
195 
Kibenge, F. S., B. Qian, et al. (1997). "Infectious bursal disease virus polyprotein 
processing does not involve cellular proteases." Arch ViroI142(12): 2401-19. 
Kikonyogo, A., F. Bouamr, et al. (2001). "Proteins related to the Nedd4 family of 
ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and 
are required for gag budding from cells." Proc Natl Acad Sci USA 98(20): 
11199-204. 
Kobayashi, K., S. Tsuge, et al. (2002). "The cauliflower mosaic virus virion-associated 
protein is dispensable for viral replication in single cells." J Virol 76(18): 9457-
64. 
Kuyumcu-Martinez, N. M., M. E. Van Eden, et al. (2004). "Cleavage of poly(A)-
binding protein by poliovirus 3C protease inhibits host cell translation: a novel 
mechanism for host translation shutoff." Mol Cell Bioi 24(4): 1779-90. 
Larke, N., A. Murphy, et al. (2005). "Induction of human immunodeficiency virus type 
I-specific T cells by a bluetongue virus tubule-vectored vaccine prime-
recombinant modified virus Ankara boost regimen." J Virol 79(23): 14822-33. 
Lazarowitz, S. G. and R. N. Beachy (1999). "Viral movement proteins as probes for 
intracellular and intercellular trafficking in plants." Plant Cell 11(4): 535-48. 
Lee, B. H., K. Yoshimatsu, et al. (2003). "Association of the nucleocapsid protein of the 
Seoul and Hantaan hantaviruses with small ubiquitin-like modifier-I-related 
molecules." Virus Res 98(1): 83-91. 
Lee, J. W. and P. Roy (1986). "Nucleotide sequence ofa cDNA clone of RNA segment 
10 of bluetongue virus (serotype 10)." J Gen Virol67 (Pt 12): 2833-7. 
196 
Leh, V., E. Jacquot, et al. (2001). "Interaction between the open reading frame III 
product and the coat protein is required for transmission of cauliflower mosaic 
virus by aphids." J Virol 75(1): 100-6. 
Lejal, N., B. Da Costa, et al. (2000). "Role of Ser-652 and Lys-692 in the protease 
activity of infectious bursal disease virus VP4 and identification of its substrate 
cleavage sites." J Gen Virol81(Pt 4): 983-92. 
Lepault, J., I. Petitpas, et al. (2001). "Structural polymorphism of the major capsid 
protein of rota virus." Embo J 20(7): 1498-507. 
Lewandowski, D. J. and S. Adkins (2005). "The tubule-forming NSm protein from 
Tomato spotted wilt virus complements cell-to-cell and long-distance movement 
of Tobacco mosaic virus hybrids." Virology 342(1): 26-37. 
Li, Y., Y. M. Bao, et al. (2004). "Rice dwarf phytoreovirus segment S6-encoded 
nonstructural protein has a cell-to-cell movement function." J Virol 78(10): 
5382-9. 
Lin, R. J., C. L. Liao, et al. (2004). "Blocking of the alpha interferon-induced Jak-Stat 
signaling pathway by Japanese encephalitis virus infection." J Virol 78(17): 
9285-94. 
Ludwig, G. V., 1. P. Kondig, et al. (1996). "A putative receptor for Venezuelan equine 
encephalitis virus from mosquito cells." J Virol 70(8): 5592-9. 
Lyles, D. S. (2000). "Cytopathogenesis and inhibition of host gene expression by RNA 
viruses." Microbiol Mol Bioi Rev 64(4): 709-24. 
197 
Lymperopoulos, K., C. Wirblich, et al. (2003). "Sequence specificity in the interaction 
of Bluetongue virus non-structural protein 2 (NS2) with viral RNA." J BioI 
Chern 278(34): 31722-30. 
Maeda, A., B. H. Lee, et al. (2003). "The intracellular association of the nucleocapsid 
protein (NP) of hantaan virus (HTNV) with small ubiquitin-like modifier-l 
(SUMO-I) conjugating enzyme 9 (Ubc9)." Virology 305(2): 288-97. 
Manna, T., T. Sarkar, et al. (2001). "Chaperone-like activity of tubulin. binding and 
reactivation of unfolded substrate enzymes." J BioI Chern 276(43): 39742-7. 
Martin-Serrano, J., T. Zang, et al. (2001). "HIV-l and Ebola virus encode small peptide 
motifs that recruit TsgIOl to sites of particle assembly to facilitate egress." Nat 
Med 7(12): 1313-9. 
Martinez-Costas, J., G. Sutton, et al. (1998). "Guanylyltransferase and RNA 5'-
triphosphatase activities of the purified expressed VP4 protein of bluetongue 
virus." J Mol BioI 280(5): 859-66. 
Mikhailov, M., K. Monastyrskaya, et al. (1996). "A new form of particulate single and 
multiple immunogen delivery system based on recombinant bluetongue virus-
derived tubules." Virology 217(1): 323-31. 
Miller, C. L. and D. J. Pintel (2002). "Interaction between parvovirus NS2 protein and 
nuclear export factor Crm1 is important for viral egress from the nucleus of 
murine cells." J Virol 76(7): 3257-66. 
Mishra, R. K., S. S. Jatiani, et al. (2004). "Dynamin interacts with members of the 
sumoylation machinery." J BioI Chern 279(30): 31445-54. 
198 
Monastyrskaya. K., T. Booth, et al. (1994). "Mutation of either of two cysteine residues 
or deletion of the amino or carboxy terminus of nonstructural protein NS 1 of 
bluetongue virus abrogates virus-specified tubule formation in insect cells." J 
ViroI68(4): 2169-78. 
Monastyrskaya, K., E. A. Gould, et al. (1995). "Characterization and modification of the 
carboxy-terminal sequences of bluetongue virus type IONS 1 protein in relation 
to tubule formation and location of an antigenic epitope in the vicinity of the 
carboxy terminus of the protein." J ViroI69(5): 2831-41. 
Mortola, E., R. Noad, et al. (2004). "Bluetongue Virus Outer Capsid proteins are 
Suffcient to Trigger Apoptosis in Mammalian Cells." J Virol 78(6): 2875-2883. 
Munoz-Jordan, J. L., G. G. Sanchez-Burgos, et al. (2003). "Inhibition of interferon 
signaling by dengue virus." Proc Natl Acad Sci USA 100(24): 14333-8. 
Munoz, M. L., A. Cisneros, et al. (1998). "Putative dengue virus receptors from 
mosquito cells." FEMS Microbiol Lett 168(2): 251-8. 
Nakata, T., K. Sobue, et al. (1990). "Conformational change and localization of 
calpactin I complex involved in exocytosis as revealed by quick-freeze, deep-
etch electron microscopy and immunocytochemistry." J Cell BioI 110(1): 13-25. 
Nason, E. L., R. Rothagel, et al. (2004). "Interactions between the inner and outer 
capsids of bluetongue virus." J Virol 78(15): 8059-67. 
Noah, D. L., K. Y. Twu, et al. (2003). "Cellular antiviral responses against influenza A 
virus are countered at the posttranscriptionallevel by the viral NSIA protein via 
199 
its binding to a cellular protein required for the 3' end processing of cellular pre-
mRNAS." Virology 307(2): 386-95. 
Ono, A. and E. O. Freed (2004). "Cell-type-dependent targeting of human 
immunodeficiency virus type 1 assembly to the plasma membrane and the 
multi vesicular body." J Virol 78(3): 1552-63. 
Owens, R., C. Limn, et al. (2004). "Role of an Arboviral Nonstructural Protein in 
Cellular Pathogenesis and Virus Release." J Virol In Press. 
Palacios, I., M. Drucker, et al. (2002). "Cauliflower mosaic virus is preferentially 
acquired from the phloem by its aphid vectors." J Gen Virol 83(Pt 12): 3163-71. 
Palukaitis, P., M. J. Roossinck, et al. (1992). "Cucumber mosaic virus." Adv Virus Res 
41: 281-348. 
Patmanidi, A. L., R. D. Possee, et al. (2003). "Formation of PlO tubular structures 
during AcMNPV infection depends on the integrity of host-cell microtubules." 
Virology 317(2): 308-20. 
Perbal, M. c., C. L. Thomas, et al. (1993). "Cauliflower mosaic virus gene I product 
(P 1) forms tubular structures which extend from the surface of infected 
protoplasts." Virology 195(1): 281-5. 
Pomillos, 0., J. E. Garms, et al. (2002). "Mechanisms of enveloped RNA VIruS 
budding." Trends Cell BioI 12(12): 569-79. 
Prasad, B. V., R. Rotbnagel, et al. (1996). "Visualization of ordered genomic RNA and 
localization of transcriptional complexes in rotavirus." Nature 382(6590): 471-3. 
200 
Precious, 8., K. Childs, et al. (2005). "Simian virus 5 V protein acts as an adaptor, 
linking DOBI to STAT2, to facilitate the ubiquitination of STATl." J Virol 
79(21): 13434-41. 
Precious, 8., D. F. Young, et al. (2005). "In vitro and in vivo specificity of 
ubiquitination and degradation of ST A T1 and ST AT2 by the V proteins of the 
paramyxoviruses simian virus 5 and human parainfluenza virus type 2." J Gen 
Virol86(Pt 1): 151-8. 
Protopopova, E. V., A. D. Khusainova, et al. (1996). "[Preparation and study of 
properties of anti-idiotypic antibodies, carrying hemagglutinating paratopes of 
tick-borne encephalitis virus on their surface]." Vopr VirusoI41(2): 50-3. 
Purse, 8. V., P. S. Mellor, et al. (2005). "Climate change and the recent emergence of 
bluetongue in Europe." Nat Rev MicrobioI3(2): 171-81. 
Quant-Russell, R. L., M. N. Pearson, et al. (1987). "Characterization ofbaculovirus plO 
synthesis using monoclonal antibodies." Virology 160(1): 9-19. 
Raiborg, C., T. E. Rusten, et al. (2003). "Protein sorting into multi vesicular 
endosomes." Curr Opin Cell Bioi 15(4): 446-55. 
Ramadevi, N., N. J. Burroughs, et al. (1998). "Capping and methylation of mRNA by 
purified recombinant VP4 protein of bluetongue virus." Proc Natl Acad Sci US 
A 95(23): 13537-42. 
Ramadevi, N. and P. Roy (1998). "Bluetongue virus core protein VP4 has nucleoside 
triphosphate phosphohydro1ase activity." J Gen Virol79 (Pt 10): 2475-80. 
201 
Reyes-del Valle, J. and R. M. del Angel (2004). "Isolation of putative dengue virus 
receptor molecules by affinity chromatography using a recombinant E protein 
ligand." J Virol Methods 116(1): 95-102. 
Risco, c., J. R. Rodriguez, et al. (2002). "Endoplasmic reticulum-Golgi intermediate 
compartment membranes and vimentin filaments participate in vaccinia virus 
assembly." J Viral 76(4): 1839-55. 
Rodriguez-Lecompte, J. c., R. Nino-Fang, et al. (2005). "Infectious bursal disease virus 
(IBDV) induces apoptosis in chicken B cells." Comp Immunol Microbiol Infect 
Dis 28(4): 321-37. 
Roy, P. (2005). "Bluetongue virus proteins and particles and their role in virus entry, 
assembly, and release." Adv Virus Res 64: 69-123. 
Roy, P. and B. M. Gorman (1990). Bluetongue virus. Berlin; London, Springer-Verlag. 
Sager, P. R. (1989). "Cytoskeletal effects of acrylamide and 2,5-hexanedione: selective 
aggregation of vim en tin filaments." Toxicol Appl PharmacoI97(1): 141-55. 
Salas-Benito, J. S. and R. M. del Angel (1997). "Identification of two surface proteins 
from C6/36 cells that bind dengue type 4 virus." J Virol 71(10): 7246-52. 
Stauber, N., J. Martinez-Costas, et al. (1997). "Bluetongue virus VP6 protein binds ATP 
and exhibits an RNA-dependent ATPase function and a helicase activity that 
catalyze the unwinding of double-stranded RNA substrates." J Virol 71(10): 
7220-6. 
202 
Stavolone, L., M. E. Villani, et al. (2005). "A coiled-coil interaction mediates 
cauliflower mosaic virus cell-to-cell movement." Proc Natl Acad Sci USA 
102(17): 6219-24. 
Stefanovic, S., M. Windsor, et al. (2005). "Vimentin rearrangement during African 
swine fever virus infection involves retrograde transport along microtubules and 
phosphorylation of vimentin by calcium calmodulin kinase II." J Virol 79(18): 
11766-75. 
Szczepanowski, R. R., R. Filipek, et at. (2005). "Crystal structure of a fragment of 
mouse ubiquitin-activating enzyme." J BioI Chern 280(23): 22006-11. 
Thepparit, C. and D. R. Smith (2004). "Serotype-specific entry of dengue virus into 
liver cells: identification of the 37-kilodaltonl67-kilodalton high-affinity laminin 
receptor as a dengue virus serotype 1 receptor." J Virol 78(22): 12647-56. 
Thomas, C. P., T. F. Booth, et al. (1990). "Synthesis of bluetongue virus-encoded 
phosphoprotein and formation of inclusion bodies by recombinant baculovirus in 
insect cells: it binds the single-stranded RNA species." J Gen Virol 71 ( Pt 9): 
2073-83. 
Ulmanen, I., B. A. Broni, et al. (1981). "Role of two of the influenza virus core P 
proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating 
viral RNA transcription." Proc Nat! Acad Sci USA 78(12): 7355-9. 
Urakawa, T., D. G. Ritter, et aI. (1989). "Expression of largest RNA segment and 
synthesis of VPl protein of bluetongue virus in insect cells by recombinant 
baculovirus: association ofVPl protein with RNA polymerase activity." Nucleic 
Acids Res 17(18): 7395-401. 
203 
Urakawa, T. and P. Roy (1988). "Bluetongue virus tubules made in insect cells by 
recombinant baculoviruses: expression of the NS 1 gene of bluetongue virus 
serotype 10." J Virol 62(11): 3919-27. 
van den Heuvel, J. F., S. A. Hogenhout, et al. (1999). "Recognition and receptors in 
virus transmission by arthropods." Trends Microbiol 7(2): 71-6. 
Van Oers, M. M., J. T. Flipsen, et al. (1994). "Specificity ofbaculovirus plO functions." 
Virology 200(2): 513-23. 
Van Regenmortel, M. H. V. (2000). Virus taxonomy: classification and nomenclature 
of viruses : seventh report of the International Committee on Taxonomy of 
Viruses. San Diego, Calif. ; London, Academic. 
Wang, K. S., R. J. Kuhn, et al. (1992). "High-affinity laminin receptor is a receptor for 
Sindbis virus in mammalian cells." J Virol 66(8): 4992-5001. 
Wang, X, M. Li, et al. (2000). "Influenza A virus NSI protein prevents activation of 
NF-kappaB and induction ofalpha/beta interferon." J Virol 74(24): 11566-73. 
Whetter, L. E., D. H. Gebhard, et al. (1990). "Temporal appearance of structural and 
nonstructural bluetongue viral proteins in infected cells, as determined by 
immunofluorescence staining and flow cytometry." Am J Vet Res 51(8): 1174-9. 
Williams, G. V., D. Z. Rohel, et al. (1989). "A cytopathological investigation of 
Autographa califomica nuclear polyhedrosis virus pI 0 gene function using 
insertion/deletion mutants." J Gen Virol 70 (Pt 1): 187-202. 
204 
Wirblich, C., B. Bhattacharya, et al. (2006). "Nonstructural Protein 3 of Bluetongue 
Virus Assists Virus Release by Recruiting ESCRT-I Protein Tsg101." I Viml 
80(1): 460-73. 
Ye, Y., Y. Shibata, et al. (2005). "Inaugural Article: Recruitment of the p97 ATPase and 
ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum 
membrane." Proc Natl Acad Sci USA 102(40): 14132-8. 
Young, M. 1. and S. A. Filichkin (1999). "Luteovirus interactions with aphid vector 
cellular components." Trends Microbiol 7(9): 346-7. 
Zhao, Y., C. Thomas, et al. (1994). "Deletion and mutational analyses of bluetongue 
virus NS2 protein indicate that the amino but not the carboxy terminus of the 
protein is critical for RNA-protein interactions." J Virol 68(4): 2179-85. 
205 
